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                      Abstract 
ABSTRACT 
 
 
The use of yeasts as vehicle for protein antigens has been demonstrated to be a highly 
effective vaccination approach. In part, this can be attributed to the intrinsic adjuvant 
properties of yeast cell wall components. Moreover, the correct processing of 
recombinantly expressed proteins and the safety status of many yeast genera has 
encouraged the onset of preclinical and clinical trials using yeast vectors. However, the 
vast majority of such studies focused the attention on yeasts of the genus 
Saccharomyces as candidate T cell vaccine. In this work, different yeast genera were 
evaluated as potential antigen carrier in view of the development of novel yeast-based 
vaccines. For this purpose, yeasts were initially assessed for their ability to induce 
maturation and activation of human dendritic cells. Next, the internalization profile of 
selected yeasts by mammalian phagocytes was analyzed, as well as the involvement of 
pattern recognition receptors in the uptake process. Subsequently, yeasts engineered to 
express foreign proteins were assessed for their antigen delivery capacity. In vitro 
antigen presentation and ex vivo whole blood assays showed that recombinant yeast 
genera differently activate antigen-specific T cells. Furthermore, antigen localization 
played a decisive role in T cell activation. The data presented here strongly support the 
potential of recombinant yeast in the development of novel vaccine strategies in order to 
induce antigen-specific T cell responses. 
 
 
Der Einsatz von Hefen als Vehikel für Proteinantigene stellt eine vielversprechende 
Vakzinierungsstrategie dar, was u.a. auf adjuvante Eigenschaften der Hefe-
Zellwandkomponenten zurückzuführen ist. Weiterhin haben der Nachweis der korrekten 
Prozessierung rekombinanter Proteine und der unbedenkliche Status vieler 
Hefegattungen ihren Einsatz in präklinischen und klinischen Studien gefördert. Bislang 
hat sich die Mehrzahl dieser Studien auf Hefen der Gattung Saccharomyces als 
Vakzinkandidaten für zellvermittelte Immunantworten konzentriert. Im Rahmen dieser 
Arbeit wurden verschiedene Hefegattungen als potentielle Antigenvehikel zur 
Etablierung neuartiger Hefe-basierter Vakzinen untersucht. Zunächst wurden 
Ausreifung und Aktivierung von Dendritischen Zellen durch diverse Hefegattungen 
analysiert. Danach wurden sowohl die Aufnahme bestimmter Hefegattungen durch 
Säuger-Phagozyten als auch die Beteiligung spezifischer Rezeptoren in diesem Prozess 
untersucht. Anschließend wurde die Fähigkeit rekombinanter Hefen zum Antigen 
„Delivery“ evaluiert. Durch in vitro Antigenpräsentation und ex vivo Vollblut-Assays 
konnte gezeigt werden, dass verschiedene Hefegattungen Antigen-spezifische T-Zellen 
unterschiedlich aktivieren. Des Weiteren spielt die Antigenlokalisierung eine wichtige 
Rolle bei der T-Zellaktivierung. Die vorliegenden Ergebnisse unterstreichen das 
Potenzial rekombinanter Hefen bei der Entwicklung neuartiger Impfstrategien zur 
Induktion Antigen-spezifischer T-Zell-Immunantworten. 
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I. INTRODUCTION 
 
 
1. The immune system – a short overview 
The immune system consists of a set of molecules, cells, tissues, and organs that work 
together to provide protection against foreign organisms. The initial phases of the host 
defense against infection depend on the mechanisms of innate immunity. It comprises 
epithelial barriers, phagocytic cells (dendritic cells (DCs), macrophages), soluble 
factors, such as complement proteins, granulocytes (basophils, eosinophils and 
neutrophils), mast cells, natural killer cells, and cytokines that coordinate the functions 
of the cells of the innate immunity. The innate immunity is always present in all 
individuals, reacts rapidly and equally to repeated infections (without developing an 
immunologic memory with repeated exposure to a given pathogen), and is able to 
distinguish between a group of related pathogens. Adaptive immunity is a response to 
antigen mediated by CD4+ and CD8+ T lymphocytes and B lymphocytes. Adaptive 
immune responses develop more slowly and are characterized by specificity for distinct 
molecules and development of immunological memory, which is the capability of 
responding more vigorously to repeated exposure to the same antigen (Janeway et al., 
2001; Abbas et al., 2007). 
Adaptive immunity can be divided into humoral and cell-mediated immune 
responses, which have different mediators and functions. In the humoral immunity, 
antibodies produced by B lymphocytes recognize microbial antigens and contribute to 
immunity in three main mechanisms: (i) neutralization, i.e. preventing pathogens from 
entering cells; (ii) opsonization, in which antibodies coat the pathogen surface 
promoting particle phagocytosis via recognition of a portion of the antibody (Fc) by a 
Fc receptor in the phagocytic cell; and (iii) complement activation, which results in 
binding of complement proteins to the microbe, promoting either enhanced 
opsonization, recruitment of phagocytes to the site of infection, or microbe lysis via 
pore formation. Cell-mediated immunity involves the action of T lymphocytes, which 
induce destruction of pathogens residing in phagocytic cells or killing of infected cells. 
T lymphocytes comprise functionally different subpopulations such as helper T cells, 
cytotoxic T lymphocytes (CTLs) and regulatory T cells. Helper T cells, upon antigenic 
stimulation, produce cytokines that promote the proliferation and differentiation of T 
cells and activate, among other cell types, macrophages and B lymphocytes. CTLs kill 
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cells displaying foreign antigens, such as cells infected with virus or intracellular 
pathogens. Regulatory T cells are mainly involved in inhibiting immune responses 
(Janeway et al., 2001; Abbas et al., 2007). 
Protective immunity against a specific pathogen can be elicited upon exposure to 
the microbe, in a process called active immunization, or by transferring serum or 
lymphocytes from an immunized host without any contact of the recipient with the 
antigen, a process named passive immunization (Abbas et al., 2007). 
 
 
1.1. Antigen recognition and presentation to T lymphocytes 
Antigen-presenting cells 
Antigen-presenting cells (APCs) are specialized elements which take up and display 
antigens to T cells. DCs, macrophages and B cells are called professional APCs, since 
they express MHC molecules and co-stimulators. However, DCs are considered the 
most effective APCs as they are the only cell type which can stimulate naïve T cells 
and, consequently, initiate T cell responses (Abbas et al., 2007). 
DCs comprise a heterogeneous cell population derived from bone marrow 
precursors and are widely distributed, in an immature state, into lymphoid and 
nonlymphoid tissues. In peripheral tissues, immature DCs sense and capture microbes 
and other antigens. After engagement of antigens with receptors, as well as detection of 
pro-inflammatory cytokines, DCs migrate to lymph nodes and undergo maturation. 
Maturation is characterized by reduced ability in internalizing antigens but increased 
antigen presentation capacity. Furthermore, MHC class II molecules are redistributed 
from intracellular compartments to the cell surface, and the expression of costimulatory 
molecules (such as CD80, CD86), MHC class I, and T cell adhesion molecules (e.g. 
CD58) is upregulated. DCs also adjust their profile of chemokine receptors that enable 
homing to lymphoid organs. Besides, the cells show “dendritic” projections, which 
enable a large contact surface to the surroundings and may enhance the odds for T cell 
interaction. In lymphoid organs, mature DCs stimulate naïve T cells priming immune 
responses. DCs are able to elicit distinct types of T cell responses, depending on their 
lineage, maturation status and activation signals (Huang et al., 2001; Liu et al., 2001; 
Mellman and Steinman, 2001; Guermonprez et al., 2002; Reis e Sousa, 2006). 
Immature DCs and macrophages can internalize antigens by distinct 
mechanisms. Antigen capture via receptor-mediated endocytosis enables efficient 
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antigen delivery to the processing compartment. Antigens that do not associate with cell 
surface receptors can be internalized by fluid phase pinocytosis and presented by APCs, 
although with lower efficiency. Fluid phase uptake can happen through different means: 
(i) micropinocytosis, in which clathrin-coated pits invaginate to form small vesicles (< 
0.1 μm). Soluble proteins that enter the vesicles associate with receptors in the coated 
pit, being further trafficked to lysosomes and degraded; and (ii) macropinocytosis, in 
which small particles enter larger vesicles (0.5-3 μm) formed at sites of membrane 
ruffling mediated by the actin cytoskeleton. Micropinocytosis is a constitutive process 
which occurs in nearly all cells, whereas macropinocytosis is restricted to distinct cell 
types (APCs), for example macrophages and immature DCs (Sallusto et al., 1995, 
Steinman and Swanson, 1995, Lam et al., 2007). 
In phagocytosis, particles larger than 1.0 µm are internalized in a receptor 
triggered, actin-based mechanism which involves membrane extension or addition in 
order to create an intracellular acidified compartment (Morrissette et al., 1999). After 
internalization, phagosomes undergo maturation by a sequence of fission and fusion 
events with components of the endocytic pathway, resulting in mature phagolysosomes 
(Aderem and Underhill, 1999). 
A number of surface receptors has been reported to recognize pathogen-
associated molecular patterns (PAMPs) present on microorganisms. These so-called 
pattern-recognition receptors (PRRs) recognize, among others, bacterial 
liposaccharides, unmethylated CpG motifs of bacterial DNA, viral double-stranded 
RNA, β-glucans, chitin, mannans, and fungal nucleic acids. PAMPs are highly 
conserved structures, since they are indispensable for the survival of the 
microorganisms. Recognition by PRRs results in microbial ingestion and killing through 
respiratory burst, among other mechanisms. PRRs activate signaling pathways, 
stimulating several cellular responses, such as cytokine and chemokine production, and 
therefore connect innate and adaptive immunity (Figdor et al., 2002; Tsoni and Brown, 
2008; Brown, 2011; Romani, 2011). A broad variety of PRRs help in the identification 
of potential pathogens, for example Toll-like receptors (TLRs), C-type lectin receptors 
(CLRs), integrins, or scavenger receptors (Brown, 2011). The observation that 
glycosylated protein antigens are more efficiently internalized than nonglycosylated 
ones indicates that CLRs are abundantly expressed in DCs (Yokota et al., 2001; Figdor 
et al., 2002). Macropinocytosis and mannose receptor-mediated endocytosis lead to 
antigen delivery to MHC class II-containing compartments, but particles engulfed via 
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mannose receptors are considerably more effective at increasing T cell proliferation 
(Tan et al., 1997; Lam et al., 2005). 
 
Antigen processing and presentation 
Antigen peptides recognized by T cells are displayed by specialized glycoproteins that 
are encoded by genes of the major histocompatibility complex (MHC), which fall into 
two classes, I and II. MHC classes I and II molecules exhibit different structures, 
functions and distribution patterns among cells. Each MHC molecule can associate with 
a broad variety of peptide antigens, enabling the formation of diverse peptide-MHC 
complexes. Therefore, the immune system can specifically react to a large diversity of 
challenges (Madden, 1995; Klein and Sato, 2000; Janeway et al., 2001; Abbas et al., 
2007). 
Basically, MHC molecules consist of a peptide-binding groove, an IgG-like 
region, a transmembrane domain, and a cytoplasmic region (Abbas et al., 2007). MHC 
class I molecules consist of two polypeptide chains, a heavy chain (α chain) which 
spans the membrane, and the non-covalently attached β2-microglobulin (β2m; Bjorkman 
et al., 1987). These molecules are expressed by almost all nucleated cells, but the 
expression level varies according to the tissue. In contrast, MHC class II molecules are 
generally found on a subgroup of immune cells, such as DCs, macrophages, B 
lymphocytes, thymic epithelial cells (Klein and Sato, 2000). MHC class II molecules 
are composed of two transmembrane polypeptide chains, α and β, which are 
noncovalenty associated (Janeway et al., 2001). 
In order to enable proper T cell recognition, MHC molecules must be capable of 
retaining the bound peptide for a sufficient time period. Even though such interaction 
normally requires high specificity, peptide-MHC binding is both stable and 
promiscuous (Madden, 1995). 
Generally, MHC class I molecules present peptides derived from degraded 
proteins synthesized by the cell or entering the cytosol, such as tumor antigens or 
proteins encoded by intracellular pathogens. Since MHC class I is expressed by the 
majority of cells, these can be inspected by circulating CD8+ cytotoxic T cells for 
potential infection or improper protein expression. Cellular proteins are degraded in the 
cytosol, essentially by the proteasome, and the resulting peptides are translocated by 
TAP (transporter associated with antigen processing) into the lumen of the endoplasmic 
reticulum (ER), where an aminopeptidase trims the peptides down to a length of 8-10 
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amino acids for association with class I molecules. After this association, the MHC 
class I molecule completes its folding and the peptide-MHC I complex leaves the ER, 
being transported via Golgi apparatus to the cell surface, where it can interact with 
CD8+ T cells (Germain and Margulies, 1993; Ackerman and Cresswell, 2004; Cresswell 
et al., 2005). 
Exogenous proteins acquired by endocytosis or from internalized plasma 
membrane proteins are degraded within acidified vesicular compartments, giving rise to 
peptides that can associate with MHC class II molecules. MHC II molecules are 
expressed mainly by B cells, DCs, and monocytes/macrophages. MHC II molecules 
assemble as αβ heterodimers in the ER and associate with an invariant chain (Ii), 
preventing the binding of ER peptides. An Ii peptide called CLIP (class II-associated 
invariant-chain peptide) occupies the peptide-binding groove. Further, in MHC class II-
containing compartments, Ii undergoes degradation and CLIP is removed afterwards so 
that a high-affinity peptide can bind (reviewed by Rocha and Neefjes, 2008). Peptide-
MHC-II complexes travel to the cell surface and interact with specific CD4+ T cells. 
Peptides generated from degradation of internalized exogenous antigens normally do 
not bind to MHC class I molecules, preventing that CTL lyse normal cells which may 
have engulfed antigens from tumor or virus-infected cells (Harding and Geuze, 1992; 
Germain and Margulies, 1993; Rodriguez et al., 1999; Ackerman and Cresswell, 2004). 
 In macrophages and DCs, exogenous antigens can escape from vacuolar 
compartments into the cytosol and enter the endogenous pathway for processing and 
presentation by MHC-I molecules (Fig. 1). This process of providing engulfed proteins 
access to proteasomes and their resulting oligopeptides entry into the MHC class I 
processing machinery is known as “cross-presentation” and constitutes a requirement 
for induction and expansion of CD8+ T cell responses (Harding and Song, 1994; 
Rodriguez et al., 1999; Ackerman et al., 2005; Wadle et al., 2006). 
Once antigens are found in phagosomes, different mechanisms can lead to MHC 
class I presentation. In the phagosome-to-cytosol pathway, the antigen escapes from the 
phagosome into the cytosol in an unknown process and is degraded by proteasomes. 
Some of the generated peptides are then transported by TAP and loaded onto MHC 
class I molecules in the ER or “ER-phagosome” vesicles. Newly synthesized MHC 
class I molecules transport peptides to the cell surface for further presentation. Several 
evidences suggest that the phagosome-to-cytosol pathway is the main one operating in 
vivo. In the vacuolar pathway, antigenic peptides are generated from internalized 
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antigens hydrolysed by proteases in the phagosome and then associate with recycling 
MHC class I molecules. A third mechanism has been proposed, the “endosome to ER 
pathway”, which would explain the cross-presentation of soluble proteins. It has been 
reported that some exogenous soluble proteins can be internalized by DCs and 
transported into the ER. Since proteins in the ER can gain access to the cytosol for 
degradation by the ER-associated degradation pathway (ERAD), this mechanism would 
elucidate the phenomenon of cross-presentation of soluble proteins (reviewed by Rock 
2003; Rock and Shen, 2005). 
The process of exogenous antigen capture by APCs, processing into the MHC 
class I presentation pathway, and subsequently priming of CTL is termed ‘cross-
priming’ (Heath and Carbone, 2001). Cross-priming is considered to be inefficient, but 
it has been postulated that dendritic cells cross-prime CD8+ T cells with more efficiency 
than other APCs. Furthermore, particulate antigens elicit, in general, more efficient 
cross-priming than their soluble counterparts. Cross-presentation is desirable in vaccine 
approaches based on proteins that aim at the generation of CD8+ T cell responses. 
Therefore, numerous attempts to enhance the effectiveness of this process have been 
made in the field of vaccine development (Maecker et al., 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Antigen-processing pathways. Simplified mechanisms for presentation of 
peptides associated with MHC I or MHC II molecules are shown. From Heath and 
Carbone, 2001. 
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T lymphocytes 
Naïve T cells are inexperienced cells that have not encountered an antigen. In lymphoid 
tissues, T cells interact with APCs in a process mediated by adhesion molecules such as 
CD54 and CD58 on the APC and LFA-1 and CD2 on the T cell. This enables T cells to 
sample MHC molecules for the presence of a certain peptide. After binding of the T cell 
receptor (TCR) and the co-receptor (CD4 or CD8) to a peptide-MHC complex and co-
stimulation, the T cell becomes activated and can proliferate and differentiate. Most of 
the T cells that undergo proliferation differentiate into effector T cells, others can 
differentiate into memory cells. Among the effector T cell population, the majority of 
the cells undergo apoptosis after antigens have been cleared, while others become long-
lived memory T cells (Abbas et al., 2007; Janeway et al., 2001). 
Naïve CD4 T cells can differentiate into distinct cytokine-producing subsets 
with different immuneregulatory functions. Effector CD4+ T helper (TH) cells have been 
divided into some lineages, including TH1, TH2, and TH17 cells. Development of a 
specific TH subset is determined by various stimuli, such as the characteristic of the 
peptide-MHC ligand, the costimulatory molecules involved and cytokines. In addition 
to ligation of the TCR and costimulatory receptors (as described before), IFN-γ and IL-
12 are the main inducers of TH1-cell differentiation and IL-4 triggers TH2-cell 
differentiation. TH17 differentiation is stimulated by TGF-β, IL-6, IL-1, and possibly 
other pro-inflammatory cytokines (Janeway et al., 2001; Dong, 2006; Abbas et al., 
2007). Other TH subsets have been described in the past few years, such as TH9, TH22, 
and TFH (follicular helper T cells), but this theme is beyond the scope of the present 
work. 
Infections by intracellular bacteria and some parasites as well as by viruses 
induce reactions of the innate immune system that are involved in the production of IL-
12, IL-18 and type I interferons. IL-12 is the main cytokine involved in TH1-cell 
differentiation. TH1 cells produce characteristic cytokines, especially IL-2 and IFN-γ, 
driving the development of strong cell-mediated immunity, most notably in combating 
intracellular pathogens. IFN-γ activates macrophages, elicits intracellular killing of 
microorganisms by phagocytes and stimulates B cells to produce opsonising and 
complement-fixing IgG antibodies. Additionally, IFN-γ induces further TH1 
differentiation and inhibits TH2-cell proliferation (Janeway et al., 2001; Farrar et al., 
2002; Dong, 2006; Abbas et al., 2007). 
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TH2 differentiation is driven by chronic T cell stimulation, which can be 
triggered by allergens or helminths, for example. TH2 cells produce a set of cytokines, 
such as IL-4, IL-5, and IL-13, mediating allergic responses and humoral immunity. IL-4 
stimulates B cells to produce neutralizing antibodies; IL-4 and IL-13 induce the 
production of IgE antibodies against helminths and also activate macrophages to 
express mannose receptors (alternative macrophage activation); IL-5 activates 
eosinophils in the neighbourhood of helminths. Mast cells are activated by IgE-
opsonized helminths, leading to degranulation. IL-4 and IL-10 inhibit TH1-cell 
differentiation (Farrar et al., 2002; Dong, 2006; Abbas et al., 2007). 
TH17 cells produce IL-17, a regulator of inflammatory responses, and may be 
involved in the induction of neutrophil-rich inflammation. TH17-cell differentiation is 
induced by TGF-β in combination with IL-1 and IL-6, and inhibited by IL-4 and IFN-γ. 
IL-23 is associated with maintenance and survival of the TH17 cell subset (Dong, 2006; 
Abbas et al., 2007). 
Naïve CD8+ T cells differentiate into CTLs, wich play a crucial role in 
combating infections caused by viruses and intracellular pathogens. CTLs kill target 
cells which display the same peptide-MHC class I complex that has driven the 
proliferation and differentiation of the naïve CD8+ T cells. CTL-mediated killing of 
target cells can occur by two main mechanisms and requires direct contact between the 
effector and target cells. In one mechanism, cytotoxic proteins such as perforin (a 
membrane-disrupting molecule) and granzymes (serine-proteases) are released by 
exocytosis, inducing apoptosis of the target cell via activation of cell-death pathways. 
Another mechanism involves interaction of surface molecules on the CTLs and the 
target cells. The target-cell death receptor Fas binds to Fas ligand (FasL) on CTL, 
leading to caspase-dependent apoptosis of target cells. CTLs can also secrete cytokines 
such as IFN-γ, TNF-α, and TNF-β. IFN-γ, among other functions, restrains viral 
replication, promotes increased MHC class I expression in infected cells, recruits 
macrophages to the site of infection and can act synergistically with TNF-α or TNF-β, 
for instance, in macrophage activation (Janeway et al., 2001; Trapani and Smyth, 2002; 
Abbas et al., 2007). 
 
Memory T cells 
After clearance of an infection by means of T-cell mediated immunity, part of the 
population of T cells specific for a given antigen remains for years or for the whole life 
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and ensures protection upon reinfection. These memory T cells respond quickly and in 
an amplified manner if they reencounter the same antigen. However, memory T cells 
might also be maintained in the presence of antigen, for example in some infections 
such as those caused by cytomegalovirus. In this case, the immune responses result in 
control of pathogen growth but not complete eradication (Rocha and Tanchot, 2004; 
Abbas et al., 2007; Gerlach et al., 2011). 
Memory T cells can be generated at distinct stages of T cell differentiation. Both 
maintenance and survival of memory CD4+ and CD8+ T cells depends on certain 
cytokines, such as IL-7 which promotes low-level proliferation of memory T cells. IL-
15 is also necessary for maintenance of memory CD8+ T cells (Abbas et al., 2007). 
Depending on their effector functions and homing characteristics, CD4+ and 
CD8+ memory T cells can be divided into central memory and effector memory T cells. 
Central memory T cells, which express CCR7 and CD62L, home to lymph nodes and 
proliferate quickly, expanding the effector lymphocyte population after reencountering 
an antigen. Effector memory T cells home to peripheral tissues and secrete effector 
cytokines such as IFN-γ upon antigen re-exposure, combating invading microbes at the 
site of infection. Development of vaccine approaches aiming at the induction of both 
sets of memory cells is highly desirable, particularly against persistent or chronic 
pathogens (Esser, 2003; Abbas et al., 2007). 
 
T cell activation 
Activation of naïve T cells by APCs requires distinct independent signals which further 
dictate the T cell fate. In the lymph node, the first signal for T cell activation implies 
interaction of the TCR with a specific MHC-peptide complex on the APC. It is antigen-
specific and makes the T cell enter the cell cycle; the TCR is then internalized and 
degraded. The second signal is provided by the interaction of costimulatory molecules 
on the surface of professional APCs with their ligands on T cells. A number of 
molecules on APCs have been described to provide the costimulatory signals for T-cell 
activation. For example, CD80/CD86 (B7.1/B7.2), the main costimulatory molecules, 
bind CD28 on T cells; CD54 (intercellular adhesion molecule-1, ICAM-1) on APCs 
binds to LFA-1; CD58 (leukocyte function-associated antigen-3, LFA-3) associates 
with CD2 on T cells. Interaction between CD40 on APCs and CD40L on T cells is also 
important during co-stimulation as it further activates the APC to express CD80/86. 
Signal 2 promotes the synthesis of IL-2 by the T cell which drives clonal expansion of 
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antigen-specific T cells. TCR binding in the absence of co-stimulation leads to either 
apoptosis or anergy. A third step involved in T cell activation is provided by signals 
delivered by the APCs to T cells, such as cytokines (either pro- or anti-inflammatory), 
driving T cell differentiation into effector cells. According to the activation status of the 
APC, a particular cytokine profile dictates which type of T cell response is to be primed. 
This concept for T cell activation has played an important role in the elucidation of the 
mechanisms involved in discrimination between self and nonself antigens (Hodge et al., 
2000; Alegre et al., 2001; Coyle and Gutierrez-Ramos, 2001; Janeway et al., 2001; Reis 
e Sousa, 2006; Mays and Wilson, 2011). 
In situations that usually generate weak innate immune reactions, such as latent 
viral infections, tumors, and organ transplants, TH cells may be required for inducing 
complete activation of naïve CD8+ T lymphocytes and differentiation into CTLs. 
Importantly, this process is only effective if both TH and CD8+ T cells recognize antigen 
on the same APC. Activation of CD8+ T cells by TH cells can occur by distinct 
mechanisms. In one pathway, TH cells secrete specific cytokines upon antigen 
recognition that further promote CD8+ T cell differentiation, such as IL-2. Another 
mechanism implicates activation of APCs by antigen-stimulated CD4+ TH cells via 
CD40-CD40L. Activated APCs subsequently express cytokines and costimulatory 
molecules, resulting in stimulation of CTL development. CD40 signaling seems to be 
unique in the ability to induce the generation of memory CTLs (Clarke, 2000; Abbas et 
al., 2007). 
 
 
2. Recombinant yeasts in biotechnological approaches 
In the past decades, the choice of a single yeast species as host for the expression of 
recombinant proteins relied heavily on the baker’s yeast S. cerevisiae. This dependence 
is nowadays circumvented by a set of nonconventional yeasts which have become 
available as expression systems for a wide range of recombinant proteins (Gellissen and 
Hollenberg, 1997; Müller et al., 1998). The spectrum of yeasts as organisms for the 
expression of heterologous gene products includes, among others, the fission yeast 
Schizosaccharomyces pombe (Giga-Hama et al., 1994; Tohda et al., 1994), the 
methylotrophic yeast Pichia pastoris (Tschopp et al., 1987; Sreekrishna et al., 1989), 
and the budding yeast Kluyveromyces lactis (Das and Hollenberg, 1982). 
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The use of recombinant yeasts as vaccine strategy has become a very attractive 
means for the induction of robust immune responses. Yeast is a versatile eukaryotic 
microorganism as it can be easily engineered, grows rapidly to high cell densities in 
inexpensive culture media and properly performs post-translational processing of the 
expressed proteins (Valenzuela et al., 1982; Smith et al., 1985). This latter ability is 
especially advantageous in immunotherapy because the expressed antigens can be 
recognized by the host as native antigens, thus contributing to the generation of more 
efficient immune responses (Bucarey et al., 2009). 
 
Saccharomyces cerevisiae 
S. cerevisiae has been used for thousands of years for fermenting food and beverages 
and is considered a GRAS (generally recognized as safe) organism (Gellisen and 
Hollenberg, 1997; Sicard and Legras, 2011). This yeast has been extensively studied in 
the past decades, and the vast knowledge about its genetics, biochemistry, physiology, 
and fermentation properties makes this yeast species the best characterized until today 
(Gellisen and Hollenberg, 1997; Porro et al., 2005). Its genome has been completely 
sequenced, revealing almost 6,000 ORFs distributed in 16 chromosomes and 12 Mb 
(Goffeau et al., 1996). For all these reasons, S. cerevisiae has become the organism of 
choice for the expression of the majority of recombinant proteins. 
However, S. cerevisiae has been reported to have some disadvantage as host for 
recombinant protein production. Low yields of heterologous proteins, plasmid 
instability, retention of the products within the periplasmic space, and 
hyperglycosylation have been repeatedly observed (Müller et al., 1998; Porro et al., 
2005). Hyperglycosylation in S. cerevisiae can hinder protein folding. Glycoproteins 
with 50–150 mannose residues have been described in S. cerevisiae. Furthermore, this 
budding yeast adds outer α-1,3-linked mannose residues to its N-glycans, which is 
considered allergenic in humans and thus prevents the pharmaceutical use of some 
proteins expressed in S. cerevisiae (Varki et al., 2009). 
 
Kluyveromyces lactis 
K. lactis is one of the most important non-Saccharomyces yeasts in biotechnology. This 
yeast has been used as a source of lactase. Enzymes produced in K. lactis have GRAS 
status, so that they can be used in several food and feed applications (Dominguez et al., 
1998; van Ooyen et al., 2006). K. lactis can grow on media containing lactose as sole 
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energy and carbon source and, under this condition, the enzymes involved in the lactose 
utilization pathway are strongly induced. A β-galactosidase encoded by the lac4 gene 
metabolizes lactose to glucose and galactose. With the establishment of a 
transformation technique for K. lactis (Das and Hollenberg, 1982), the strong inducible 
LAC4 promoter turned out to be a widely used element in recombinant protein 
expression. K. lactis can grow to very high cell densities and a large number of proteins 
from diverse sources have been successfully expressed in this organism (Gellissen and 
Hollenberg, 1997; Colussi and Taron, 2005; van Ooyen et al., 2006). The K. lactis 
genome is 10.6 Mb in size, organized into 6 chromosomes and more than 5,300 coding 
sequences (Dujon et al., 2004). 
 
Schizosaccharomyces pombe 
The fission yeast Sz. pombe was discovered in 1893 by P. Lindner. The name “pombe” 
comes from the Swahili word for beer, since it was first isolated in millet beer from 
eastern Africa (Wixon, 2002). This rod-shaped yeast grows by increasing length but 
constant diameter and divides by medial fission, generating equal-sized daughter cells. 
Although Sz. pombe is evolutionarily distant from common ascomycetes such as S. 
cerevisiae, it is nowadays also widely used for genetic manipulations (Wixon, 2002; 
Forsburg and Rhind, 2006; Varki et al., 2009). Sz. pombe has a fully-sequenced 13.8 
Mb genome, with 3 chromosomes and approximately 4,800 ORFs (Wood et al., 2002). 
A number of plasmids containing Sz. pombe-specific elements has been developed for 
recombinant protein production (Giga-Hama et al., 1994; Tohda et al., 1994). The cell 
wall of Sz. pombe differs from the one of S. cerevisiae in terms of carbohydrate 
composition, for example due to the presence of galactomannan and alkali-soluble α-
1,3-glucan (Kopecká et al., 1995; Varki et al., 2009). 
 
Pichia pastoris 
P. pastoris is a nonpathogenic microorganism capable of utilizing methanol as sole 
carbon source. It was discovered in 1969 in a screen for yeasts able to use methanol. P. 
pastoris can grow to extremely high cell densities in minimal media (Varki et al., 2009). 
In peroxisomes, methanol is converted to formaldehyde by the alcohol oxidase (AOX) 
in a reaction in which oxygen is simultaneously reduced to hydrogen peroxide. The 
formaldehyde leaves the peroxisome and is oxidized in a series of reactions to carbon 
dioxide and water (Ellis et al., 1985). The major enzymes involved in methanol 
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metabolism can comprise up to 30% of the total intracellular protein content in cells 
cultivated in methanol-containing media. The genes coding for these enzymes are 
regulated by strong inducible promoters, which can be used for expression of 
heterologous genes, such as the methanol-inducible AOX promoter. The Pichia genome 
contains the two alcohol oxidase genes, aox1 and aox2, which are highly homologous 
(Koutz et al., 1989). 
After the establishment of transformation methods, high-yield systems were 
developed for recombinant protein production. Moreover, Pichia secretes relatively low 
levels of endogenous proteins, facilitating purification of secreted recombinant proteins. 
The fact that N-glycosylated proteins produced in P. pastoris contain only 5–15 
mannose residues and that this yeast does not add outer α-1,3-linked mannose residues 
to its N-glycans, makes P. pastoris one of the most efficient yeasts for biotechnological 
applications (Varki et al., 2009). The P. pastoris expression system has been 
extensively used for production of several recombinant proteins, impressing not only 
due to the expression levels that can be attained, but also by virtue of the bioactivity of 
the heterologous proteins (Gellissen and Hollenberg, 1997; Macauley-Patrick et al., 
2005). The genomes of some P. pastoris strains have been sequenced (De Schutter et 
al., 2009; Mattanovich et al., 2009; Küberl et al., 2011), for instance, the 9.43 Mb-
genome of the GS115 strain, with 5,313 protein-coding genes distributed in 4 
chromosomes (De Schutter et al., 2009). 
 
 
2.1. Yeasts and the immune system 
Immune recognition of fungi mostly depends on the interaction of receptors at the 
surface of the phagocytic cells with structural components of the fungal cell wall. In 
general, yeast cell walls consist of an outer layer of mannosylated proteins and an inner 
layer of β-glucans and chitin. However, β-glucans may be permanently exposed at the 
surface in specific regions, which is sufficient for Dectin-1 sensing. The cell wall 
composition in fungi is species- and morphology-dependent. In addition, the cell wall 
represents a highly dynamic structure which is considerably remodeled during the 
particular yeast life cycle (Gantner et al., 2005; Brown, 2011). 
Recognition of fungal particles relies on diverse PRRs including lectin receptors 
such as mannose receptor (MR) and Dectin-1, Toll-like receptors (TLRs), scavenger 
receptors, as well as integrins, like the complement receptor type 3 (CR3). The 
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distribution of these receptors for sensing of potential pathogens depends on the cell 
type (Brown, 2011). 
Many of the lectin receptors, such as MR and Dectin-1, belong to the calcium-
dependent (C-type) lectin family which is classified into two types, I and II, depending 
on their structure. Type I surface lectins contain multiple carbohydrate recognition 
domains (CRDs) on their N-termini, whereas type II surface lectins consist of a single 
CRD on their C-terminal regions, as shown in Fig. 2 (Keler et al., 2004). CRDs contain 
calcium-binding pockets that are fundamental for binding of the carbohydrate ligand. 
Although some indications suggest preferential binding of C-type lectin receptors 
(CLRs) to carbohydrates derived from pathogens, there is no further evidence for 
discrimination between self and non-self antigens (Figdor et al., 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Schematic representation of the basic structures of the C-type lectin receptors 
(CLRs) mannose receptor (MR) and Dectin-1 expressed by APCs. MR is a type I CLR 
with eight carbohydrate recognition domains (CRDs), whereas Dectin-1 bears a single 
CRD, being therefore classified as type II CLR. Adapted from Keler et al., 2004. 
 
 
Dectin-1 is a small membrane-integrated type II surface CLR. Besides the extracellular 
CRD, this receptor also contains an immunoreceptor tyrosine-based activation motif 
(ITAM)-like sequence in its cytoplasmic domain (Ariizumi et al., 2000; Yokota et al., 
2001). Dectin-1 is predominantly expressed in DCs, macrophages and neutrophils, and 
recognizes diverse fungi- and plant-derived β-1,3-linked and β-1,6-linked glucans 
(Ariizumi et al., 2000; Yokota et al., 2001; Brown and Gordon, 2001; Willment et al., 
2001; Taylor et al., 2002). Dectin-1 has been demonstrated to recognize intact yeasts, 
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including Candida albicans, S. cerevisiae, and Pneumocystis carinii (Brown and 
Gordon, 2001; Steele et al., 2003; Gantner et al., 2005). 
Dectin-1 induces phagocytosis, killing via production of reactive oxygen 
species, and the expression of chemokines and cytokines including IL-1β, IL-2, IL-10, 
IL-12, and TNF-α (Brown et al., 2003; Gantner et al., 2003; Steele et al., 2003; 
Underhill et al., 2005; Brown, 2006). These events result from activation of intracellular 
signaling pathways, the Syk (spleen tyrosine kinase)-CARD9 (caspase recruitment 
domain-containing protein 9) pathway, and the Raf-1 kinase pathway. Both pathways 
act synergistically and are activated through the ITAM-like motif of Dectin-1. Also, 
Dectin-1 collaborates with TLRs to modulate cytokine production (Brown, 2011; 
Romani, 2011). Dectin-1 recognizes various types of β-1,3-linked and β-1,6-linked 
glucans as well as intact yeast cells (Brown and Gordon, 2001). 
The mannose receptor (MR, also CD206) is a type I CLR expressed, among 
others, on macrophages, DCs, subsets of endothelial cells and myeloid cells. MR 
contains eight CRDs, a fibronectin type II repeat domain, a cysteine-rich domain and a 
short cytoplasmic tail (Keler et al., 2004; Hollmig et al., 2009; Brown 2011). This 
receptor has been shown to specifically bind to mannose, fucose and N-
acetylglucosamine in many fungal species and to mediate subsequent particle 
internalization (Avraméas et al., 1996; Ezekowitz et al., 1991; Giaimis et al., 1993; 
Mansour et al., 2002). Even though classical signaling motifs are missing in the 
cytosolic region of MR, this receptor has been shown to mediate a number of cellular 
events, such as NF-κB signaling and cytokine production (e.g. GM-CSF, IL-1β, IL-6 
IL-10, IL-12). The majority of the MR molecules is located within the intracellular 
endocytic pathway (Hollmig et al., 2009; Brown, 2011). MR has been demonstrated to 
recognize several organisms, including C. albicans (Ezekowitz et al., 1990), C. 
neoformans (Syme et al., 2002), P. carinii (Ezekowitz et al., 1991), and M. furfur 
(Buentke et al., 2000). Furthermore, MR connects innate and adaptive immunity as it 
has been demonstrated that selective targeting of an antigen fused to a specific anti-MR 
antibody and uptake by the MR on DCs induced MHC-restricted antigen-specific CD4+ 
and CD8+ T cell responses (Ramakrishna et al., 2004). 
TLRs are also capable of recognizing fungal components, such as zymosan (a 
derivative of yeast cell walls), O-linked mannans, phospholipomannan and fungal DNA 
(Nakamura et al., 2008; Romani, 2011). The TLRs comprise a well-characterized 
family of PRRs which contain an extracellular domain for ligand binding and a 
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conserved cytoplasmic domain that triggers specific signaling pathways, driving 
specific patterns of gene expression and the synthesis of cytokines and chemokines that 
activate innate and adaptive immune responses (Brown, 2006; Diebold, 2009; Hollmig 
et al., 2009). TLR2, TLR4 and TLR9 are the major TLRs implicated in recognition of 
fungal elements (Romani, 2011). The influence of TLRs on phagocytosis of fungal 
particles remains unclear but seems to depend on the host cell type, the fungal species 
and morphotypes, the route of infection and receptor cooperativity. TLRs have been 
shown to facilitate the presentation of fungal-derived antigens by DCs and modulate T 
cell responses (Brown, 2006; Romani, 2011). 
The complement receptor 3 (CR3, Mac-1) has also been demonstrated to interact 
with zymosan and yeasts such as S. cerevisiae (Ross et al., 1985) and C. albicans 
(Forsyth et al., 1998). CR3 is a heterodimeric integrin of CD11b (αM) and CD18 (β2) 
subunits and recognizes β-glucan, N-acetyl-D-glucosamine, mannose-containing 
polysaccharides and glucose via a cation-independent lectin region situated C-terminal 
to the I-domain of CD11b (Thornton et al., 1996). CR3 mediates phagocytosis both in a 
complement-dependent and -independent manner and is expressed by several cell types, 
including DCs, neutrophils, monocytes and macrophages (Ross et al., 1985; Tsoni and 
Brown, 2008; van Bruggen et al., 2009). It has been shown that phagocytosis of β-
glucan-bearing particles by human neutrophils is completely CR3 dependent (van 
Bruggen et al., 2009). 
Several other PRRs have been shown to associate with fungal PAMPs, in a 
process which is dependent on the cell type involved and on fungal characteristics such 
as species and morphology. The final host immune response to a certain fungus will 
depend on distinct factors, like the relative degree of stimulation of each receptor, the 
level of receptor cooperativity and cellular localization (Romani, 2011). 
It is well established that yeast cell wall components are able to activate the 
immune system. For instance, β-1,3-D-glucan and mannan have been demonstrated to 
act as natural adjuvants (Suzuki et al., 1989, Toda et al., 1997). Fungal β-glucan has 
been shown to possess immunomodulating (acting on both innate and adaptive 
immunity) and antitumor activities, which depend on polymer structure, length and 
degree of branching. By virtue of their anti-cancer effects, β-glucans have been tested in 
pre-clinical and clinical trials (Suzuki et al., 1989; Tsoni and Brown, 2008; Chan et al., 
2009; Li et al., 2010). Fungal β-glucans comprise a group of heterogeneous glucose 
polymers consisting of a linear 1,3-β-glycosidic chain core with β-1,6-linked branches 
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of varying length and structure (Fig. 3 A and B). The branching pattern seems to be 
species-specific. Evidences indicate that higher structural complexity is associated with 
stronger immunmodulatory and antitumor effects (Akramiene et al., 2007; Chan et al., 
2009). 
Mannans are polymers of α-linked mannose residues (Fig. 3 C-F). Studies on S. 
cerevisiae mannan have revealed a highly branched polysaccharide with α-1,2- and α-
1,3-linked side chains attached to an α-1,6-linked backbone (Stewart et al., 1968; Jones 
and Ballou, 1969). Mannan has also been analyzed for its effect on the immune system. 
Toda et al. (1997) demonstrated that mannan-coated liposomes showed potent adjuvant 
activity in eliciting cell-mediated immunity and activated TH1-mediated immune 
responses in vivo, when administered in combination with a DNA vaccine (Toda et al., 
1997). Other groups have also shown that fungal mannosylated antigens enhanced 
antigen presentation and stimulated antigen-specific CD4+ and CD8+ T cell responses 
(Lam et al., 2005; Lam et al., 2007; Luong et al., 2007). 
Chitin, a polymer of β-1,4-linked N-acetylglucosamine (Fig. 3 G), forms chains 
generaly larger than 1,000 residues that are primarily found at the bud neck or septa in 
fungi (Varki et al., 2009). Contradictory data exist on the receptor(s) involved in chitin 
recognition. Chitin particles have been demonstrated to be phagocytosed by murine 
macrophages most probably via MR (Shibata et al., 1997). Recently, it has been shown 
that Dectin-1 is required for chitin recognition, however without directly binding this 
polysaccharide (Mora-Montes et al., 2011). In the past years, chitin has been shown to 
be a potent adjuvant stimulating adaptive TH1, TH2, and TH17 immune responses in 
mice (Da Silva et al., 2010). 
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Fig. 3. Schematic representation of some β-glucan, mannose (Man) and chitin 
structures. (A) Linear β-1,3-glucan; (B) β-1,3-glucan with β-1,6 branching; (C) 
Mannose; (D) Man-α-1,3-Man; (E) Man-α-1,6-Man; (F) Man-α-1,3-Man-α-1,6-Man; 
(G) chitin. Adapted from Rani et al., 1999, Tsoni and Brown, 2008; Voet et al., 2010. 
 
 
3. General concepts of vaccines 
Some of the first attempts to protect induviduals from pathogen-associated diseases date 
from ancient China where healthy people were given smallpox scabs or clothes from 
infected patients. This practice reached Europe in the 18th century. In 1796, Edward 
Jenner, performing human experimentation, showed that individuals immunized with 
the cowpox virus were protected from disease caused by the smallpox virus (Hilleman, 
2000; Esser et al., 2003). This well-succeeded vaccination (Latin vaccinus = from or of 
cows) was worldwide accepted and smallpox was declared eradicated in the early 
1980s. 
Hitherto, vaccination remains the most effective means to avoid infectious 
diseases. A number of prophylactic vaccines against bacteria and viruses have 
contributed to a significant decrease in morbidity and mortality worldwide. 
The following vaccination approaches are nowadays routinely used: live 
attenuated, inactivated, subunit, conjugate, and toxoid vaccines. More recent techniques, 
such as those employing DNA vaccines, autologous cells and recombinant vectors are 
still being evaluated. 
Attenuated vaccines consist of a weakened version of the microbe through 
repeated passaging in cells which are not its natural host. Since the microbe has to adapt 
to the new environment, it will not be capable of replicating at sufficient levels in 
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humans to cause disease. Classical examples include vaccines against polio, mumps, 
measles, rubella and varicella (Cáceres and Sutter, 2001; Hanna et al., 2009). 
Inactivated vaccines are obtained by treating a certain pathogen with chemicals, 
radiation or heat. The pathogen cannot replicate but remains intact. Vaccines against 
hepatitis A and polio are examples of inactivated vaccines (Just and Berger, 1992; 
Simizu et al., 2006). 
Toxoid vaccines consist of chemically inactivated toxins which are produced by 
some bacteria. In this case, the disease is not caused by the microorganism itself but by 
the toxin it secretes. Examples are the vaccines against tetanus and diphtheria (Smith, 
1969). 
Subunit vaccines contain specific antigens from a certain pathogen instead of the 
whole microbe. This can be achieved by isolating a protein (or a portion of it) from the 
microorganism or by expressing the antigen recombinantly, such as in the case of the 
vaccines against hepatitis B virus or human papilomavirus (Poland and Jacobson, 2004; 
Barr and Tamms, 2007). 
Conjugate vaccines are a type of subunit vaccine, for instance when a 
polysaccharide from a bacterial coating is covalently linked to a more immunogenic 
proteinaceous antigen in order to elicit stronger immune responses, especially in 
immature immune systems. A classical example is the vaccine against Haemophilus 
influenzae type B (Ojo et al., 2010). 
DNA vaccines resort to plasmids containing pathogen- or tumor-associated 
antigens (and additional immunostimulatory factors) under the regulation of an 
appropriate eukaryotic promoter. Upon inoculation of the plasmid, the DNA is taken up 
by some cells and the specific proteins are synthesized in the cytosol for subsequent 
presentation to lymphocytes (Abbas et al., 2007, Eschenburg et al., 2010). 
Immunization with autologous cells is used, for example, for combating cancer. 
The classical example employs DC-based vaccines, which can be generated by genetic 
modification or by loading DCs with tumor-associated antigens or whole dead tumor 
cells (Janikashvili et al., 2010). 
“Live” vectors are a recent approach for delivering antigens. In general, 
attenuated viruses or bacteria are used as antigen carrier inducing humoral and cellular 
immune responses. Viral vectors, such as vaccinia virus and bacteria (e.g. Listeria 
monocytogenes or Yersinia enterocolitica) can be engineered to deliver recombinant 
molecules (Wiedig et al., 2005; Loeffler et al., 2006; Embry et al., 2011). In the 21th 
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century, antigen delivery strategies using whole recombinant yeasts have been 
demonstrated a promising approach (reviewed by Ardiani et al., 2010). 
 
 
3.1. Vaccines for cellular immune responses 
The major purpose of vaccines is to provide long-term immunological protection. 
Traditionally, most vaccine strategies in the 20th century have driven the attention to the 
generation of high titers of antibodies, with modest understanding of the role of the 
cellular immune responses (Kaech et al., 2002; Esser et al., 2003). Since the vast 
majority of vaccines routinely used today elicit humoral immunity, many efforts to 
promote cell-mediated immunity through vaccination have been made in the past years. 
However, combating tumors and pathogens that cause chronic or persistent 
infections implicates eliciting the mechanisms of cellular immunity. For this reason, 
development of vaccines that stimulate long-lived cellular immune responses is critical 
to fighting against a number of diseases, including those caused by cytomegalovirus, 
hepatitis C virus, human immunodeficiency virus (HIV) and Mycobacterium 
tuberculosis (Esser et al., 2003). 
Long-term protection is based on the quantity and the quality of the memory T 
cells that are produced. Ideally, vaccines should elicit the formation of a very large 
effector T-cell population, which represents a challenge (Kaech et al., 2002). 
Elimination of pathogen-infected or malignant cells by T-cell mediated immune 
responses mainly relies on cell-mediated cytotoxicity via CD8+ CTLs. However, 
vaccines must also be capable of inducing CD4+ T cell responses because they secrete 
several immunomodulatory cytokines to subsequently trigger the generation and 
proliferation of the robust CD8+ CTL responses required (Ardiani et al., 2010). 
Distinct approaches have been employed in order to increase the activation of 
CTLs specifically against affected cells. DCs have been considered an interesting target 
due to their unique ability to cross-present antigens. Therefore, strategies aiming at the 
delivery of antigens to DCs and inducing their maturation and activation are critical in 
stimulating cell-mediated responses against diseased cells. Among the different 
approaches for activating cell-mediated immunity are DNA vaccines, viral vectors, 
autologous and allogeneic cells, and delivery of molecules by virulence-attenuated 
bacterial strains and yeast (reviewed by Franzusoff et al., 2005). DNA vaccines have 
low boosting capacity; viral vectors are neutralized by antibodies after repetitive 
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applications; besides being very expensive and complex, immunotherapy with tumor 
cells is patient-specific, and cell-mediated immunity is poorly activated due to the lack 
of danger signals; bacterial vectors can cause unwanted side effects associated with the 
host-bacteria interactions (Franzusoff et al., 2005; Pálffy et al., 2006). The benefit of 
using yeast as vaccine carrier has been demonstrated in recent pre-clinical and clinical 
trials, making this approach very attractive. 
 
 
3.2. Yeast as vehicle for generating antigen-specific immune responses 
The use of recombinant yeast as vaccine strategy has become a very promising means 
for the induction of robust immune responses. The ability of yeasts to properly perform 
post-translational processing on the expressed proteins is especially advantageous in 
immunotherapy because the expressed antigens can be recognized by the host as native 
antigens, thus contributing to the generation of high-quality immune responses (Bucarey 
et al., 2009). Furthermore, antigen processing by DCs after administration of whole 
recombinant yeast carrying recombinant proteins provides a wide spectrum of epitopes 
derived from the delivered proteins, which allows the presentation of epitopes relevant 
for the MHC repertoire from a certain individual (Bui et al., 2010). 
It has been postulated that protein-based vaccines have the major disadvantage 
of insufficient immunogenicity and, as a consequence, the majority of them requires co-
administration with adjuvants to elicit protective immune responses (Petrovsky and 
Aguilar, 2004). Thus, some efforts have been made in an attempt to develop more 
effective vaccine strategies, in particular for inducing potent T cell-mediated immune 
responses needed against viral and tumor antigens. Among the different approaches, the 
use of recombinant yeast cells as antigen delivery system turned out to be an auspicious 
strategy. 
The first experiments performed in order to examine the potential use of whole 
recombinant S. cerevisiae as a vaccine to elicit antibody responses came with Schreuder 
et al. (1996a). In a cell-surface display system, an antigen bearing two major 
hydrophilic regions of the hepatitis B surface antigen (HBsAg) was fused to the C-
terminal region of α-agglutinin from S. cerevisiae and exposed on the yeast cell surface. 
Heat-killed yeasts were used to immunize mice intraperitoneally and serum immune 
responses were analyzed. Very low specific immune responses against the recombinant 
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protein were observed, in contrast to strong immune responses elicited against the yeast 
carrier itself. 
 The observations of Schreuder et al. (1996a) demonstrating the stimulation of 
the immune system by yeasts alone, combined with other reports showing the 
immunnogenic characteristics of fungal β-glucan and mannan, have encouraged the 
onset of several approaches using whole yeasts expressing recombinant antigens as 
carrier systems for generation of specific immune responses (Suzuki et al., 1989; 
Williams et al., 1992; Toda et al., 1997). Additionally, uptake of fungal particles by 
phagocytic cells has been demonstrated (Newman et al., 1990; Suzuki et al., 1998; 
Newman and Holly, 2001; Breinig et al., 2003), so that many studies have directed their 
attention to the use of yeasts carrying proteinaceous antigens in immunotherapy. 
In the first study analyzing cell-mediated immunity after vaccination of mice 
with live yeasts, Stubbs et al. (2001) showed that S. cerevisiae cells expressing Ova 
were capable of stimulating protective CD8+ T cells in vivo. Mice vaccinated with 
recombinant yeast and challenged with Ova-expressing lymphoma cells were protected 
from tumor formation. They also demonstrated that whole heat-killed yeast led to DC 
maturation and IL-12 secretion and to increased presentation of Ova to antigen-specific 
CD4+ and CD8+ T lymphocytes. When they tested a clinically relevant antigen, such as 
the envelop protein SF2-gp160 from HIV-1, they observed that cells expressing this 
protein were killed by cytotoxic T lymphocytes derived from mice vaccinated with 
yeast/SF2-gp160, but not with PBS or yeast carrying an empty vector. Proliferative 
responses of T lymphocytes specific for HIV-1-gp120 (gp160 devoid of gp41) were 
also reported for mice immunized with yeast/SF2-gp160. It was the first demonstration 
that whole recombinant yeast could induce potent cell-mediated responses (Stubbs et 
al., 2001). 
After that study, many other groups have resorted to this strategy, with different 
antigens and mouse models. For example, cellular immune responses against the 
hepatitis C virus (HCV) were examined in mice using heat-inactivated whole yeasts 
expressing NS3/Core fusion protein. In this study, Haller and colleagues (2007) 
demonstrated antigen-specific and dose dependent in vitro cytotoxicity. They have also 
shown that repeated weekly immunization did not induce neutralization or tolerance, 
and that immunized mice were protected from challenge with tumor cells expressing 
HCV NS3. Further, mice vaccinated after NS3-positive tumor cell implantation showed 
no or reduced tumor growth compared to an untreated group (Haller et al., 2007). 
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Many studies using tumor-bearing mice have analyzed the therapeutic effect of 
recombinant S. cerevisiae expressing tumor-associated antigens (TAAs), such as 
mammalian mutant Ras proteins, the carcinoembryonic antigen (CEA), and a 
melanocyte⁄melanoma antigen (MART-1), with promising results. Besides tumor 
regression, increased survival time, cytotoxicity and cytokine production, no toxicity or 
autoimmunity related to the yeast-based vaccine was observed (Lu et al., 2004; 
Wansley et al., 2008; Tanaka et al., 2011). Clinical trials of immunotherapy with yeast 
carrying Ras or CEA have been conducted with patients bearing Ras mutation+ or CEA+ 
tumors (ClinicalTrials.gov Identifiers: NCT00300950, NCT00924092; Ardiani et al., 
2010). 
The use of recombinant yeast in prophylactic vaccine approaches has also been 
investigated, for example with yeasts carrying MART-1 or BCR-ABLT315I, a mutated 
protein in drug-resistant leukemia cells. Protection against tumor challenge, in vitro 
cytotoxic activity and production of cytokines, as well as prolonged survival were 
observed (Riemann et al., 2007; Bui et al., 2010). 
A number of studies using yeasts displaying antigens on the cell surface to 
immunize animals have also been conducted, most of them aiming at the development 
of humoral immune responses (Zhu et al., 2006; Upadhyaya and Manjunath, 2009; Kim 
et al., 2010). 
Although S. cerevisiae has been used in the vast majority of studies, other well-
accepted yeast species have rarely been tested. A vaccine using live P. pastoris as 
protein delivery system was tested by Saiki and colleagues (2005). The pcd-17, an 
antigen associated with the paraneoplastic cerebellar degeneration, an autoimmune 
disease, was chosen for recombinant expression in Pichia. Lymph node cells of mice 
immunized with yeast/pcd-17 showed proliferative responses and IFN-γ production 
after peptide restimulation, in contrast to cells derived from mice receiving the wild 
type yeast only. The presence of autoantibodies in serum of vaccinated mice has also 
been confirmed. However, these responses have only been observed in one out of four 
mouse strains tested and no cytotoxicity assay was performed. In another study, heat-
treated H. polymorpha expressing cytosolic HBsAg was used to vaccinate mice. Yeasts 
led to an increase in the number of T cells and DCs in the mouse spleen and elicited DC 
maturation. Furthermore, yeasts/HBsAg induced the generation of anti-HBsAg 
antibodies in a greater extent than HBsAg alone or administered with an alum adjuvant. 
Cytotoxicity and cytokine secretion was also observed. This report confirmed the idea 
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that recombinant yeasts stimulate both cellular and humoral immunity and promote 
mixed Th1/Th2-type immune responses (Bian et al., 2010). 
Recently, an approach for delivering nucleic acids by recombinant yeast to 
antigen-presenting cells has been developed. In that work, S. cerevisiae and Sz. pombe 
were analyzed as carrier for antigen-encoding DNA and mRNA. Recombinant protein 
expression (e.g. eGFP and Ovacyt) in mammalian APCs was confirmed after yeast 
internalization, and ex vivo activation of pp65-specific memory T cells was 
demonstrated using S. cerevisiae as DNA/RNA delivery system (Walch, 2009; Walch et 
al., 2011). 
As previously described, activation of naïve T cells by APCs involves a set of 
distinct signals. Yeasts lead to augmented expression of MHC class I and II (needed for 
the first signal), as well as of the costimulatory and adhesion molecules CD40, 
CD80/CD86, CD54, CD58 (necessary for the second signal), and stimulate secretion of 
cytokines by DCs (providing the third signal). 
In sum, the use of inherently nonpathogenic yeast as antigen delivery system 
turned out to be an especially versatile technique. The main points in this issue are: (i) 
phagocytic cells, especially DCs, are able to ingest a wide variety of antigens, including 
whole yeasts; (ii) after internalization of fungal particles, DCs mature and efficiently 
process the antigens in context of MHC class I and II molecules for presentation, 
express a set of costimulatory molecules and secrete cytokines, stimulating the 
differentiation of T lymphocytes into distinct classes of effector cells, controlling the 
quality of the T cell response; (iii) upon using whole yeasts, all three signals necessary 
for T cell activation are increased, due to the natural adjuvant characteristics of the yeast 
PAMPs. This important feature facilitates the generation of robust adaptive immunity. 
Therefore, since antigen-specific, adaptive responses play a critical role in combating 
infections and tumors (Mellman et al., 2001; Heath and Carbone, 2001), the use of 
whole yeasts is a promising vaccine strategy (Fig. 4). All efforts that have been made in 
the vaccination field to target and activate DCs and consequently providing the potential 
to generate both CD4+ and CD8+ T cells immune responses are worth. 
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Fig. 4. Yeast as antigen carrier. Simplified mechanism of action. Adapted from Ardiani 
et al., 2010. 
 
 
4. Experimental systems 
As part of this work, recombinant yeasts were analyzed for their ability to deliver 
different antigen variants to antigen-presentig cells and influence the generation of 
specific T cell responses due to their adjuvant properties. 
 
4.1. Ovalbumin as model antigen 
Ova is a monomeric protein from chicken egg-white with a molecular weight of 
approximately 43 kDa. This protein contains an internal secretion signal possibly 
located between residues 21 and 47 (Nisbet et al., 1981; Huntington and Stein, 2001). 
Ova belongs to the serpin superfamily (serine protease inhibitors), but possesses no 
inibitory activity. Rather, its function has not been elucidated (Hunt and Dayhoff, 1980; 
Huntington and Stein, 2001). An immunodominant MHC class I epitop in the 
Ovalbumin sequence between amino acid residues 257 and 264 has been characterized 
(Rötzschke et al., 1991). This octamer SIINFEKL (Serine-Isoleucine-Isoleucine-
Asparagine-Phenylalanine-Glutamate-Lysine-Leucine) epitope is restricted to mouse H-
2Kb MHC class I molecules, rendering Ova a model antigen for analysis of antigen 
presentation via the MHC class I pathway, as well as generation of CD8+ T cell immune 
responses. For this reason, Ova is widely used in immunologic approaches. 
Yeast
PRRs
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In order to target Ova to different subcellular compartments, the following Ova 
derivatives were constructed and analyzed: i) full-length Ova which contains an internal 
signal peptide that directs the protein into the secretory pathway for secretion of the 
protein (Ova), ii) a derivative which lacks this signal, but still contains the SIINFEKL 
epitope, and that is expressed intracellularly within the yeast cytosol (Ovacyt), and iii) a 
fusion of Ovacyt with the yeast cell wall protein Sed1p which targets the protein to the 
cell surface (Ovacyt/Sed1p). To direct this fusion into the yeast secretory pathway, a 
genus-specific ER-import signal was added at the N-terminus. In another strategy, 
Ovacyt was fused to the Gag protein from the S. cerevisiae L-A virus and intracellularly 
expressed as Ovacyt-containing virus-like particles. 
The efficiency with which different Ova derivatives in different yeast genera can 
trigger antigen-specific CD8+ T cell responses was subsequently tested in vitro by 
means of IFN-γ detection. 
 
 
4.2. Pp65, a matrix protein from human cytomegalovirus, as model antigen 
The human cytomegalovirus (HCMV) is a betaherpesvirus with high prevalence in the 
population in the whole world. The virus consists of an icosahedral capsid containing a 
linear, double-stranded, 235-kb DNA genome encoding approximately 165 genes and 
surrounded by a matrix or tegument within a lipid envelope. Primary infection with 
HCMV is usually asymptomatic, but latent infection remains for the entire life, with 
eventual reactivation and shedding of virus particles from mucosal sites (Mocarski Jr 
and Courcelle, 2007; Khanna and Diamond, 2006). 
The phosphoprotein 65 (pp65, also known as lower matrix protein or UL83) 
from HCMV is the major constituent of viral particles and has been demonstrated to be 
a relevant T cell antigen (reviewed by Kalejta, 2008). This structural protein associates 
with host and viral kinases, but it is not clear whether pp65 itself possesses kinase 
activity (Mocarski Jr and Courcelle, 2007; Kalejta, 2008). It has been shown that pp65 
can be found in infected cells all times after viral infection, although pp65 is produced 
in the late phase of viral gene expression, i.e. 24 h post infection (Grefte et al., 1992). 
The recognition and lysis of HCMV-infected cells by the majority of virus-specific CTL 
without the requirement of de novo viral protein synthesis indicates that structural 
proteins are introduced into the cytoplasm of infected cells in sufficient amount to enter 
the class I pathway after viral penetration (Riddell et al., 1991; Grefte et al., 1992). 
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McLaughlin-Taylor and co-workers (1994) have shown that pp65 is a target 
antigen for HCMV-specific MHC class I-restricted CTL. In one study, when fourteen 
HCMV antigens were compared in their abilities to stimulate helper T cells in vitro, 
pp65 was by far the most reacting protein (Beninga et al., 1995). Kern and colleagues 
(2002) determined the frequencies of CD4+ and CD8+ T cell responses to pp65 in 
healthy HCMV-positive individuals. They found that 63% and 83% of the donors tested 
showed a CD4+ or a CD8+ T cell response, respectively, to pp65-derived peptides. In 
addition, the frequencies of pp65-specific T cells among responders showed a great 
variation. In another study conducted by Wills et al. (1996) it was demonstrated that, 
among all CTL which were able to recognize HCMV-infected cells, 70-90% were 
specific for pp65. They hypothesized that since this high frequency of pp65-specific 
memory CTL was maintained for 18-22 months, this structural protein is probably 
continuously expressed. This fact might indicate that either episodic reactivation or 
continual replication of the virus at low levels enables restimulation of pp65-specific 
CTL precursors and preservation of the pool of memory CTL. 
The repeated observation that a number of HCMV-seropositive donors does not 
respond to some established pp65 dominant epitopes, combined with the suggestions 
that these individuals might respond to unpredicted or subdominant peptides makes the 
use of a full-length protein more promising in terms of stimulating CTL expansion 
(Solache et al.,1999; Vaz-Santiago, 2001; Kern et al., 2002). 
Cell-mediated immunity plays a crucial role in control of latent HCMV 
infection. However, in individuals with compromised or immature immune systems, 
such as transplant recipients and neonates, HCMV is constantly associated to morbidity 
and mortality in a number of disease patterns. Despite many efforts that have been made 
in the past decades, no vaccine against HCMV is available to date. Thus, vaccine 
development is nowadays a main biomedical research concern, especially in the 
following scenarios: congenital primary infection, primary infection in 
immunosuppressed individuals and virus reactivation in immunosuppressed adults 
(Mocarski Jr and Courcelle, 2007; Schleiss, 2005; Khanna and Diamond, 2006). 
Recently, a phase I clinical trial has been performed, in which a vaccine consisting of a 
two-component alphavirus replicon vector system expressing both the pp65 fused to a 
72-kDa immediate-early protein (IE1) and the major HCMV surface glycoprotein (gB) 
was evaluated in HCMV-seronegative individuals. The vaccine elicited cytokine 
responses in CD8+ and CD4+ T cells against all three proteins and induced the 
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generation of neutralizing antibodies to HCMV, most likely against gB (Bernstein et al., 
2010). However, a vaccine with promising therapeutic potential for HCMV-positive 
individuals is still missing. 
 
 
4.3. Virus-like particles (VLP) as antigen carrier 
The S. cerevisiae L-A virus is a double-stranded RNA virus which replicates in the 
cytoplasm of yeast cells without a known phenotype. Its viral icosahedral particles are 
composed of a 76-kDa major protein (Gag) and a 180-kDa minor Gag-Pol fusion 
protein. The 4.6-kb viral genome consists of two overlapping open reading frames (gag 
and pol). A -1 ribosomal frameshift is responsible for the formation of the Gag-Pol 
fusion protein. The L-A capsid has a diameter of approximately 39 nm, comprising 118 
Gag molecules and 2 Gag-Pol molecules (Wickner, 1996). N-terminal Gag acetylation 
by the MAK3 gene product is crucial for VLP assembly (Tercero and Wickner, 1992). 
Gag alone has been demonstrated to be sufficient for the assembly of VLP, therefore 
strategies aiming at the development of biotechnologically or pharmaceutically relevant 
chimeric Gag-VLP have been employed (Fujimura et al., 1992; Wickner, 1996; 
Powilleit et al., 2007). 
VLP have been shown to function as adjuvants, eliciting the generation of innate 
and cell-mediated immune responses against both the carrier itself and the delivered 
antigen. VLP are considered a promising setting in the field of vaccine production, not 
only because of their particulate structure and size range (40-50 nm), which have been 
shown to facilitate their capture by DCs, but also because of the repetitive, high-density 
display of epitopes, which is generally efficient in stimulating robust immune responses. 
Furthermore, VLP are optimal delivery systems in prophylactic and therapeutic 
approaches by virtue of their intrinsic ability to break self-tolerance (Fifis et al., 2004; 
Grgacic and Anderson, 2006; Schumacher et al., 2007; Crisci et al., 2009). 
In the L-A virus, Pol projects into the inner side of the capsid, participating in 
replication and transcription of the viral genome (Fujimura et al., 1992). In this work, 
the interior of the capsid was modified by substituting Pol for Ovacyt or full-length pp65. 
Nonetheless, in contrast to pol, ovacyt and pp65 were cloned in frame with gag, so that 
all molecules produced are Gag/Ovacyt or Gag/pp65 fusions, respectively. For 
expression of Gag-variants, the virus-free S. cerevisiae strain S86c was chosen as host 
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(Powilleit, 2004). S86c derives from the S86 strain, which was heat-treated for 
elimination of the viral genome (Schmitt, 1995). 
 
 
5. Aim of the study 
The main objective of this work was to compare different yeast strains as carrier for 
recombinant protein antigens as well as to analyze the influence of the subcellular 
localization of the heterologous protein on activation of antigen-specific T lymphocytes 
for a possible application in vaccination approaches. 
First, the effect of distinct yeast genera, species, strains, or cell wall mutants on 
maturation and activation of human dendritic cells was investigated by analyzing 
upregulation of diverse cell surface markers and cytokines. The major components of 
the yeast cell wall, mannan and β-glucan, which are known to possess adjuvant 
properties, were examined for establishment of a potential association with the results 
observed. Further, the biotechnologically relevant yeasts Saccharomyces cerevisiae, 
Kluyveromyces lactis, Schizosaccharomyces pombe and Pichia pastoris were assessed 
for the interaction kinetics with human DCs or murine macrophages, and the 
involvement of major pattern recognition receptors MR and Dectin-1 in their 
internalization was determined. The influence of heat-treatment of yeast on phagocyte 
activation, as measured by production of reactive oxygen species in human whole 
blood, was also investigated. 
Next, the different yeasts were used for the expression of model proteins such as 
Ova and the clinically significant antigen pp65 from human cytomegalovirus, and 
activation of antigen-specific T lymphocytes was examined in vitro and ex vivo. The 
efficiency of yeast-delivered pp65 or pp65 VLP to activate pp65-specific memory CD4+ 
and CD8+ T lymphocytes was measured in blood from cytomegalovirus-seropositive 
donors by means of an ex vivo whole blood assay. In the case of Ova, in vitro antigen 
presentation assays using murine bone marrow macrophages and antigen-specific CD8+ 
T lymphocytes were used to assess the MHC I-restricted antigen presentation after 
protein delivery by the distinct yeast genera. Moreover, the influence of the subcellular 
localization of Ova on the degree of T cell activation was investigated, in which yeasts 
harbouring different antigen variants – intracellular, secreted or cell-wall anchored – 
were compared. Finally, a preliminary in vivo experiment using a selected yeast species 
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and a single antigenic variant was performed in order to obtain basic information with 
respect to the establishment of future immunization protocols in an animal model. 
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II. MATERIALS 
 
 
1. Organisms 
The organisms used within this work, as well as their respective source and 
characteristics, are listed below. Bacteria, yeasts and cell lines utilized belong to the 
culture collection of the Institute for Molecular and Cell Biology at Saarland University, 
unless otherwise stated. 
 
1.1. Escherichia coli strains 
Table 1. E. coli strains used in this work, as well as their respective genotype and 
source. 
Strain Genotype Reference or Source 
TOP10 
F´mcrA Δ(mrr-hsdRMS mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 araD139 Δ(ara-leu)7697 galU 
galK rpsL (StrR) endA1 nupG 
Invitrogen 
(Germany) 
DH5α 
F-, recA1, endA3, gyrA96, thi-1, hsdR17, 
supE44, relA1, deoR, Δ(argF lacZYA)U196, 
φ80dlacZΔM15 
Hanahan 
(1983) 
Nova Blue 
SinglesTM 
Competent Cells 
endA1 hsdR17 (rK12– mK12+) supE44 thi-1 recA1 
gyrA96 relA1 lac F′[proA+B+ 
lacIqZΔM15::Tn10] (TetR) 
Novagen 
(Germany) 
 
 
1.2. Yeast strains 
Table 2. Yeast strains used throughout this work, their respective genotype and source. 
Strain Genotype Reference or Source 
Saccharomyces 
cerevisiae S86c 
MATα ura3-2 leu2 his3 pra1 
prb2 prc1 cps1 (heat cured) Schmitt (1995) 
Saccharomyces 
cerevisiae W303-1a 
MATa leu2-3, 112 ura3-1 trp1-
1 his3-11, 15 ade2-1 can1-100 Parlati et al. (1995) 
Saccharomyces 
cerevisiae BY4742 
MATα his3Δ1 leu2Δ0 lys2Δ0 
ura3Δ0 Brachmann et al. (1998) 
Saccharomyces 
cerevisiae BY4742 
Δmnn11 
MATα his3Δ1 leu2Δ0 lys2Δ0 
ura3Δ0 YJL183w::kanMX4 
EUROSCARF 
(Germany) 
Saccharomyces 
cerevisiae BY4742 
Δost3 
MATα his3Δ1 leu2Δ0 lys2Δ0 
ura3Δ0 YOR085w::kanMX4 
EUROSCARF 
(Germany) 
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Table 2 continuation 
Strain Genotype Reference or Source 
Kluyveromyces lactis 
GG799 
No auxotrophies or genetic 
markers 
Industrial isolate. New 
England Biolabs 
(Germany) 
Pichia pastoris GS115 his4 Invitrogen (Germany) 
Pichia pastoris KM71 his4, arg4, aox1::ARG4 Invitrogen (Germany) 
Schizosaccharomyces 
pombe PW260 h
-leu1.32 ura4. dl18 ade 6.210 Peter Wagner (Saarland University, Germany) 
Hansenula polymorpha wild type Institut Pasteur (France) 
Yarrowia lipolytica wild type 
Institut National de la 
Recherche Agronomique 
(France) 
Candida glabrata wild type National Collection of Yeast Cultures (UK) 
 
 
1.3. Cell lines 
IC21 murine macrophages 
This cell line is derived from C57BL/6 mouse peritoneal macrophages transformed with 
simian virus 40 (Walker and Gandour, 1980). These cells share many features with 
normal mouse macrophages, like phagocytic and cytolytic activities, and also express 
macrophage specific antigens. Cells were kindly provided by Dr. Gernot Geginat 
(Institute for Medical Microbiology and Hygiene, Faculty for Clinical Medicine 
Mannheim of the University Heidelberg, Germany). 
 
 
1.4. Mice 
OT-I mice (C57BL/6-Tg(TcraTcrb)1100Mjb) express a transgenic T-cell receptor 
(TCR) that recognizes OVA257-264 peptide (SIINFEKL) in context of MHC class I H-
2Kb (Hogquist et al., 1994). This TCR can be specifically identified with the anti-mouse 
Vα2 and Vβ5.5, 5.2 monoclonal antibodies. Experiments with OT-I mice were 
performed at the Medical Clinic for Rheumatology and Clinical Immunology (Charité, 
Berlin), in cooperation with Elisabeth Kenngott. 
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2. Culture Media and Supplements 
The chemicals for the following media and supplement stock solutions were solubilized 
in distilled water and autoclave-sterilised, unless otherwise noted. Glucose as well as 
galactose solutions were autoclaved separetely. Liquid media were generally stored at 
room temperature. Solid agar media were stored at 4°C. 
 
2.1. Bacterial culture media 
SOC Medium 
Yeast extract     0.5% w/v 
Peptone        2% w/v 
Glucose          20 mM 
Potassium chloride        2.5 mM 
Magnesium chloride         10 mM 
Magnesium sulphate         10 mM 
Sodium chloride          10 mM 
The medium was stored at 4°C. 
 
Luria Bertani (LB) 
Peptone        1% w/v 
Yeast extract     0.5% w/v 
Sodium chloride        1% w/v 
(Agar    1.5% w/v) 
 
Ampicillin 
Ampicillin      50 mg/ml 
in 50 % ethanol 
The solution was filter-sterilized and stored at -20°C. 
 
Kanamycin 
Kanamycin      25 mg/ml 
The solution was filter-sterilized and stored at -20°C. 
 
IPTG 
IPTG        100 mM 
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The solution was filter-sterilized and stored at -20°C. 
 
X-gal 
X-gal      40 mg/ml 
in dimethylformamide 
The solution was filter-sterilized and stored in the dark at -20°C. 
 
 
2.2. Yeast culture media 
 
YPD 
Yeast extract        1% w/v 
Peptone        2% w/v 
Glucose         2% w/v 
(Agar    1.5% w/v) 
 
10× Yeast nitrogen base (YNB) standard stock solution 
YNB without aminoacids           17 g/l 
and ammonium sulfate 
The solution was filter-sterilized before use. 
 
Synthetic Complete Medium (SC Medium) 
10× YNB standard stock solution       10% v/v 
Ammonium sulphate     0.5% w/v 
Glucose        2% w/v 
Bases and amino acids mix  0.087% w/v 
 
Bases and amino acids mix 
Adenine sulphate            0.2 g 
Uracil            0.2 g 
L-tryptophan            0.2 g 
L-histidin HCl            0.2 g 
L-arginin HCl            0.2 g 
L-methionin HCl            0.2 g 
L-tyrosin HCl             0.3 g 
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L-lysin            0.3 g 
L-isoleucin HCl            0.3 g 
L-phenylalanin            0.5 g 
L-leucin HCl            1.0 g 
L-valin            1.5 g 
L-threonin            2.0 g 
L-serin            4.0 g 
L-aspartic acid            6.0 g 
L-glutamic acid            6.0 g 
Powders were ground into a homogeneous mixture and stored at 4°C. In the dropout 
(d/o) media described below uracil or histidin, respectively, were omitted in the mix. 
 
 
2.2.1. S. cerevisiae media 
Ura d/o Glucose 
10× YNB standard stock solution       10% v/v 
Ammonium sulphate     0.5% w/v 
Bases and amino acids 0.087% w/v 
mix without uracil 
Glucose       2% w/v 
(Agar    1.5% w/v) 
 
 
2.2.2. P. pastoris media 
10× YNB stock for P. pastoris 
YNB           34 g/l 
Ammonium sulphate         100 g/l 
The YNB amount in this solution is twice as concentrated as the standard YNB stock 
solution. The solution was filter-sterilized before use. 
 
BMG (Buffered Minimal Glycerol) 
1 M potassium phosphate buffer       10% v/v 
10× YNB stock for P. pastoris       10% v/v 
500× Biotin stock      0.2% v/v 
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Glycerol         1% v/v 
 
BMM (Buffered Minimal Methanol) 
Potassium phosphate, pH 6.0       100 mM 
10× YNB stock for P. pastoris       10% v/v 
500× Biotin stock      0.2% v/v 
Methanol      0.5% v/v 
 
1 M Potassium Phosphate Buffer, pH 6.0 
Potassium dihydrogenphosphat      118.1 g/l 
Di-potassium hydrogenphosphat           23 g/l 
 
500× Biotin stock 
Biotin      20% w/v 
The solution was filter-sterilized and stored at 4°C 
 
His d/o Glucose 
10× YNB standard stock solution       10% v/v 
Ammonium sulphate     0.5% w/v 
Bases and amino acids mix 0.069% w/v 
without histidin 
Glucose        2% w/v 
(Agar    1.5% w/v) 
 
 
2.2.3. Sz. pombe media 
Yeast extract with supplements (YES) 
Yeast extract      0.5% w/v 
Glucose      3.0% w/v 
Agar         2% w/v 
10× supplements       10% v/v 
 
Edinburgh minimal medium (EMM) with supplements 
Potassium hydrogen phthalate      14.7 mM 
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Di-sodium hydrogenphosphate      15.5 mM 
Ammonium chloride       93.5 mM 
Glucose        2% w/v 
(Low glucose     0.5% w/v) 
50× Salt stock          2% v/v 
1,000× Vitamin stock     0.1 % v/v 
10,000× Mineral stock   0.01 % v/v 
10× Supplements       10% v/v 
(2,000× Thiamin stock   0.05% v/v) 
(Agar        2% w/v) 
 
50× Salt stock 
Calcium chloride dihydrate      4.99 mM 
Magnesium chloride hexahydrate         0.26 M 
Potassium chloride         0.67 M 
Sodium sulfate      14.1 mM 
The solution was filter-sterilized and stored at 4°C 
 
1,000× Vitamin stock 
Biotin       40.8 µM 
Inositol      55.5 mM 
Nicotinic acid      81.2 mM 
Pantothenic acid        4.2 mM 
The solution was filter-sterilized and stored at 4°C 
 
10,000× Mineral stock 
Boric acid      80.9 mM 
Citric acid monohydrate      47.6 mM 
Copper(II)-sulfate pentahydrate        1.6 mM 
Iron(III)-chloride hexahydrate        7.4 mM 
Manganese sulfate monohydrate      23.7 mM 
Molybdic acid      2.47 mM 
Potassium iodide      6.02 mM 
Zinc sulfate heptahydrate      13.9 mM 
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The solution was filter-sterilized and stored at 4°C 
 
10× Supplements 
Adenine        2.25 g/l 
L-histidine        2.25 g/l 
L-leucine        2.25 g/l 
L-lysine        2.25 g/l 
Uracil        2.25 g/l 
The solution was filter-sterilized and stored at 4°C. For preparation of EMM leu d/o 
medium, leucine was omitted. 
 
2,000× Thiamin stock 
Thiamin           10 g/l 
The solution was filter-sterilized and stored at -20°C 
 
 
2.2.4. K. lactis media 
YPGal 
Yeast extract        1% w/v 
Peptone        2% w/v 
Galactose        3% w/v 
 
YCB acetamid 
Yeast carbon base   1.17% w/v 
Acetamid         1% v/v 
Sodium phosphate buffer, pH 7.0         3% v/v 
Agar        1% w/v 
The sodium phosphate buffer was prepared separetely. The medium was cooled to 
approximately 40°C before addition of acetamide. 
 
1 M sodium phosphate buffer pH 7.0 
Sodium dihydrogen phosphate              1 M 
Di-sodium hydrogen phosphate              1 M 
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The buffer was prepared mixing 423 ml of the 1 M sodium dihydrogenphosphate 
solution with 577 ml of the 1 M di-sodium hydrogenphosphate solution. 
 
100× Acetamid stock solution 
Acetamid       500 mM 
The solution was filter-sterilized and stored in the dark at 4 °C. 
 
 
2.3. Mammalian cells culture media 
RPMI 1640 was used as the basic medium for all mammalian cells. This culture 
medium contains 2 mM L-glutamine, sodium bicarbonate, and phenol red. Fetal calf 
serum included in all media was inactivated for 10 minutes at 42°C. 
 
2.3.1. IC-21 murine macrophages 
RPMI 1640 
Fetal calf serum       10% v/v 
 
 
2.3.2. Human monocytes, dendritic cells 
RPMI 1640 
Fetal calf serum (LPS-free)        10% v/v 
Penicillin     100 U/ml 
Streptomycin    100 μg/ml 
 
 
2.3.3. Human lymphocytes 
RPMI 1640 
Fetal calf serum       10% v/v 
Penicillin     100 U/ml 
Streptomycin    100 μg/ml 
 
 
2.3.4. Freezing medium 
RPMI 1640       20% v/v 
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DMSO       10% v/v 
FCS       60% v/v 
 
 
3. Buffers and Solutions 
 
3.1. Common buffers 
10× TE 
Tris-HCl         10 mM 
EDTA (disodium)           1 mM 
pH 7.5 
 
10× Phosphate-buffered saline (PBS) 
Sodium chloride           1.5 M 
Disodium hydrogen phosphate           0.1 M 
pH 7.4 
 
Hank’s balanced salt solution (HBSS) 
• Stock 1 
Sodium chloride        8% w/v 
Potassium chloride     0.4% w/v 
• Stock 2 
Disodium hydrogen phosphate   0,36% w/v 
Potassium dihydrogen phosphate     0.6% w/v 
• Stock 3 
Calcium chloride   1.44% w/v 
• Stock 4 
Magnesium sulphate heptahydrate   2.46% w/v 
• Stock 5 
Sodium hydrogen carbonate     3.5% w/v 
 
All stock solutions were filter-sterilized and stored at 4°C. Prior to use, solutions were 
mixed as follows: 
Stock 1       10% v/v 
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Stock 2         1% v/v 
Stock 3         1% v/v 
Stock 4         1% v/v 
Stock 5         1% v/v 
 
250× Luminol solution 
Lminol       100 mM 
in DMSO 
Aliquots were stored at -20°C. 
 
Lysis buffer 
Tris         20 mM 
Magnesium chloride         10 mM 
Ammonium sulphate           0.3 M 
EDTA           1 mM 
Glycerin         5% v/v 
Dithiothreitol           1 mM 
Protease inhibitor cocktail                1× 
 
Isolation buffer 
Tris-HCl, pH 7.8         10 mM 
100× PMSF         1% v/v 
 
100× PMSF 
PMSF       100 mM 
in isopropanol 
The solution was stored at -20°C. 
 
1,000× DTT 
DTT              1 M 
in 10 mM sodium acetate, pH 5.2. 
The solution was filter-sterilized and stored at -20°C. 
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3.2. Buffers for agarose gel electrophoresis 
GLB (Gel Loading Buffer) 
Glycerol      50% w/v 
SDS        1% w/v 
EDTA       125 mM 
Bromophenol blue   0.05% w/v 
Xylenecyanol   0.05% w/v 
 
10× TBE 
Tris base         0.89 M 
Boric acid         0.89 M 
EDTA         20 mM 
 
 
3.3. Buffers for isolation of plasmid DNA 
GTE 
Glucose         50 mM 
Tris-HCl, pH 8.0         25 mM 
EDTA         10 mM 
 
5 M Potassium acetate 
Acetic acid (98%)    29.5% v/v 
pH 4.8 
 
NaOH/SDS 
NaOH       200 mM 
SDS        1% w/v 
 
 
3.4. Solutions for transformation of Sz. pombe 
10× TE 
Tris       100 mM 
EDTA         10 mM 
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pH 7.5 
 
Lithium acetate / EDTA 
Lithium acetate       100 mM 
EDTA           1 mM 
pH 4.9, filter-sterilized 
 
PEG / lithium acetate / EDTA 
Polyethylene glycol 3350      40% w/v 
EDTA           1 mM 
Lithium acetate       100 mM 
 
 
3.5. Solutions for transformation of P. pastoris 
10 × Bicin-NaOH pH 8.3 
Bicin       100 mM 
pH 8.3 
 
BEDS Buffer 
10 x Bicin-NaOH pH 8.3       10% v/v 
Ethylene glycol         3% v/v 
DMSO         3% v/v 
Sorbitol              1 M 
 
1 M Sorbitol 
Sorbitol              1 M 
The solution was filter-sterilized and stored at 4 °C. 
 
 
3.6. Solutions for transformation of S. cerevisiae 
10× lithium acetate 
Lithium acetate              1 M 
pH 7.5 
The solution was filter-sterilized and stored at room temperature. 
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10× TE 
Tris       100 mM 
EDTA         10 mM 
pH 7.5 
 
Lithium acetate / TE 
10× TE       10% v/v 
10× lithium acetate pH 7.5       10% v/v 
 
PEG solution 
10× Lithiumacetat       10% v/v 
10× TE pH 7,5       10% v/v 
PEG 4000 50% (w/v)       80% v/v 
 
 
3.7. Solutions for transformation of K. lactis 
Yeast Transformation Reagent (New England Biolabs) 
 
 
3.8. Buffers for VLP preparation 
Spheroplasting buffer 
Tris-HCl pH7.5         10 mM 
Sorbit           0.8 M 
CaCl2         10 mM 
1,000× DTT      0.2% v/v 
Zymolyase 20T    200 µg/ml 
DTT and zymolyase were added separately. 
 
PBSE(S) 
NaCl       150 mM 
Na2HPO4         10 mM 
Na2EDTA         10 mM 
(Sorbitol              1M) 
pH 7.4 
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Sucrose gradient solutions 
Sucrose                          20%, 45%, or 70% w/v 
in PBSE 
The 20-70% sucrose linear gradient was prepared with a gradient former (BioRad) 
using equal volumes of 20% sucrose and 70% sucrose solutions. 
 
 
3.9. Buffers and solutions for SDS-PAGE 
Tris-Glycin 
Tris         25 mM 
Glycin       250 mM 
SDS     0.1% w/v 
 
10× SDS gel loading buffer 
Tris-HCl pH 6.8              1 M 
SDS      10% w/v 
Bromophenol blue     0.5% w/v 
Glycerol       50% v/v 
β-Mercaptoethanol              1 M 
 
 
3.10. Buffers and solutions for western blotting 
10× TBS 
Tris              1 M 
NaCl           1.5 M 
pH 7.5 
 
Transfer buffer 
Tris-HCl, pH8.4         25 mM 
Glycine       190 mM 
Methanol       20% v/v 
SDS     0.1% w/v 
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Wash buffer 
10× TBS       10% v/v 
Tween 20    0.05% v/v 
 
Blocking buffer 
10× TBS       10% v/v 
Tween 20    0.05% v/v 
Low-fat milk        5% w/v 
 
 
3.11. Buffers and solutions for cell culture 
Erythrocyte lysing solution 
Potassium bicarbonate         0.01 M 
Ammonium chloride       0.155 M 
EDTA        0.1 mM 
The pH was adjusted to 7.5 and the solution was filter-sterilized. 
 
FACS buffer 
Fetal calf serum         5% v/v 
BSA     0.5% w/v 
Sodium azide   0.07% w/v 
in PBS 
 
FACS Fix 
Paraformaldehyde        1% w/v 
Sodium chloride          8.5 g/l 
pH 7.4 
 
MACS buffer 
BSA     0.5% w/v 
EDTA           2 mM 
in PBS 
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4. Primers 
Table 3 shows the oligonucleotide primers used in this work for PCR amplification. 
Primers were synthesized by Sigma. 
 
Table 3. Oligonucleotide primers used and their respective sequences. Restriction 
enzyme recognition sites are underlined; start and stop codons are written in bold; 
mutations are written in italics. 
Primer name Sequence (5’ – 3’) 
5’HindIII_EcoRI_Ova AAG CTT GAA TTC ATG GGC TCC ATC GGC GCA G 
3’BglII_NotI_Ova GCG GCC GC A GAT CTT TAA GGG GAA ACA CAT CTG CCA AAG AAG 
5’EcoRI_XhoI Ova 
(Walch, 2009) GAA TTC CTC GAG ATG GGC TCC ATC GGC GCA G 
3’SalI_BglII_Ova 
(Walch, 2009) 
GTC GAC AGA TCT TTA AGG GGA AAC ACA TCT 
GCC AAA GAA G 
5’AvrII_Sed1 
(Müller, 2008) 
CCT AGG TTT TCC AAC AGT ACA TCT GCT TCT 
TCC ACC 
3’NotI_Sed1 
(Müller, 2008) 
GCG GCC GCT TAT AAG AAT AAC ATA GCA ACA 
CCA GCC AAA CC 
3’BglII_Sed1 AGA TCT TTA TAA GAA TAA CAT AGC AAC ACC AGC CAA ACC 
3’Ova_AvrII_ohneStop CCT AGG AGG GGA AAC ACA TCT GCC AAA GAA GAG 
5’ Ovacyt_mut TAT TCA AGG AGC TTA TCA ATT CCT GGG TA 
3’ Ovacyt_mut TAC CCA GGA ATT GAT AAG CTC CTT GAA TA 
5’ XbaISacI_Ovacyt TCT AGA GAG CTC ATG GGC TCC ATC GGC GCA GCA 
5’pp65 
(Walch, 2009) 
GAA TTC CTC GAG GAG CTC ATG ATA TCC GTA 
CTG GGT CCC ATT TCG 
3’ pp65 
(Walch, 2009) 
TCT AGA GTC GAC TCA ACC TCG GTG CTT TTT 
GGG C 
3’BamHIpp65 
(Schumacher, 2001) GGA TCC TCA ACC TCG GTG CTT TTT GGG C 
5’SacI pp65 GAG CTC ATG ATA TCC GTA CTG GGT CCC 
5’Prepropp65 AGC AGG GCT TAG AAG AAC GTA TGA TAT CCG TAC TGG GT 
3’Prepropp65 ACC CAG TAC GGA TAT CAT ACG TTC TTC TAA GCC CTG CT 
5’pp65mutBstXI TTC GTG TTT CCC ACA AAG GAC GTG 
3’pp65 mutBstXI CAC GTC CTT TGT GGG AAA CAC GAA 
5’ K28 
(Sendzik, 2006) 
CTC GAG GAA TTC ATG GAG AGC GTT TCC TCA 
TTA TTT AAC ATT TTT TC 
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5. Antibodies 
5.1. Primary antibodies 
All primary antibodies used in this work are listed in Table 4. 
 
Table 4. Primary antibodies utilized throughout this work, their main characteristics and 
sources. 
Antigen Clone Host Isotype Conjugation Manufacturer 
Chicken Ovalbu-
min (polyclonal) - rabbit - - Sigma 
HCMV pp65 2 and 6 mouse IgG1 κ - Leica 
β-1,3-glucan  mouse IgG κ - Biosupplies Australia 
Mouse CD8a 53-6.7 rat IgG2a κ FITC Becton Dickinson 
Mouse IFN-γ XMG1.2 rat IgG1 κ PE-Cy7 Becton Dickinson 
Mouse Vβ5.1/5.2 MR9-4 mouse IgG1 κ PE Becton Dickinson 
Mouse Dectin-1 2A11 rat IgG2b - Serotec 
Mouse/human 
Mannose receptor 15-2 mouse IgG1 - Abcam 
Human Dectin-1 GE2 mouse IgG1 - Serotec 
Human IFN-γ 4S.B3 mouse IgG1 κ FITC Becton Dickinson 
Human CD1a NA1/34 mouse IgG2a κ FITC Dako 
Human CD3 UCHT1 mouse IgG1 FITC Beckman Coulter 
Human CD4 SK3 mouse IgG1 κ PerCP Becton Dickinson 
Human CD8 SK1 mouse IgG1 PerCP Becton Dickinson 
Human CD14 TÜK4 mouse IgG2a κ PE Dako 
Human CD19 J3-119 mouse IgG1 PE Beckman Coulter 
Human CD28 L293 mouse IgG1 - Becton Dickinson 
Human CD40 5C3 mouse IgG1 κ FITC Becton Dickinson 
Human CD49d 9F10 mouse IgG1 κ - Becton Dickinson 
Human CD54 HA58 mouse IgG1 κ PE Becton Dickinson 
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Table 4 continuation 
Antigen Clone Host Isotype Conjugation Manufacturer 
Human CD58 1C3 mouse IgG2a κ FITC Becton Dickinson 
Human CD69 TP1.55.3 mouse IgG2b PE Beckman Coulter 
Human CD80 MAB104 mouse IgG1 PE Beckman Coulter 
Human CD83 HB15a mouse IgG2b PE Beckman Coulter 
Human CD86 2331 (FUN-1) mouse IgG1 κ FITC 
Becton 
Dickinson 
Human CCR7 3D12 rat IgG2a κ PE Becton Dickinson 
Human HLA 
A,B,C W6/32 mouse IgG2a κ PE Dako 
Human HLA DP, 
DQ, DR CR3/43 mouse IgG1 κ FITC Dako 
 
 
5.2. Secondary antibodies 
The secondary antibodies used in this work are listed in Table 5. 
 
Table 5. Secondary antibodies used in this work, their main characteristics and 
manufacturers. 
Antigen Host Conjugation Manufacturer 
Mouse IgG goat FITC Sigma 
Mouse IgG goat PE Sigma 
Mouse IgG goat horseradish peroxidase type VI Sigma 
Rabbit IgG goat FITC Sigma 
Rabbit IgG goat horseradish peroxidase type VI Sigma 
Rat IgG goat FITC Sigma 
 
 
6. Proteins and peptides 
Chicken ovalbumin, Sigma-Aldrich (Schnelldorf, Germany) 
wheat germ agglutinin-FITC 
Concanavalin A-FITC Invitrogen (Darmstadt, Germany) 
Pp65 from HCMV Miltenyi Biotec (Bergisch Gladbach, Germany) 
                    Materials 
 
  61 
SIINFEKL peptide Eurogentec (Cologne, Germany) 
 
 
7. Enzymes 
DNase-free RNase, restriction  Fermentas (St. Leon-Rot, Germany) 
enzymes, T4 DNA Ligase 
Klenow Polymerase Roche (Mannheim, Germany) 
Laminarinase Sigma-Aldrich (Schnelldorf, Germany) 
Zymolyase 20T (A. luteus) AMS Biotechnology (Abingdon, UK) 
 
 
8. Molecular weight markers 
PageRuler prestained protein ladder Fermentas (St. Leon-Rot, Germany) 
Quick-Load 1 kb DNA Ladder New England Biolabs (Frankfurt, Germany) 
Smart Ladder DNA ladder Eurogentec (Seraing, Belgium) 
 
 
9. Reagents for cell culture 
Brefeldin A, ionomycin, LPS, 
penicillin/streptomycin, PMA, 
RPMI1640 with phenol red, 
saponin, Staphylococcus 
enterotoxin B 
Sigma-Aldrich (Schnelldorf, Germany) 
HCMV lysate Virion\Serion (Würzburg, Germany) 
FACS lysing solution Becton Dickinson (Heidelberg, Germany) 
Lymphocyte separation medium, 
Fetal calf serum 
PAA (Cölbe, Germany) 
Recombinant human GM-CSF 
(rhGM-CSF) 
Berlex Laboratories (Richmond, USA) 
Recombinant human IL-4 (rhIL-4) Miltenyi Biotec (Bergisch Gladbach, Germany) 
 
 
10. Kits 
Expand High Fidelity PCR System Roche Diagnostics (Mannheim, Germany) 
E.Z.N.A. Gel Extraction Kit OMEGA bio-tek (Norcross, USA) 
K. lactis Protein Expression Kit New England Biolabs (Frankfurt, Germany) 
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MACS CD14 microbeads, sepa- 
ration columns, and separation unit 
Miltenyi Biotec (Bergisch Gladbach, Germany) 
peqGOLD Plasmid Miniprep Kit II PEQLAB Biotechnologie (Erlangen, Germany) 
pSTBlue-1 AccepTor 
Vector Giga Kit 
Novagen (Darmstadt, Germany) 
SuperSignal West Dura Substrat Thermo Scientific (Reinach, Switzerland) 
 
 
11. Other chemicals and materials 
Agar, peptone, yeast extract Marcor (New Jersey, USA) 
Agarose Biozym (Oldendorf, Germany) 
Ampicillin, bromophenolblue Sigma-Aldrich (Schnelldorf, Germany) 
Complete protease inhibitor 
cocktail, PVDF Membrane 
Roche (Mannheim, Germany) 
Dialysis filter Millipore (Schwalbach, Germany) 
Difco YNB w/o amino acids 
and ammonium sulphate 
Becton Dickinson (Heidelberg, Germany) 
Electroporation cuvette, 
extra thick blot paper 
BioRad (Munich, Germany) 
Luminol, salmon sperm DNA, 
β-mercaptoethanol 
Serva (Heidelberg, Germany) 
Vivaspin Sartorius (Goettingen, Germany) 
All other chemicals and materials Merck (Darmstadt, Germany);  
Roth (Karlsruhe, Germany) 
 
 
12. Plasmids 
The source and main characteristics of the plasmids used as PCR template or for 
cloning, subcloning, or sequencing purposes are listed in Table 6. Constructed plasmids 
used for expression of recombinant proteins in this work are listed in Table 7. 
 
Table 6: Plasmids used throughout this work and their main properties. 
Plasmid (size) Source Properties 
pSTBlue-1 
(3.8 kbp) Novagen 
Linearized vector for TA cloning, ampR, kanR, 
T7 and SP6 promoters, lacZα-reporter gene for 
blue/white screening, 
pKLAC1 
(9.0 kbp) 
New England 
Biolabs 
K. lactis integrative expression vector, LAC4 
promoter, amdS gene, α-mating factor, ampR 
pREP1 
(8.9 kbp) Maundrell, 1993
Sz. pombe episomal expression vector, nmt1 
promoter, leu2 gene, autonomous replicating 
sequence, ampR 
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Table 6 continuation 
Plasmid (size) Source Properties 
pREP-BD 
(9.0 kbp) Diehl, 2008 
pREP1 vector with improved multiple cloning 
site 
pPIC3.5 
(7.8 kbp) Invitrogen 
P. pastoris integrative expression vector, aox1 
promoter, his4 gene, ampR 
pPIC9 
(8.0 kbp) Invitrogen 
P. pastoris integrative expression vector, aox1 
promoter, his4 gene, α-mating factor, ampR 
pPIC9/sed1 Müller, 2008 pPIC9 vector containing the sed1 sequence 
pPGK 
(6.1 kbp) 
Kang et al., 
1990 
S. cerevisiae episomal expression vector, pgk 
promoter, ura3 gene, 2µ origin, ampR 
pPGK-
6His/Xa/GST 
(6.7 kbp) 
Bernardy, 2006 pPGK vector containig a 6×His/Xa/GST/TGA gene fusion 
pPGK-M28-I 
(6.9 kbp) 
Schmitt and 
Tipper, 1995 
pPGK vector containing a K28preprotoxin 
coding sequence  
pFB2 
(6.3 kbp) Breinig, 2002 
pPGK-M28-I-derived vector containing 
Kre1/HA/Cwp2 genes 
pYES/OVA 
(7.0 kbp) Walch, 2009 
S. cerevisiae expression vector pYES 
(Invitrogen), ura3 gene, GAL1 promoter, 2µ 
origin, ampR; containing the ova gene 
pYES/OVAcyt 
(6.7 kbp) Walch, 2009 
S. cerevisiae expression vector pYES 
(Invitrogen), ura3 gene, GAL1 promoter, 2µ 
origin, ampR; contains the Ovacyt coding 
sequence 
pPGK/pp65 
(7.7 kbp) 
Schumacher, 
2001 
pPGK vector containing the sequence coding 
for full-length pp65 
pG[0]G 
(8.9 kbp) Powilleit, 2004 pPGK vector containing gag/gfp gene fusion  
pG 
(8.1 kbp) Powilleit, 2004 pPGK vector containing gag gene 
YEp 352 
(5.2 kbp) Hill et al., 1986 
S. cerevisiae vector, ura3 gene, 2µ origin, 
ampR 
 
 
Table 7: Plasmids constructed in this work for recombinant protein expression and their 
properties. 
Plasmid (size) Properties 
pPGK/ova 
(7.2 kbp) 
pPGK vector containing the sequence coding for full-length 
Ova 
pPGK/ovacyt 
(6.9 kbp) pPGK vector containing the Ovacyt coding sequence 
pFB2/ovacyt/sed1 
(7.9 kbp) 
pFB2 vector containing the OVAcyt/sed1 open reading frame 
downstream of the Kre1 leader sequence 
pPGK/kre1/pp65 
(7.8 kbp) 
pPGK vector containing the sequence coding for full-length 
pp65 downstream of the Kre1 leader sequence 
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Table 7 continuation 
Plasmid (size) Properties 
pG[0]G/ovacyt 
(9.0 kbp) 
pG[0]G vector containing the Ovacyt coding sequence 
downstream of the gag gene (replacing gfp) 
pG[0]G/pp65 
(9.8 kbp) 
pG[0]G vector containing the sequence coding for full-length 
pp65 downstream of the gag gene (replacing gfp) 
pREP-BD/ova 
(9.9 kbp) 
pREP-BD vector containing the sequence coding for full-length 
Ova 
pREP-BD/ovacyt 
(9.6 kbp) pREP-BD vector containing the sequence coding for Ovacyt 
pREP1/pp65 
(10.6 kbp) 
pREP1 vector containing the sequence coding for full-length 
pp65 
pREP1/prepropp65 
(10.7 kbp) 
pREP1 vector containing the sequence coding for full-length 
pp65 downstream of a K28preprotoxin leader sequence 
pPIC3.5/ova 
(8.9 kbp) 
pPIC3.5 vector containing the sequence coding for full-length 
Ova 
pPIC3.5/ovacyt 
(8.6 kbp) pPIC3.5 vector containing the sequence coding for Ovacyt 
pPIC3.5/pp65 
(9.4 kbp) 
pPIC3.5 vector containing the sequence coding for full-length 
pp65 
pPIC9/ovacyt/sed1 
(9.7 kbp) 
pPIC9 vector containing the sequence coding for Ovacyt 
downstream of the α-mating factor sequence and upstream of 
the sed1 coding sequence 
pPIC9/pp65 
(9.6 kbp) 
Contains the sequence coding for full- length pp65 downstream 
of the α-mating factor sequence 
pKLAC1/ova 
(10 kbp) 
pKLAC1 vector without the α-mating factor sequence and 
containing the sequence coding for full-lehgth OVA 
pKLAC1/ovacyt 
(9.7 kbp) 
pKLAC1 vector without the α-mating factor sequence and 
containing the Ovacyt coding sequence 
pKLAC1/ovacyt/ 
sed1 
(10.7 kbp) 
pKLAC1 vector containing the ovacyt/sed1 fusion downstream 
of the α-mating factor sequence 
pKLAC1/pp65mut 
(10.5 kbp) 
pKLAC1 vector without the α-mating factor sequence and 
containing the sequence coding for pp65 
pKLAC1/ 
secpp65mut 
(10.7 kbp) 
pKLAC1 vector containing the sequence coding for pp65 
downstream of the α-mating factor sequence 
 
 
12.1. Plasmid maps 
The maps of the plasmids used in this work for sequencing or transformation purposes 
are given below (Fig. 5). 
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G                                                                           H 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Schematic representation of DNA plasmids used for sequencing (A) or for 
heterologous gene expression in K. lactis (B), P. pastoris (C and D), Sz. pombe (E and 
F), and S. cerevisiae (G). The plasmid YEp352 (H) was only used as control vector in 
S. cerevisiae. 
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III. METHODS 
 
 
1. Molecular Biology Methods 
 
1.1. DNA amplification by polymerase chain reaction 
The polymerase chain reaction (PCR) allows the amplification of a specific DNA 
fragment flanked by regions of known sequence. This method relies on the selective 
replication of a certain DNA segment catalyzed in vitro by a heat-stable DNA 
polymerase in a series of cycles (Saiki et al., 1985). Two oligonucleotides which are 
complementary to the 3’ ends of the region to be amplified are used as primers. These 
can also contain additional restriction sites, in order to permit further cloning of the 
DNA fragment into specific plasmid vectors. A typical reaction mixture contains the 
template DNA, a thermostable DNA polymerase, at least two oligonucleotide primers, 
and the four deoxynucleotides in a reaction buffer containing Mg2+. First, the reaction 
mixture is heated to 94°C in order to denature the DNA, than cooled down below the 
melting temperature of the primers (40-60°C) for hybridization of these synthetic 
oligonucleotides to the complementary DNA strands (annealing). Next, when the 
optimum temperature for the DNA polymerase is reached (68-72°C), elongation occurs. 
In this step, DNA is synthesized by polymerization, starting from the oligonucleotide 
primers. The most widely used polymerase is derived from the thermophilic bacterium 
Thermus aquaticus and referred to as Taq polymerase. In order to minimize the 
occurrence of mutations, a high-fidelity DNA polymerase with proofreading activity 
was used. 
A typical 50 μl-reaction was prepared as follows: 
 
Template DNA (1:10 dilution)                      1.0 µl 
10 mM dNTP mix                      0.5 µl 
100 µM Forward primer                      0.5 µl 
100 µM Reverse primer                      0.5 µl 
Taq DNA Polimerase 5U/µl                      0.7 µl 
10× reaction buffer containing Mg2+                      5.0 µl 
Distilled water                  ad 50 µl 
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PCRs were performed in a Peqlab or an Eppendorf thermocycler. A classical reaction 
was run as follows: 
 
Initial denaturation  94ºC       3 min 
Denaturation   94ºC          30 s 
Annealing   45-65ºC         30 s        30 cycles 
Elongation   72ºC  1 min/kb 
Terminal elongation  72ºC       6 min 
 
 
SOE PCR 
The “splicing by overlap extention” (SOE) method is used to construct a DNA fragment 
encoding a fusion protein. In this technique, the sequences are fused in frame without 
the use of restriction sites. A total of four oligonucleotide primers are used, so that the 
reverse primer of the first sequence has an overlapping region with the forward primer 
of the second coding sequence. 
First, the genes to be fused are amplified in separate PCRs. Then, the PCR 
products are isolated and brought together in a reaction tube containing the forward 
primer of the first sequence and the reverse primer of the second sequence, among the 
other reagents necessary for a classical reaction, as described above. In the course of the 
reaction, the strands with the matching sequences overlap, acting as primers for each 
other and allowing extension by DNA polymerase. Therefore, the resulting molecule is 
a product of recombined genes, whose original sequences were ‘spliced’ together (Ho et 
al., 1989; Horton et al., 1989). Reactions were basically run as described above in this 
section. 
 
 
1.2. Agarose gel electrophoresis 
Agarose gel electrophoresis is a method used for determination of length and purity of 
DNA molecules that migrate in an electric field (Aaij and Borst, 1972). Double-
stranded DNA molecules pass through the gel at rates that are inversely proportional to 
the log10 of the number of base pairs. Large DNA fragments migrate through the matrix 
pores with less efficiency in comparison to smaller molecules (Sambrook et al., 1989). 
Migration patterns of DNA molecules also depend on molecular conformation and 
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agarose concentration. Since the phosphate backbone confers negative charge to nucleic 
acids, these molecules migrate toward the positive electrode under the selected buffer 
conditions (TBE, pH 8.3). 
An appropriate amount of agarose (0.8-1% w/v) was diluted in 1× TBE buffer 
and heated in a microwave oven until it was completely dissolved. After cooling to 50-
60°C, the solution was poured into a mould and allowed to gelatinize. After 
solidification, the gel was submerged in 1X TBE running buffer. The DNA samples 
were mixed with “Gel Loading Buffer” (5:1) before being loaded on the agarose gel. 
This buffer also contains glycerol, which enhances the density of the samples, rendering 
them to sink into the pockets. Electrophoresis was performed at approximately 8 V/cm. 
The electrophoretic separation was monitored by the position of dyes (bromophenol 
blue and xylene cyanol). Smart Ladder (range 200 bp – 10,000 bp, Fermentas) or Quick 
Load 100 bp DNA Ladder (range 100 bp – 1517 bp, New England Biolabs) were used 
as molecular weight markers. 
After electrophoresis, the gel was incubated for 10 minutes in a water bath 
containing 0.3 ‰ (v/v) ethidium bromide. This dye intercalates between base pairs of 
nucleic acids, generating fluorescent complexes which can be visualised under UV 
light. 
 
 
1.3. Elution of DNA fragments from agarose gels 
Reisolation of DNA fragments was performed with the “E.Z.N.A. Gel Extraction Kit” 
(Omega Biotek). This procedure relies on the melting of agarose and subsequent 
binding of the DNA to a membrane in the presence of chaotropic ions. The desired 
DNA band was excised from the ethidium bromide stained agarose gel with a scalpel 
and placed into a 2 ml tube. The gel slice was melted in 400 µl of XP2 binding buffer at 
65°C for 7 minutes. The mixture was transferred to the silica column and centrifuged at 
13,000 rpm for 1 minute. Then, the column was washed with 300 µl of XP2 binding 
buffer, followed by 700 µl of SPW wash buffer. The column was further centrifuged for 
2 min at 13,000 rpm to dry the matrix and 30 µl of sterile distilled water were added. 
After 2 minutes, the DNA was eluted by centrifugation at 13,000 rpm. 
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1.4. Restriction enzyme digestion of plasmid DNA 
Restriction enzymes are endonucleases of bacterial origin that bind to double-stranded 
DNA at specific sites, breaking phosphodiester bonds inside or beyond the recognition 
sequence. Restriction endonucleases have been divided into three groups (type I, type II, 
type III), and type II enzymes are the most routinely used in molecular cloning, since 
they digest the DNA within the recognition sequence. Some restriction endonucleases 
generate staggered cuts, leaving short, 5’ or 3’ single-stranded overhanging ends at the 
tails of the fragments, which are known as cohesive or sticky ends. Other DNA 
endonucleases generate blunt-ended fragments. The majority of the recognition 
sequences are 4-8 base pairs long and palindromic, i.e., rotationally symmetrical 
(Bigger et al., 1973; Sambrook et al., 1989). 
Restriction digestion was performed using 5 U of the specific enzyme, 0.5–2 µg 
plasmid DNA, the correspondent buffer properly diluted (10-fold or 5-fold dilutions, 
depending on the enzyme), and sterile distilled water to 20 µl. If DNA preparations 
were derived from alkaline lysis, 5 U of RNase A was added in order to degrade any 
remaining RNA in the sample. Reactions were incubated at the optimum temperature 
for each enzyme (generally 37°C) for 1.5 h, then mixed with “Gel Loading Buffer” and 
analyzed by agarose gel electrophoresis. 
 
 
1.5. Cloning of PCR products using AccepTor Vector Kit 
PCR amplification products were ligated to pSTBlue-1 vector (Novagen) for 
sequencing purposes. This linearized vector contains single 3’-dU overhangs, providing 
optimal conditions for ligation with PCR fragments generated by some thermostable 
DNA polymerases, like Taq polymerase, which add single 3’-dA to the amplified 
products. The dU residues are substituted for dT residues as the plasmid is replicated 
within bacteria. 
A typical ligation reaction of a PCR product in the pSTBlue-1 vector was 
performed as follows: 0.5 µl (25 ng) of pSTBlue-1 vector were mixed with 1 µl of the 
purified PCR product and 2.5 µl of “Clonables 2× Ligation Premix”. Water was added 
to 5 µl and the reaction tube was incubated for 1 h at 16°C. After that, the ligation 
product was used to transform “NovaBlue Singles Competent Cells” (Novagen), as 
described in section 4.1. 
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Colonies were screened for the presence of insert in the pSTBlue-1 plasmid 
following the method for blue/white selection. The pSTBlue-1 plasmid contains a gene 
which codes for a lacZ α-peptide that complements the lacZ ω-fragment produced by 
the E. coli strain supplied with the kit. The resulting product, β-galactosidase, 
hydrolizes the galactoside substrate X-gal (5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside) yielding 5,5'-dibromo-4,4'-dichloro-indigo, an insoluble blue 
pigment, which confers the colony a blue phenotype. Inserts successful cloned into 
pSTBlue-1 vector interrupt the sequence encoding the α-peptide, which generates a 
white colony on X-gal/IPTG plates. 
 
 
1.6. DNA ligation 
Ligation of two DNA molecules involves the formation of a phosphodiester bond 
between the 3’-hydroxyl group at the terminus of one strand and a 5’phosphate at the 
end of another strand, in a reaction that consumes ATP. In molecular cloning, 
bacteriophage T4 DNA Ligase is the most routinely used enzyme, as it can efficiently 
link blunt-ended DNA segments under normal reaction conditions (Sambrook et al., 
1989; Nelson and Cox, 2005). 
 
Sticky-end ligation 
A previously digested and purified DNA fragment was mixed with the correspondent 
vector DNA carrying compatible cohesive ends. Normally, a threefold molar excess of 
the insert in comparison to the vector was used. For a typical 20-µl reaction, 1 U of T4 
DNA Ligase and 2 µl of 10× ligation buffer containing ATP were added. If necessary, 
sterile distilled water was added up to 20 µl. Reactions were incubated overnight at 
16°C or for 2 h at room temperature. After that, the ligation mixture was dialyzed 
against 10% glycerine on a nitrocellulose membrane (0.025 µm mean pore size, 
Millipore) at room temperature, for 1 h. 
 
Blunt-end ligation 
In order to fill recessed 3’ termini or to digest protruding 3’ ends created by digestion of 
DNA with restriction enzymes, the large fragment of DNA polymerase I (Klenow 
Fragment) was used. Klenow Fragment is a product of proteolytic cleavage of E. coli 
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DNA polymerase I which possesses polymerization and 3'→ 5' exonuclease activities, 
but no 5'→ 3' exonuclease activity (Klenow and Henningsen, 1970). Klenow was used 
to generate blunt ends by removing of 3´ overhangs or filling-in of 5´ overhangs. For 
removal of protruding 3´ ends, 2 U of Klenow enzyme were added to the digestion 
reaction after 1.5 h restriction, and the volume was brought up to 30 µl with sterile 
distilled water and restriction enzyme buffer. Samples were incubated for 1 h at 37°C 
and subsequently purified with “E.Z.N.A. Gel Extraction kit” for further digestion. For 
filling 5´ overhangs, 4 µl 10 mM dNTPs were also added to the reaction mixture. 
Ligation was performed as follows: for a 20-µl reaction, specific volumes of 
insert and vector were mixed with 1 µl of 10 mM ATP, 1 µl of 40% PEG 8000, and 1 U 
of T4 DNA Ligase. PEG 8000 is a condensing agent, which enhances macromolecular 
crowding, increasing the efficiency of ligation reactions (Zimmerman and Pheiffer, 
1983). Reactions were incubated overnight at 16°C and dialyzed on a filter membrane, 
as described previously for sticky-end ligation. 
 
 
1.7. Determination of DNA concentration and purity 
Spectrophotometric determination of DNA concentration relies on the fact that nucleic 
acids strongly absorb UV light at 260 nm. Since the aromatic amino acids 
phenylalanine, tyrosine and tryptophane absorb strongly at 280 nm, purity of DNA 
preparation can be assessed by the quotient A260/A280. An optimum A260/A280 ratio 
ranges between 1.8-2.0 for a cuvette spectrophotometer. Values under 1.8 indicate 
protein contamination, whereas values above 2.0 suggest the presence of RNA in the 
sample. 
One microliter of a DNA solution was mixed with 59 µl of sterile distilled water 
and transferred to a 1 cm-thick quarz cuvette. Water was used as reference. 
Concentrations were calculated in µg/ml. 
Alternatively, the DNA concentration was roughly estimated by comparing the 
intensity of the DNA band to a molecular marker of known concentration. Two 
microliters of DNA solution were mixed with GLB and water to a final volume of 10 
µl, applied on 1% agarose gel and allowed to migrate a certain distance, so that the 
bands of the marker would be well separated. After incubation of the gel in ethidium 
bromide bath for 30 minutes (for sufficient staining of the less concentrated bands), 
bands were visualized under UV light for direct comparison. 
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1.8. DNA sequencing 
DNA sequence analysis by the dideoxy chain termination method (Sanger, 1977) makes 
use of labeled dideoxynucleotides as chain terminating agents. A new DNA strand is 
synthesized, starting from a specific primer, and synthesis is interrupted after 
incorporation of a dideoxynucleotide. The reactions are base-specific, so that the sizes 
of the fragments are used to determine the exact positions in which a specific base 
appears. At the very end of the procedure, four sets of labeled fragments are present, 
which are then separated on a gel matrix and identified by a detector (Nelson and Cox, 
2005). 
Aliquots of miniprep-purified plasmid DNA (75 ng/µl) were subjected to 
sequence analysis to confirm the predicted nucleotide sequences. For verification of 
inserts cloned into the pSTBlue-1 vector the oligonucleotide primers T7 and SP6 were 
used. Analyzes were performed on an automated DNA sequencer (GATC Biotech, 
Konstanz, Germany). Data analysis was carried out using the softwares Chromas Lite 
(Technelysium Pty Ltd) and GeneRunner (Hastings Software, Inc.). 
 
 
1.9. Plasmid DNA extraction 
1.9.1. Alkaline lysis 
The alkaline lysis is the most routinely used method for isolation of plasmid DNA. 
Bacteria are first resuspended in the osmotic stabilizing solution GTE. EDTA 
destabilizes cell membranes by complexing with divalent cations. Then, cells are lysed 
with SDS and NaOH denatures chromosomal DNA (unlike close circular DNA, linear 
chromosomal DNA denatures upon exposure to alkaline pH). By adding potassium 
acetate, the pH is neutralized, causing chromosomal DNA to aggregate, and protein-
SDS complexes and high-molecular weight RNA to precipitate. Thus, plasmid DNA 
can be separated from the major contaminating macromolecules by centrifugation and 
subsequently concentrated by ethanol precipitation (Birnboim and Doly, 1979). 
A single bacterial colony was picked and inoculated in 5 ml of LB medium 
supplemented with the appropriate antibiotic. The culture was incubated overnight at 
37°C and 220 rpm. Solutions needed for isolation are described in Section 3.3 of 
Materials. Cells from 1.5 ml culture were centrifuged at 13,000 rpm for 30 s. The 
bacterial pellet was resuspended in 100 µl of GTE solution by vigorous vortexing. After 
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3 minutes of incubation at room temperature, 200 µl of NaOH/SDS were added. The 
contents were mixed by inverting the tube rapidly and the tube was stored on ice for 5 
min, after which 150 µl of potassium acetate were added. The tube was inverted for 10 
seconds, stored for another 5 minutes on ice and then centrifuged at 13,000 rpm for 5 
minutes at 4°C to pellet cell debris and chromosomal DNA. The supernatant was 
transferred to a fresh 1.5 ml tube. The double-stranded plasmid DNA was precipitated 
with 1 ml of ethanol at room temperature. After mixing, the mixture was incubated for 3 
minutes at room temperature and centrifuged at 13,000 rpm for 10 min at 4°C. The 
supernatant was removed and the DNA pellet was allowed to dry at 60°C for 10 
minutes. The pellet was dissolved in 20 µl of distilled water at 60°C and stored at -
20°C. For restriction endonuclease digestion purposes, residual low-molecular weight 
RNA was degraded by DNase-free RNase. 
 
 
1.9.2. Plasmid DNA isolation with Miniprep-kit 
By exploiting the selective binding of plasmid DNA to a silica membrane, this method 
allows the isolation of plasmid DNA without RNA. After a modified alkaline lysis of 
bacterial cells and removal of cellular debris by centrifugation, the supernatant is loaded 
onto a silica membrane. Chaotropic salts lead to denaturation of contaminants, which 
are washed away with wash buffers. Selectively bound circular DNA can then be eluted 
from the membrane. 
A bacterial colony grown on selective LB agar medium was inoculated in 5 ml 
of liquid LB containing the appropriate antibiotic and incubated overnight at 37°C, 
under agitation of 220 rpm. Cells from 4 ml culture were centrifuged at 13,000 rpm for 
1 minute. Supernatant was discarded and the bacterial pellet was treated with reagents 
of the “peqGOLD Plasmid Miniprep Kit II” (Peqlab) for plasmid DNA purification. 
First, the pellet was thoroughly resuspended in 500 µl Solution I containing RNase. 
Then, 500 µl of Solution II was added for lysis and the reagents were mixed by 
inversion. After a short incubation period at room temperature (~ 3 minutes), 700 µl of 
Solution III were added for neutralization. The tube was repeatedly inverted and 
centrifuged at 13,000 rpm for 10 minutes (room temperature). The clarified supernatant 
was transferred to the silica membrane and centrifuged for 1 minute at 10,000 rpm. This 
step was followed by two sequential washes, with 600 µl HB buffer and 850 µl wash 
buffer, respectively. The membrane was dried by further centrifugation at 13,000 rpm 
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for 2 minutes and the column was transferred to a 1.5 ml eppendorf tube. The plasmid 
DNA was eluted after incubation with 40 µl sterile water for 2 minutes at room 
temperature and a centrifugation step at 13,000 rpm for 2 minutes. The purified DNA 
was kept at -20°C for any downstream application. 
 
 
1.10. Isolation of genomic DNA from yeast 
For PCR amplification of sequences within yeast genomic DNA, yeast cells were 
mechanically broken and the DNA was isolated upon extraction with 
phenol/chloroform/isoamyl alcohol and ethanol precipitation. This protocol was adapted 
from Hoffman and Winston (1987). 
One mililiter from a yeast culture grown overnight was centrifuged at 11,000 
rpm for 3 minutes (room temperature), washed once with 1.5 ml distilled water and 
resuspended in 100 μl of lysis buffer. Then, approximately 0.03 g of glass beads were 
added, followed by addition of 100 μl of phenol/chloroform/isoamyl alcohol (25:24:1 
v/v/v). Yeasts were lysed by vortexing for 3 minutes. Subsequently, 100 μl of TE were 
added, briefly vortexed, and the mixture was centrifuged at 12,500 rpm for 5 minutes. 
The aqueous phase was carefully transferred to another microcentrifuge tube and 
incubated with 1 ml of 99% ethanol. The tube was kept at -20°C overnight and then 
centrifuged at 12,500 rpm for 3 minutes at 4°C. The DNA pellet was washed twice with 
70% ethanol, air-dried, dissolved in 30 μl distilled water and kept at -20°C until use. 
 
 
2. Culture conditions 
 
2.1. E. coli 
E. coli was cultured in LB medium at 37°C and 220 rpm. Plates containing LB agar 
medium were incubated overnight at 37°C. For culture of bacteria carrying recombinant 
plasmid DNA, LB medium was supplemented with 100 μg/ml ampicillin or 25 μg/ml 
kanamycin. For blue/white screening of colonies, 20 μl of X-gal stock solution (40 
mg/ml) and 20 μl of IPTG stock solution (100 mM) were spread on agar plates 
containing kanamycin. 
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2.2. Yeasts 
All yeasts were cultivated aerobically either in YPD or in complete SC medium at 30°C, 
under agitation of 220 rpm. In order to induce hyphal growth of C. albicans, a culture 
grown in YPD medium was shifted to YPD containing 10% FCS and incubated at 37°C 
and 220 rpm for 6 h. With respect to solid media, untransformed yeasts were grown in 
YPD, except for Sz. pombe, which was grown in YES medium. 
When recombinant protein production was necessary, the species S. cerevisiae, 
Sz. pombe, K. lactis and P. pastoris were cultivated as follows: 
S. cerevisiae transformants were selected on uracil-deficient (ura d/o) SC agar 
medium. Recombinant protein expression was achieved by culturing yeasts for 3 days in 
ura d/o-glucose medium at 30 °C and 220 rpm. 
For transformation purposes, Sz. pombe was grown in EMM low glucose 
medium. Transformants were selected on EMM plates containing 15μM thiamine. To 
induce expression from the nmt1 promoter, transformants were grown in EMM medium 
lacking leucine for 3 days at 30 °C and 220 rpm. 
K. lactis transformants were selected onto YCB agar medium. For expression of 
heterologous proteins cells were cultured in inducing YPGal medium at 30 °C for 72 h. 
After transformation of P. pastoris, cells were plated onto selective SC agar 
medium lacking histidine (his d/o). Colonies were cultivated in BMG medium for 3 
days. Then, cultures were centrifuged at 7,000 rpm for 5 min, resuspended in BMM 
medium and cultivated for another 3 days. Methanol (final concentration = 0.5%) was 
added every 24 h to induce recombinant protein expression. 
 
 
2.3. Mammalian cells 
All mammalian cells were cultured in tissue culture flasks at 37°C under 5% CO2 
atmosphere, unless otherwise stated. 
 
2.3.1. IC-21 mouse peritoneal macrophages 
For routine passaging of IC-21, cells were grown until approximately 80% confluence, 
then the culture medium was aspirated and cells were detached from flasks with cold 
PBS for approximately 10 minutes. Subsequently, cells were splitted 1:3 with pre-
warmed culture medium in 25 cm2 tissue culture flasks and incubated for 3-4 days. 
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2.4. Freezing and thawing cells 
 
2.4.1. Bacteria and yeasts 
Bacteria and yeast stocks were prepared by mixing equal volumes of a grown culture 
and 99% sterile glycerol. Cryogenic vials were stored at -80°C. For recovering of a 
stored microorganism, the strain was scraped with a pipette tip and streaked onto a 
proper agar plate. 
 
2.4.2. Freezing mammalian cells 
Cells were counted, centrifuged at 300× g at 4°C, and resuspended with culture medium 
in one half the volume needed to give the desired cell concentration. Subsequently, the 
same volume of 2× freezing medium was added dropwise and the suspension was 
carefully mixed. Cells were aliquoted in sterile cryogenic vials, frozen at -80°C 
overnight, and then transferred to a liquid nitrogen tank. 
 
2.4.3. Thawing mammalian cells 
Cells in a storage vial were thawed in a water bath at 37°C for 2 minutes and then 
transferred to a 15 ml tube containing 5 ml pre-warmed culture medium. After 
centrifugation at 300× g for 10 minutes at 4°C, supernatant was discarded and the pellet 
was resuspended with 5 ml culture medium. After that, cells were plated at a density of 
1×106 cells/ml in 75 cm2. 
 
 
3. Cell number determination 
 
3.1. Optical density 
The optical density of a bacterial or yeast culture in liquid medium was determined 
spectrophotometrically at the wavelength λ = 600 nm in a 1 cm-thick cuvette against 
sterile medium. 
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3.2. Determination of yeast cell number 
The total number of yeast cells in a culture was determined by light microscopy with a 
Neubauer hemacytometer (0.1 mm depth). Yeast cells were properly diluted in PBS and 
counted in 80 squares. The cell number was then calculated using the formula: yeast 
cells/ml = number of yeasts counted in 5 large squares × number of large squares in the 
entire chamber × dilution × (chamber volume)-1. The chamber volume was 10-4 ml and 
there were 5 large squares in the chamber. Therefore, yeasts/ml = number of yeasts in 5 
large squares × 5 × dilution factor × 104. 
 
 
3.3. Determination of mammalian cell number 
The total number of mammalian cells was determined using a hemacytometer 
“Neubauer improved” (0.1 mm depth). Cells were diluted in PBS as needed and clumps 
were dispersed. Cells were counted in the four corner squares and the mean value was 
determined. The total number of cells per milliliter was calculated as follows: cells/ml = 
average count per square × dilution factor × 104 (Phelan, 2007). 
 
 
4. Transformation methods 
 
4.1. E. coli transformation 
Preparation of electrocompetent bacteria 
Electrocompetent cells become permeable to nucleic acids upon exposure to high-
strength electric fields. Bacteria are grown to mid-log phase and washed thoroughly in a 
low conductivity medium such as glycerol to reduce the ionic strength of the cell 
suspension (Miller and Nickoloff, 1995). 
Six mililiters of an E.coli DH5α or TOP10 overnight culture were inoculated in 
300 ml LB medium and cultured at 37°C, 220 rpm, until OD600 = 0.6-0.8. The culture 
was placed on ice for 5 minutes, then centrifuged at 6,000 rpm for 10 minutes at 4°C 
and the pellet was washed twice with 100 ml of ice-cold 10% glycerol. Next, cells were 
resuspended in the remaining fluid and transferred to sterile 1.5 ml eppendorf tubes on 
ice. After centrifugation for 5 minutes at 8,000 rpm (4°C), the supernatant was 
                     Methods 
 
  79 
discarded, cell pellets were resuspended with the remaining fluid and stored as 40-µl 
aliquots at -80°C. 
 
Transformation of competent bacteria by electroporation 
In the electroporation process, short electric impulses of high frequency produce 
transient pores in the outer membranes of exponentially grown cells, which are then 
able to take up high molecular mass molecules, such as DNA (Calvin and Hanawalt, 
1988; Dower et al., 1988). This method allows highly efficient transformations, up to 
109-1010 cfu/µg plasmid DNA (Dower et al., 1988). 
A 40-µl aliquot of competent E. coli DH5α or TOP10 was thawed on ice and 
incubated with plasmid DNA (50-200 ng) for 5 min. If cells were incubated with the 
product of a ligation reaction, this latter had to be previously dialyzed against a 10% 
glycerol solution for 1 h in order to reduce the salt content. Too high salt or DNA 
concentrations in the electroporation cuvette result in arcing, which damages the cells. 
The mixture was then transferred to a prechilled electroporation cuvette (2 mm gap) and 
the cells were pulsed at 2,5kV/cm, 200Ω, 25 µF in an electroporator (“Gene Pulser II”, 
BioRad). Immediately after the pulse, cells were incubated with 500 µl SOC medium at 
37°C under agitation of 220 rpm for 1 h. After this period, the transformed cells were 
plated in suitable dilutions on selective LB agar plates and incubated overnight at 37°C. 
 
Transformation of Nova Blue Singles™ competent bacteria 
Nova Blue Singles™ competent bacteria were transformed with pSTBlue-1 vectors 
containing PCR-derived inserts. These chemically competent bacteria belong to the 
AccepTor™ kit. 
Competent cells were thawed on ice for 5 minutes. Then, 1 μl of the ligation 
reaction was added directly to the cells and the tube was incubated on ice for 5 minutes. 
Subsequently, tubes were heated for 30 s at 42°C in a water bath and immediately 
placed on ice. After 2 minutes, cells were given 250 μl of SOC medium at room 
temperature and shaken at 220 rpm for 45 minutes before being plated on LB agar 
medium supplemented with kanamycin, X-gal, and IPTG, as described in section 2.1 of 
Materials. Plates were incubated overnight at 37°C. 
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4.2. Transformation of S. cerevisiae 
The most common procedure for introducing plasmid DNA into S. cerevisiae cells is 
the lithium-acetate method. This technique was first described by Ito et al. (1983), who 
observed that alkali metal ions, especially Li+, are able to induce the uptake of DNA by 
yeast cells. Addition of PEG and a heat-shock by 42°C have been shown to improve 
transformation (Ito et al., 1983). Schiestl and Gietz (1989) demonstrated that adding 
heat-denatured salmon sperm DNA to LiAc competent cells led to increased 
transformation efficiency (approximately 105 transformants per µg DNA), since it 
functions as carrier DNA. Interactions between negatively charged PEG, monovalent 
cations, and the yeast cell surfaces alter membrane charges, which may lead to 
conformational changes. The effectiveness of monovalent cations might be attributed to 
a mild chaotropic effect (Kawai et al., 2010).  
A volume of 2 ml of an overnight S. cerevisiae culture grown in YPD was 
centrifuged at 7,000 rpm for 5 min. Solutions for S. cerevisiae transformation are 
described in Section 3.6. The cell pellet was washed with 500 µl of LiAc/TE solution 
and resuspended in 200 µl of this solution. To this yeast suspension 20 µl of salmon 
sperm DNA, 2 µl of plasmid DNA (from an alkaline lysis), 600 µl of PEG solution and 
50 µl of 10× LiAc were added. The cells were incubated at 30°C under agitation at 220 
rpm for 2 h and then heat-shocked at 42°C for 15 min. After that, yeasts were spun at 
13,000 rpm, washed twice with 500 µl of TE solution and resuspended in 500 µl of TE. 
Cells were plated as 250 µl aliquots on ura d/o plates and incubated at 30°C for 3 days. 
 
 
4.3. K. lactis transformation (New England Biolabs) 
Transformation of chemical competent K. lactis cells was performed using the kit “K. 
lactis Competent Cells” and “NEB Yeast Transformation Reagent” (New England 
Biolabs). A linearised pKLAC1-derived expression cassette is introduced into 
chemically competent cells and integrates at the LAC4 locus in the K. lactis genome. 
Selection of transformants is based on growth onto acetamide-containing medium. The 
amdS gene in the pKLAC1 vector codes for acetamidase, which breaks down acetamide 
to ammonia, which in turn can be used by K. lactis as a nitrogen source. 
A tube of K. lactis GG799 Competent Cells was thawed on ice. One hundred 
and fifty five microliter of NEB Yeast Transformation Reagent was added to the cells. 
The solution was homogenized by inverting the tube. Linearized pKLAC1-DNA 
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containing the gene of interest (1 μg) was added to the cell mixture. After an incubation 
time of 30 minutes at 30°C, the cell mixture was heat-shocked by incubation at 37°C for 
1 hour in a water bath. Cells were pelleted by centrifugation at 7,000 rpm for 2 minutes 
and washed with 1 ml sterile deionized water. Cells were pelleted by centrifugation at 
7,000 rpm for 2 minutes, resuspended in 1 ml YPD medium, transferred to a sterile 
culture tube and incubated with shaking (220 rpm) at 30°C for 30 minutes. The cell 
mixture was transferred to a sterile 1.5 ml microcentrifuge tube and pelleted by 
microcentrifugation at 7,000 rpm for 2 minutes. The cell pellet was resuspended in 1 ml 
sterile deionized water. One, 10 and 50 μl of the cell suspension were removed to 
separate fresh sterile tubes each containing 50 μl of sterile deionized water. The entire 
cell mixture from each tube was spread onto separate YCB Agar Medium plates 
containing 5 mM acetamide. Plates were incubated at 30°C for 3 days. 
 
 
4.4. Sz. pombe transformation by the rapid lithium acetate method 
Of the several existing methods for transformation of Sz. pombe cells, the one that 
yields the highest transformation frequency utilizes alkali cations. Kanter-Smoler et al. 
(1994) have described for Sz. pombe an adaptation of the LiAc method developed for S. 
cerevisiae. 
Sz. pombe PW260 cells were grown in 5 ml EMM low glucose medium to a 
density of 0.5 - 1.0 x 107 cells/ml (2 - 3 days). Growth in low glucose medium has been 
shown to increase transformation efficiency for this transformation method (Kanter-
Smoler et al., 1994). The cells were then harvested at 7,000 rpm for 5 min at room 
temperature and washed twice with 1 ml of sterile water. Solutions for Sz. pombe 
transformation are described in section 3.4. The cells were washed with 200 µl of 
lithium acetate/EDTA and resuspended in 50 µl of lithium acetate/EDTA solution. After 
that, 30 µl of TE buffer containing 1 µg of plasmid DNA and 300 µl of lithium 
acetate/EDTA/PEG solution were added. Cells were incubated under agitation at 220 
rpm at 30°C, for 30 min and then heat-shocked at 42°C for 15 min. The cells were 
centrifuged at 7,000 rpm, resuspended in 1 ml of TE buffer, plated on EMM leu d/o 
thiamine solid medium as 200 µl-aliquots and incubated for 5 days at 30°C. 
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4.5. P. pastoris transformation 
Preparation of competent cells 
P. pastoris (GS115 or KM71) was inoculated in 5 ml of YPD. The culture was 
incubated at 30°C, under agitation at 220 rpm, for 16 hours. After this period, culture 
was re-inoculated in 50 ml of YPD. This culture was cultivated at 30°C, 220 rpm, until 
an O.D. of 0,8-1,0 was reached. After that, culture was centrifugated at 500 g, 5 minutes 
at room temperature. Supernatant was discarded and cells were resuspended in 9 ml of 
cold BEDS and 1 ml 1M DTT. The suspension was incubated at 30°C, under agitation 
at 100 rpm, and centrifuged again as previously. Cells were ressuspended in 1 ml of 
BEDS and frozen at -80°C as 55-µl aliquots. 
 
Transformation 
A 55 µl-aliquot of competent cells was mixed with 5 µl of linearized plasmid DNA and 
incubated on ice for 5 minutes. The mixture was transferred to a previously cooled 
electroporation cuvette (2 mm) and subjected to a pulse of 200 Ω, 25 µF, 1.5 kV/cm. 
Imediatelly after the pulse, cells were resuspended in 1 ml of cold 1M sorbitol and 0.5 
ml of YPD, transferred to a sterile 15 ml tube and incubated at 220 rpm, 30°C, for 3 
hours. After that, 750 µl of culture were plated onto his d/o agar medium. Plates were 
incubated for 3 days at 30°C. 
 
 
5. Protein Methods 
 
5.1. Protein extraction from yeast cells or from cell-free culture medium 
Mechanical shearing of yeasts by vortexing with glass beads releases their 
cytoplasmatic contents by virtue of the abrasive action of the vortexed beads. 
Protein extracts were prepared from 3×108 yeast cells collected by centrifugation (7,000 
rpm for 5 minutes), washed three times with PBS and resuspended in 200 µl of 
disruption buffer containing a cocktail of protease inhibitors (Complete, Roche). One 
volume of glass beads (0.5 mm diameter) was added and cells were disrupted using a 
Beadbeater (Retsch) for 10 min at maximum speed at 4 °C. After cell breakage, the 
soluble protein fraction was recovered by centrifugation at 13,000 rpm for 10 min at 
4°C, transferred to new microcentrifuge tubes, and precipitated as described in section 
5.3. 
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For analysis of secreted proteins, a volume of culture medium corresponding to 
3×108 cells was centrifuged at 7,000 rpm for 5 minutes to remove the cells. 
Supernatants were transferred to new microcentrifuge tubes and concentrated by 
employing one of the methods described in section 5.3. 
 
 
5.2. Protein isolation from yeast cell walls 
Glucanase extraction of proteins from yeast cell walls was performed as described by  
Schreuder et al. (1993), with minor modifications. Yeast cells grown for three days 
under inducing conditions were counted, and 3×108 cells were centrifuged and washed 
three times in ice-cold isolation buffer. Then, 3 ml of isolation buffer and 10 g of glass 
beads were added per gram of cells (fresh weight) and yeasts were lysed in a Beadbeater 
at maximum speed for 10 minutes. Cell extracts were transferred to a new tube, and 
glass beads were extensively washed. Raw cell extracts and washes were pooled and 
centrifuged for 5 minutes at 1,000 × g. Pellets were washed three times with 1 ml of 100 
mM-sodium acetate, pH 5.0, containing 1 mM PMSF, and resuspended in the same 
buffer (20 µl of buffer for 10 mg of cell walls). To this volume was added 0.5 mU of β-
1,3-glucanase (laminarinase), and the tubes were incubated for 2 h at 37°C. Then, 
another 0.5 mU of laminarinase was added and the mixtures were further incubated for 
2 h at 37°C. Afterwards, samples were centrifuged for 5 minutes at 12,000 rpm and the 
supernatant was precipitated as described in section 5.3. 
 
 
5.3. Protein precipitation 
A number of precipitation techniques has been routinely used for recovery of proteins. 
In order to concentrate proteins present in a large volume of a certain solution, 
precipitation can be induced by addition of organic solvents or by changes in the pH, for 
example. 
 
Ethanol precipitation 
Dehydration caused by ethanol makes proteins attract each other in such an extent that 
they become insoluble in ethanol-water mixtures (van Oss, 1989). One volume of 
culture supernatant was mixed with 3 volumes of 99% ethanol. Samples were kept 
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overnight at -80°C and centrifuged at 13,000 rpm for 30 min at 4°C. Pellets were 
allowed to dry and subsequently resuspended in SDS-loading buffer. 
 
Deoxycholate (DOC) and 2,2,2-trichloroacetic acid (TCA) precipitation 
TCA is one of the most efficient agents used for protein precipitation, although its 
mechanism of action has not been completely elucidated yet. Rajalingam et al. (2009) 
suggested that the tricholoroacetate ions lead to protein unfolding by disrupting 
electrostatic interactions. Partial unfolding of proteins gives rise to exposure of nonpolar 
surfaces, resulting in intermolecular coalescence of protein molecules and consequently 
precipitation. Addition of the detergent DOC improves recovery (Bensadoun and 
Weinstein, 1976). To one volume of protein solution, 0.01 volume of 2% sodium 
deoxycholate was added. Samples were vortexed and incubated for 30 minutes at 4°C. 
Then, 0.1 volume of 100% trichloroacetic acid was added, and samples were incubated 
overnight at 4°C after brief vortexing. Next, tubes were centrifuged at 15,000 rpm for 
15 minutes at 4°C and the pellets were washed twice with 1 ml of cold acetone (kept at -
20°C). Samples were centrifuged for 5 minutes at 15,000 rpm between washes, allowed 
to dry at room temperature, and resuspended in a minimal volume of SDS-loading 
buffer. 
 
 
5.4. Polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis (PAGE) is a method that allows protein separation 
by applying an electric field. This procedure is carried out under conditions that permit 
dissociation of the proteins into their individual subunits and minimize aggregation. 
Samples are denaturated at high temperatures with the anionic detergent sodium 
dodecyl sulfate (SDS), which interacts with the hydrophobic amino acid residues of the 
proteins, disrupting their folded structure and allowing them to adopt an extended 
conformation. Since the amount of SDS bound is proportional to the molecular weight 
of the polypeptide and independs on its sequence, SDS-polypeptide complexes migrate 
through polyacrylamide gels at rates that reflect their sizes. The denatured polypeptides 
become negatively charged and migrate towards the positive electrode (anode). A thiol 
reducing agent such as β-mercaptoethanol is often used to reduce disulfide bonds within 
or between molecules (Sambrook et al. 1989). 
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Following the classical system developed by Laemmli (1970), tris-glycine 
polyacrylamide gels (8-12%) were assembled in a “Mini-PROTEAN 3” system 
(BioRad) and run as a stacking gel bottomed by a running gel, in a discontinuous buffer 
system, according to Sambrook et al. (1989). The resolving gel (10% polyacrylamide) 
were prepared as follows (final volume = 10 ml): 
 
Distilled water          4.0 ml 
30% polyacrilamide mix          3.3 ml 
1.5 M tris pH 8.8          2.5 ml 
10% SDS          0.1 ml 
10% APS          0.1 ml 
TEMED      0.004 ml 
 
The mixture was pippeted between two assembled glass plates (1.0 or 1.5 mm 
spacer), followed by addition of 1 ml isopropanol. After polymerization, the 
isopropanol was removed, plates were carefully dried, the stacking gel was poured and 
the comb was inserted. 
The stacking gel (5% polyacrylamide) was prepared in the following manner 
(final volume = 5 ml): 
 
Distilled water          3.4 ml 
30% polyacrilamide mix        0.83 ml 
1.0 M tris pH 6.8        0.63 ml 
10% SDS        0.05 ml 
10% APS        0.05 ml 
TEMED      0.005 ml 
 
After complete polymerization, the plates were loaded into the cassette, which in turn 
was placed inside an electrophoresis chamber. Protein samples were mixed with SDS 
buffer containing β-mercaptoethanol, incubated at 100°C for 10 minutes and loaded on 
the gel. The “Page Ruler Prestained Protein Ladder” (Fermentas) was applied as a 
molecular mass standard. After applying the samples, the gel was run in tris-glycine 
buffer at a constant voltage of 150 V. 
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5.5. Western blotting 
Western blotting is a method for immunologic detection of a specific protein 
immobilized on a membrane. Proteins separated by electrophoresis are transferred to a 
membrane, such as PVDF, which is then incubated with a specific antibody that 
recognizes the protein of interest. Subsequently, the primary antibody is bound by a 
secondary antibody (anti-immunoglobulin), which is normally coupled to an enzyme. 
Addition of an appropriate substrate generates a detectable product (Towbin et al., 
1979). 
 After SDS-PAGE, the gel was incubated with transfer buffer for removal of 
salts and detergents. The PVDF membrane was previously immersed in methanol and 
then equilibrated with transfer buffer. One piece of transfer buffer-soaked Whatmann 
filter paper was placed on the lower electrode of a semi-dry transfer apparatus, followed 
by the PVDF membrane, the gel and another buffer-soaked filter paper. Transfer was 
carried out at 0.85 mA/cm2, in a “Trans Blot SD Electroforectic Transfer Cell” 
(BioRad) for 1.5 h. 
The membrane was blocked overnight at 4°C in blocking buffer in order to 
prevent nonspecific binding of the antibodies and then incubated for 1 h at room 
temperature with a properly diluted primary antibody. The membrane was washed with 
TBST for 15 min and then incubated for 1 h at room temperature with specific 
peroxidase-conjugated anti-IgG diluted in blocking buffer, under agitation. This step 
was followed by 15-min washes in TBST and TBS. The membrane was further 
incubated with reagents of an enhanced chemiluminescence detection kit consisting of 
luminol and peroxide solutions. The horseradish peroxidase coupled to the secondary 
antibody catalyzes the oxidation of luminol by peroxide. This reaction generates a 
product (3-aminophthalate) in an excited state, which emits light at 425 nm upon decay 
to a lower energy state. Luminescence was detected and recorded by a ChemiDoc XRS 
System (BioRad). 
Protein quantitation was performed by comparison of the relative intensity of the 
bands from 3×108 cells or the corresponding amount of culture medium to a standard 
curve of commercially available protein of known concentration by densitometry using 
QuantityOne software (version 4.6.2, Bio-Rad). 
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5.6. VLP preparation and transmission electron microscopy (TEM) 
The protocols for VLP isolation and preparation for TEM analysis were performed as 
described by Powilleit et al., 2004. Yeasts are treated for spheroplast formation, lysed, 
and the cell extract is submitted to two ultracentrifugation steps and dialysis before the 
electron microscopy. 
S. cerevisiae S86c transformed with pG[0]G/ovacytmut, pG[0]G/pp65, and pG 
were inoculated in 8 ml ura d/o glucose for 72 h, transferred to 400 ml ura d/o medium 
and grown to a density of 4-6×107cells/ml at 30°C, 220 rpm. Next, cells were 
centrifuged at 6,000 rpm for 5 minutes, washed with 50 ml of prechilled water and 
subsequently with the same volume of spheroplasting buffer, and resuspended in 50 ml 
spheroplasting buffer containing 2 mM DTT and 200 µg/ml zymolyase 20T. After 1.5 h 
of incubation at 120 rpm and 30°C, spheroplasts were centrifuged for 20 min at 2,200 
rpm (4°C) and washed with 50 ml of cold PBSES. Then, cells were resuspended in 10 
ml PBSE and 10 g of micro glass beads (0.25–0.50 mm diameter) were added. Cells 
were lysed by vortexing six times for 1 min, with 1 min intervals on ice. Total yeast 
extracts were supplemented with 5 ml PBSE and pelleted at 10,000 rpm for 1 h at 4°C. 
The supernatant (15 ml) was layered onto a 15-ml cushion of 45% sucrose and 
ultracentrifuged at 19,000 rpm overnight at 4°C using a Beckman SW28 rotor. In this 
step, only high molecular weight structures can pass the cushion and form a pellet. The 
cushion pellet was gently resuspended in 1 ml PBSE, layered onto a linear density 
gradient of 20–70% sucrose, and further ultracentrifuged at 20,000 rpm overnight at 
4°C. After that, the gradient was fractionated into 2-ml fractions and the gradient pellet 
was resuspended in 2 ml PBSE. Aliquots of each fraction were analyzed by SDS-PAGE 
and western blotting. For reisolation of VLP, a maximum of 6 gradient fractions was 
pooled and dialyzed against 5 l PBSE overnight (4°C) in membranes with an exclusion 
limit of 14 kDa. The dialysed solution was concentrated to 200–500 μl using a 10 kDa 
cut-off Vivaspin and examined for the presence of VLP by TEM analysis. 
For TEM analysis, samples were adsorbed to poly-L-lysine-coated cupper grids 
for 5 min. The grids were rinsed twice with distilled water, negatively stained with 2% 
uranyl acetate for 5 min, and allowed to to air-dry. Samples were imaged with diverse 
magnifications with a TECNAI 12 (FEI) transmission electron microscope at the 
Department of Anatomy and Cell Biology of Medical Faculty at the Saarland University 
(Homburg, Germany). 
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6. Cell- and immunobiology methods 
 
6.1. Immunolabelling of yeasts 
Immunostaining of yeasts was performed as follows: 100 µl of an exponentially 
growing yeast culture were pelleted, washed three times with phosphate-buffered saline 
(PBS, 10 mM potassium phosphate buffer, 150 mM sodium chloride, pH 7.4), and 
resuspended in 100 μl PBS. The cell suspension was incubated with the primary 
antibody at a dilution rate of 1:100 for 1 h at room temperature in an orbital shaker. 
After the cells had been washed three times with PBS, the second antibody (FITC- or 
PE-conjugated) was diluted to 1:100 and allowed to react with the cells at room 
temperature for 1 h in the dark. The cells were then washed three times with PBS and 
examined using either a fluorescence microscope (Keyence), or a confocal laser 
scanning microscope equipped with a 560-615 nm filter (Zeiss LSM 510 meta). 
Microscopic observations were carried out using 100× objectives. When necessary, 
cells were analyzed by flow cytometry. Data for 50,000 events were collected. 
For detection of mannose or chitin in yeast cell walls, staining was performed as 
described above, except for the incubation steps with antibodies, which were substituted 
for a one-step incubation with 200 μg/ml of Concanavalin A-FITC or wheat germ 
agglutinin-FITC, respectively, in the dark (Buck and Andrews, 1999). 
 
 
6.2. Staining cell surface antigens in mammalian cells 
Cells were centrifuged at 1,400 rpm for 6 minutes, washed with PBS containing 10% 
FCS and resuspended in 100 µl at a concentration of at least 106 cells/ml. Then, an 
appropriate volume of antibody (previously determined by titration) was added to the 
cells, and samples were vortexed and incubated on ice for 45 minutes in the dark. After 
this period, cells were washed with 3 ml PBS containing 10% FCS, fixed with 150 µl of 
FACS-Fix and kept at 4°C in the dark until flow cytometric analysis. 
 
 
6.3. Intracellular cytokine staining in mammalian cells 
Detection of intracellular molecules presupposes permeabilization of the cell membrane 
in order to allow access of the antibodies to the antigens within the cells. Cells are 
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initially stimulated in the presence of a secretion inhibitor. Brefeldin A from Penicillium 
brefeldianum destroys the structure and function of the Golgi apparatus, so that 
secretion of proteins no longer occurs. Therefore, generally secreted proteins remain in 
the cell interior and can be detected. Cells are then fixed to prevent leakage of the 
proteins, permeabilized, and incubated with a specific conjugated antibody, which 
penetrates the cell, subsequently binding to its target. Cells were made permeable upon 
incubation with saponin, a surfactant from Quillaya saponaria bark that increases the 
penetration of macromolecules through cell membranes (Jacob et al., 1991). 
Cells were incubated in FACS-buffer containing 0.5% saponin for 10 minutes at 
room temperature. Then, cells were centrifuged at 1,400 rpm for 6 minutes, supernatant 
was discarded and the antibody was added to the cells in the remaining buffer. After 
brief vortexing, cells were incubated on ice for 45 minutes in the dark, then washed with 
2 ml of FACS-buffer, fixed with 150 µl of FACS-Fix and kept at 4°C in the dark until 
flow cytometric analysis. 
When both surface and intracellular staining in the same cell population was 
necessary, stainings were carried out successively, i.e., cells were first stained for 
surface molecules (as described above) and thereafter permeabilized with saponin for 
intracellular staining. 
 
 
6.4. Flow cytometry 
Flow cytometry is a powerful method for detecting individual cells from a certain cell 
population or subset, based on their morphologic characteristics (such as size and 
granularity) and the presence of specific surface or intracellular molecules, which are 
previous stained with fluorescent substances. A mixture of cells is forced with a sheath 
fluid through a nozzle, which generates a stream of single cells. These cells pass 
through a laser beam, scattering the light, and the fluorochrome molecules are excited, 
emitting fluorescence. Photomultipliers sense fluorescence emissions and scattered 
light. The fluorescence intensity gives information on the presence of a certain molecule 
in the cell interior or on the cell surface. Scattered light is collected as forward scatter 
(FSC) and side scatter (SSC). FSC measures the light scattered in the same axis of the 
laser beam path and is proportional to the particle size. SSC is detected at approximately 
90 degrees to the laser path and is directly proportional to cell granularity (Janeway et 
al., 2001). 
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It is possible to set a gate on a FSC vs. SSC plot so that the resulting information 
refers only to the cell population inside it. For two or three colour analysis, spectral 
overlap compensation was performed. 
Cells were stained as described in section 2.29 and examined on a FACScan or a 
FACScalibur (Becton Dickinson). Data were analyzed using CELLQuest software 
(Becton Dickinson). 
 
 
6.5. Isolation of peripheral blood mononuclear cells (PBMC) 
Dendritic cells can be obtained from isolated monocytes cultured with appropriate 
cytokines. Mononuclear cells are isolated from peripheral whole blood by density 
gradient centrifugation (Ficoll-Paque, 1.077 g/ml), which is a widely used method. 
Lymphocytes and monocytes, according to their respective densities, accumulate in the 
interphase between supernatant (which contains plasma and thrombocytes) and Ficoll 
(where erythrocytes and granulocytes sediment by virtue of their higher densities). 
Sallusto and Lanzavecchia (1994) demonstrated the generation of DCs from adult 
peripheral blood in the presence of IL-4 and GM-CSF. This protocol has been widely 
used, with some minor modifications. 
Fresh human anticoagulated blood (100 ml) was obtained from the blood bank 
of the Winterberg Klinik in Saarbrücken. Human blood was carefully transferred to five 
sterile 50 ml tubes containing 15 ml PBS (Ca2+- and Mg2+-free) until a final volume of 
35 ml each, and carefully mixed. The diluted cell suspension was gently transferred to 
tubes containing 15 ml of the lymphocyte separation medium Ficoll-Paque. Tubes were 
centrifugated at 1,600 rpm for 25 minutes at room temperature without brake, in order 
to preserve the layering. Ten millilitres of plasma from each tube were discarded. The 
white blood cell ring fraction (buffy coat with PBMC) was carefully aspirated and 
transferred to new 50 ml tubes. The volume was adjusted to 50 ml per tube using PBS. 
Samples were centrifuged for 6 minutes at 1,600 rpm (brake switched on) and the 
supernatant was carefully discarded. Each pellet was resuspended in 5 ml of sterile 
water to lyse remaining erythrocytes, immediately adding enough PBS to the PBMC to 
make up 50 ml. Cells were centrifuged and this step was repeated until no red blood 
cells could be seen. Cells were then joined in one tube by pipetting PBS from tube to 
tube. Tubes were rinsed with PBS and volume was adjusted to 50 ml. After 10 minutes 
of centrifugation at 900 rpm in order to eliminate trombocytes, the pellets were 
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resuspended in PBS and cells were counted under the light microscope, as described in 
section 3.3. 
 
 
6.6. Monocytes isolation and differentiation into dendritic cells 
Monocyte isolation by adherence to plastic surfaces 
The isolated PBMC were suspended in RPMI 1640 containing 10% heat-inactivated 
FCS (LPS-free), 100 U/ml penicillin and 0.1 mg/ml streptomycin at a density of 7.5 × 
106 cells/ml, plated onto cell-culture flasks (20 ml culture for 125 cm2 area), and 
incubated for 1.5 h at 37°C. Then, the peripheral blood lymphocytes (PBL), which do 
not adhere to plastic surfaces, were harvested, centrifuged at 1,400 rpm for 6 minutes, 
resuspended in PBS, counted, and properly frozen as described in section 2.4.2. 
Adherent cells (monocytes) were gently rinsed with PBS to remove remaining 
nonadherent cells. Monocytes were cultured at 7.5 × 106 cells/ml in RPMI 1640 
containing 10% heat-inactivated FCS (LPS-free), 100 U/ml penicillin, 0.1 mg/ml 
streptomycin, 20 U/ml recombinant human IL-4, and 800 U/ml recombinant human 
GM-CSF. Immature monocyte-derived dendritic cells (MDDCs) were obtained after 
cells had been incubated at 37 °C with 5% CO2 for 7 days, and re-fed on day 3. Cells 
harvested at day 7 were analyzed by flow cytometry for typical immature DC surface 
phenotype (CD1a+, CD14low, CD80+, CD86+, HLA-I+, HLA-II+, CD83low) and 
contamination with CD3+ T cells or CD19+ B cells. 
 
Monocyte isolation by positive selection using magnetic microbeads 
Alternatively, monocytes were isolated from PBMC using magnetic microbeads 
conjugated with anti-CD14 antibody. Taking advantage of the fact that CD14 is strongly 
expressed on the surface of monocytes, these cells can be labeled with anti-CD14 micro 
beads. In the presence of a magnetic field, the cell suspension is applied onto a column, 
and the magnetically labeled cells are retained, whereas the other cells pass through. 
When the column is removed from the magnetic field, the CD14+ cells can be eluted. 
Binding of antibody to CD14 does not trigger any signal transduction. 
PBMC isolated as described in section 7.1 were counted and resuspended in 
MACS buffer (80 µl per 107 cells). For 107 cells, 20 µl of anti-CD14 micro beads were 
added, and the cell suspension was incubated for 15 minutes at 4°C. Then, 2 ml MACS 
buffer were added per 107 cells. After centrifugation for 10 minutes at 1,200 rpm, the 
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supernatant was discarded and cells were resuspended in MACS buffer (50 µl per 107 
cells). A column was placed in the magnetic field of a separator and rinsed with 3 ml of 
MACS buffer. Then, the cell suspension was applied onto the column and the cells that 
passed through were collected. The column was washed three times with 3 ml of MACS 
buffer and subsequently placed on a sterile tube. Afterwards, 5 ml of buffer was 
pipetted onto the column and the magnetically labeled cells were forced through the 
column with a plunger. Cells were then incubated in tissue culture flasks containing the 
appropriate medium to induce differentiation into DCs as described above in this 
section. 
 
 
6.7. Maturation of dendritic cells by different stimuli and analysis of cytokine 
secretion 
For maturation studies, day 7-immature dendritic cells were harvested, resuspended at 
1×106 cells/mL, plated in 24-well plates and incubated either with yeasts at a ratio of 
1:1, or with other maturation factors (250 ng/ml LPS and 32 μl/ml of a lysate of 
HCMV-infected fibroblasts), or left untreated, for 48 h, at 37°C in 5% CO2. Cells were 
then analyzed by dual-color flow cytometry for classical surface maturation markers 
using the following monoclonal antibodies: anti-HLA DP/DQ/DR FITC, anti-HLA 
A/B/C PE, anti-CD80 PE, anti-CD83 PE, anti-CD86 FITC, anti-CD58 FITC, anti-CD54 
PE, anti-CD40 FITC, anti-CCR7 PE. Cells were stained as described in section 6.2 and 
fixed with 1% paraformaldehyde before flow cytometric analysis (section 6.4). DCs 
were gated following characteristic forward/side scatter patterns. Data were collected 
from 10,000 cells and expressed as median of fluorescence intensity of all cells, or 
percentage of positive cells. 
 For quantitation of diverse cytokines secreted by stimulated DCs, supernatants 
from DCs incubated with the various stimuli were collected and stored at -80°C until 
analysis with a multiplex cytokine kit (PROGEN Biotechnik, Heidelberg, Germany). 
 
 
6.8. Incubation of immature dendritic cells with yeast vectors 
Human MDDCs were generated as described in section 6.6, collected on day 7 by 
centrifugation at 1,400 rpm for 6 minutes, counted, and aliquoted at 106 cells/ml. For 
phagocytosis of yeasts carrying pp65, 2×106 DCs from HCMV-infected individuals 
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were incubated with yeasts expressing recombinant pp65 or harbouring empty vectors 
(MOI 5) in sterile 50 ml tubes. Samples were briefly centrifuged, incubated for 2 days at 
37°C and subsequently added to autologous T lymphocytes (Methods, section 6.9). 
 
 
6.9. Stimulation of antigen-specific memory T lymphocytes by autologous dendritic 
cells 
For stimulation of antigen-specific memory T lymphocytes by autologous dendritic 
cells from HCMV-seropositive donors, a protocol based on Scheller et al. (2008) was 
used. Frozen lymphocytes obtained after monocyte isolation by adherence to plastic 
(section 6.6) were thawed, washed twice with medium, and counted. Subsequently, 
2×106 cells were incubated in 15-ml tubes with 1 µg/ml of the costimulatory antibodies 
anti-CD28 and anti-CD49d and with DCs (1:1) which had been previously incubated 
with yeasts expressing pp65 or control yeasts. Samples were incubated for 2 h at 37°C, 
then 10 µg/ml Brefeldin A were added and tubes were further incubated at 37°C for 4 h. 
Subsequently, EDTA was added (final concentration = 0.4 mM), followed by 
incubation at room temperature for 15 minutes. Thereafter, samples were incubated for 
5 minutes with 0.008% EDTA in PBS. After centrifugation at 1,400 rpm for 6 minutes, 
supernatants were discarded and 300 µl of 4% paraformaldehyde were added. After 
incubation for 5 minutes at room temperature, 2 ml of FACS-buffer were added and 
samples were centrifuged for 6 minutes at 1,400 rpm. Supernatants were discarded and 
cells were stained for surface and intracellular antigens as described in sections 6.2 and 
6.3 of Methods. 
 
 
6.10. Measurement of ROS production in whole blood 
The ability of phagocytes to produce reactive oxygen species (ROS) is a critical aspect 
in host immune responses against potential pathogens. ROS play an important role as 
antimicrobial agents by killing microorganisms directly and as signaling molecules 
involved in various physiological pathways in neutrophils and macrophages (Fialkow et 
al., 2007; Kelly et al., 2010). Chemiluminescence is a low-cost method used to examine 
the respiratory burst of phagocytes. Luminol reacts with diverse ROS, such as 
superoxide, hydrogen peroxide, and hydroxyl radicals, generating aminophthalate ion in 
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an excited state, which emits light when returning to the ground state (Marquette and 
Blum, 2006). 
Production of ROS by phagocytic cells in whole blood after incubation with the 
yeasts S. cerevisiae, Sz. pombe, K. lactis and P. pastoris was examined. Yeasts were 
grown in SC medium, washed three times with HBBS, counted and aliquoted at 108 
yeasts cells/ml in HBBS. Then, yeasts were incubated at 65°C for 1 h or left at room 
temperature before the chemiluminescence assay. 
Fresh heparinised whole blood was 1:10 diluted in HBSS containing 0.1% 
gelatine. Diluted blood samples were divided into three groups: stimulated, resting and 
blank. In stimulated samples 90.5 μl diluted blood were incubated with 7.5 μl (2.5×105 
yeasts) of a yeast suspension (108 yeasts cells/ml in HBSS) and 2 μl of luminol solution 
(final concentration = 400 μM/well); in resting samples the same volume of blood was 
incubated with 7.5 μl HBSS and 400 μM luminol; in blank samples blood was 
incubated with 2.5×105 yeasts and 2 μl DMSO. All samples were plated in triplicates 
(100 μl/well) in a white Lumitrac Greiner 96-well plate. Luminescence was recorded at 
37°C over a 150-minute interval with 1s integration time, using a plate reader 
(PARADIGM, BeckmanCoulter). Data were analyzed with the software Multimode 
Analysis version 3.3.0.9 (BeckmanCoulter). 
 
 
6.11. In vitro yeast phagocytosis assays 
 
6.11.1. Determination of percent phagocytic cells and phagocytic index 
Human dendritic cells or murine IC21 macrophages were seeded in 24-well plates at a 
density of 1×105 cells/well. In the case of macrophages, cells were allowed to adhere 
overnight. Phagocytes were then incubated with yeasts at various MOI for 4 h or at 
MOI 5 for various periods of time, in 1 ml culture medium per well, at 37 °C in 5% 
CO2. Plates were briefly centrifuged to ensure that yeasts and cells were brought 
together. After incubation, samples were vigorously resuspended to detach loosely 
bound yeasts from cells. The cells were then washed with PBS and fixed in 1% 
paraformaldehyde at 4 °C. At least 100 cells were examined per well for attachment and 
uptake of yeasts by direct visual enumeration using a light microscope equipped with a 
40× objective lens (Olympus) to determine the percentage of phagocytes containing at 
least one yeast cell (% phagocytic cells) or the number of yeasts in 100 phagocytes 
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(phagocytic index). Experiments were performed in triplicate and results are shown as 
mean ± standard deviation (SD). 
 
6.11.2. Effect of blocking antibodies on yeast phagocytosis 
Immature DCs or murine IC21 macrophages (1×105cells/ml in the respective culture 
media) were pre-incubated with 25 μg/ml of the mouse monoclonal antibodies anti-
human Dectin-1, or anti-human mannose receptor, as well as with a correspondent 
isotype control antibody, in 24-well plates for 1 h at 37°C. All assays were performed in 
media supplemented with heat-inactivated serum to exclude contributions of 
complement. Yeasts were added at a 5:1 ratio and incubated for another 4 h. Mean ± SD 
of triplicate experiments is shown. Student’s t test was used to establish the statistical 
significance of differences between mean values using GraphPad Prism 4. One-sided p 
values less than 0.05 were considered statistically significant.  
 
 
6.12. Whole blood assay 
The presence of antigen-specific memory T cells in human blood can be quantified by 
means of a whole blood assay. The antigens are incubated with aliquots of whole blood 
where they are taken up by phagocytic cells, processed and presented to CD4 and CD8 
T lymphocytes in context of MHC class I and II, respectively. Activated T cells produce 
certain molecules, such as CD69 on the cell surface and secreted IFN-γ. Simultaneous 
staining of CD4 or CD8, CD69, and IFN-γ allows identification and determination of 
the frequency of antigen-specific activated T lymphocytes. Incubation of cells with 
Brefeldin A avoids secretion of IFN-γ, which remains intracellular and can be stained 
for flow cytometric analyses after cell permeabilisation with saponin. The incubation 
time of the assay (6 h) is not enough for activation of naïve T cells, so that only effector 
and memory T cells are specifically stimulated (Breinig et al., 2006). 
Whole blood assays were performed as described by Breinig et al. (2006). 
Aliquots of 450 µl heparinized human blood were incubated in 15-ml polypropylene 
tubes and mixed with 1 µg/ml of the costimulatory antibodies anti-CD28 and anti-
CD49d. As positive control, 2.5 µg/ml Staphylococcus enterotoxin B were used and 
cells incubated with costimulatory antibodies only served as negative control. A lysate 
of HCMV-infected fibroblasts (3.8 μl) was used to confirm whether donors were 
positive for this virus. 
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The polypropylene tubes were incubated at 37°C and 5% CO2. After 2 h, 10 
µg/ml of Brefeldin A were added and samples were further incubated for 4 h. After this 
period, the blood was incubated for 15 min in the presence of 2 mM EDTA and then for 
10 min with “FACS lysing solution” to lyse erythrocytes and fix leukocytes. Cells were 
washed with FACS buffer (PBS, 5% FCS, 0.5% BSA, 0.07% NaN3) and let overnight at 
4°C. Cells were then permeabilized with FACS buffer containing 0.1% saponin for 10 
min and immunostained using saturating conditions of the antibodies anti-CD4 (4 µl), 
anti-CD8 (4 µl), anti-IFNγ (5 µl, 1:10 diluted) and anti-CD69 (2 µl). 
Cells were washed with FACS buffer, fixed in 1% paraformaldehyde and 
analyzed (at least 25,000 of CD4- and CD8-positive lymphocytes each) on a FACScan 
flow cytometer (Beckton Dickinson). Antigen-specific activated T lymphocytes were 
identified and quantified as CD69 and IFN-γ double-positive cells. 
 
 
6.13. In vitro antigen presentation assay 
These experiments were performed in collaboration with Dr. Gernot Geginat at the 
Institute for Medical Microbiology and Hygiene (Faculty for Clinical Medicine 
Mannheim of the University Heidelberg). 
Bone marrow macrophages from C57BL/6 mice were plated at a density of 
1×105 cells per well (100 μl DMEM high glucose supplemented with L-glutamine, 100 
U/ml penicillin, 100 μg/ml streptomycin) in 96-well microtiter plates and loaded with 
the different yeast genera (MOIs 1.75, 3.5, and 7), as well as with synthetic OVA257–264 
peptide (SIINFEKL), or left untreated. Phagocytes and yeasts were brought together 
after centrifugation at 300 rpm for 3 min. After overnight incubation at 37°C, infected 
cells were washed twice and resuspended in culture medium supplemented with nystatin 
(200 U/ml) to kill any remaining uninternalized yeast cells. T cells specific for the H-
2Kb-restricted epitope SIINFEKL were added 16 h after infection (3×104/well). Culture 
supernatants were harvested 18 h after addition of T cells and IFN γ protein content was 
assessed using a specific enzyme-linked immunosorbent assay (ELISA) kit with a 
detection limit of 0.05 pg (Bazan et al., 2011). The ELISA was carried out as directed 
by the manufacturer. The amount of IFN-γ in individual wells was determined based on 
a supplied recombinant mouse IFN-γ standard. 
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6.14. Immunization of OT-I mice 
These experiments were carried out in cooperation with Elisabeth Kenngott at the 
Medical Clinic for Rheumatology and Clinical Immunology (Charité, Berlin). 
OT-I transgenic mice were immunized subcutaneously (s.c.) at the tail base with 
5×107 yeasts (either expressing Ovacyt or carrying empty vector), in 100 µl PBS, or with 
PBS alone. Boost injections were given 7 and 14 days after priming. On day 21, 
inguinal lymph nodes and spleens were collected for ex vivo restimulation and further 
analysis of IFN- γ production. 
 
 
6.15. Analysis of cellular immune responses in lymph nodes and spleen cells from 
immunized OT-I transgenic mice 
These experiments were performed in collaboration with Elisabeth Kenngott at the 
Medical Clinic for Rheumatology and Clinical Immunology (Charité, Berlin). 
Immunized OT-I mice were killed by cervical dislocation. Inguinal lymph nodes and 
spleens were harvested one week after the last immunization. Single cell suspensions 
were obtained by grinding the lymph nodes or spleens with a syringe plunger against 
cell strainers in RPMI 1640 containing 10% FCS. Spleen cells preparations were 
incubated with erythrocyte lysing solution for 3 minutes at 4°C. Cells were centrifuged 
at 1,200 rpm at room temperature for 8 minutes, washed with PBS and counted. 
Subsequently, 2×106 lymphoid cells in 1 ml culture medium were restimulated in sterile 
15-ml tubes with 10 µg/ml of SIINFEKL peptide or PMA/ionomycin, at 37°C under 5% 
CO2 atmosphere. After 2 h of incubation, 10 μg/ml Brefeldin A were added and 
SIINFEKL-stimulated cells were incubated for further 4 h, and PMA/ionomycin were 
incubated for further 2h. Then, cells were harvested, washed with PBS/BSA, fixed with 
2 % paraformaldehyde in PBS, washed twice with PBS/BSA and stained for the surface 
molecules CD8 and Vβ5 TCR as described in section 6.2. Samples were left overnight 
at 4°C in the dark. Afterwards, cells were centrifuged and resuspended in 100 µl PBS 
containing 0.5% saponin, 10 µg/ml rat IgG and anti-IFN-γ PECy7 (100-fold diluted) or 
PECy7-conjugated isotype control. After incubation at room temperature for 30 
minutes, cells were washed with 1 ml of saponin buffer, then with 1 ml PBS, and 
resuspended in 200 µl PBS prior to flow cytometric analyses on a FACSCanto (BD 
Biosciences). 
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For determination of the frequencies of activated (IFN-γ-producing) cells, CD8+ 
Vβ5+ lymphocytes were gated. Samples were measured using a FACSCanto flow 
cytometer equipped with a FACSDiva software (BD Biosciences) and analyzed using 
Flowjo (Tree Star, Inc). 
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IV. RESULTS 
 
 
1. Effects of different yeast genera on maturation and activation of human 
immature DCs 
Interaction of non-pathogenic as well as disease-associated yeasts with mammalian 
APCs such as DCs has been repeatedly demonstrated (Buentke et al., 2000; Newman 
and Holly, 2001; Heintel et al., 2003). Here, the expression profile of diverse cell 
surface markers and cytokines by DCs after incubation with distinct yeast genera, 
species, strains, or yeast mutants was examined and compared in an attempt to identify 
attractive antigen delivery vehicles for potential vaccination approaches. 
 
1.1. Maturation of human DCs by diverse yeast genera 
Maturation of human and murine DCs stimulated with whole yeasts or yeast 
components has been described. Among the species analyzed are the baker’s yeast S. 
cerevisiae, and the potentially pathogenic yeasts C. albicans, M. furfur and C. 
neoformans (Buentke et al., 2001; Romani et al., 2004; Stubbs et al., 2001; Pietrella et 
al., 2005). However, no study comparing several yeast strains with respect to their 
ability to stimulate DCs has so far been performed. 
Other inflammatory stimuli, such as bacteria and viruses, have also been 
demonstrated to induce DC maturation (Rescigno et al., 1998; Rudolf et al., 2001). In 
this way, DC responses to fungal, bacterial and viral stimuli were examined in the 
present work. Immature DCs derived from PBMC of four individuals were cultured for 
48 h with various yeast genera, E. coli LPS, a lysate from HCMV-infected fibroblasts, 
or left untreated. Then, phenotypic analysis of DCs was performed by flow cytometry 
using specific antibodies. The influence of each stimulus on DC maturation was 
determined by analyzing changes in the expression of 9 surface markers (CD40, CD54, 
CD58, CD80, CD83, CD86, CCR7, HLA I, and HLA II molecules). 
The expression of all these molecules is upregulated in mature DCs. The initial 
association of DCs with naïve T cells is mediated by cell-adhesion molecules, such as 
CD54 and CD58 on DC surface and LFA-1 and CD2, respectively, on the T cell. 
Costimulatory molecules, including CD80 and CD86, provide the second 
(costimulatory) signal needed for the clonal expansion of antigen-specific T cells. 
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Interaction between CD40 on DCs and CD40L on T cells transmits activating signals to 
the T cell and stimulates the APC to express CD80 and CD86, promoting further T cell 
proliferation. Mature DCs also produce high levels of MHC molecules for enhanced 
peptide presentation. Moreover, activated DCs express the chemokine receptor CCR7 
for sensing of lymph node-derived chemokines and migration into lymphoid tissues 
(Janeway et al., 2001; Abbas et al., 2007). 
As seen in Fig. 6, DCs showed increased expression of the surface markers 
CD80, CD86, HLA I, HLA II, CD40, CD54, CD58 and CCR7 (as median of 
fluorescence intensity levels) after 48 h of incubation with the appropriate stimulus 
compared to untreated DCs. Similarly, the percentage of CD83 positive cells also 
increased after treatment. Notably, yeast genera differently up-regulated the surface 
expression of maturation markers in human DCs. The lysate from HCMV-infected 
fibroblasts also led to an increase in MFI levels for all surface markers analyzed; LPS, 
the classical inducer of DC maturation in vitro, elicited the highest increases in median 
fluorescence of the same molecules. 
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Fig. 6: Upregulation of various DC surface markers induced by fungal, bacterial and 
viral components. Human immature DCs were incubated for 48 h with diverse yeasts 
(MOI 1), E. coli LPS, a HCMV lysate, or left untreated, and subsequently stained with 
specific antibodies for flow cytometric analyses. Results are depicted as percent positive 
cells (for CD83) or median values of fluorescence intensities (for all other markers). 
Bars represent median values from four donors. Sc = S. cerevisiae. 
 
 
In order to allow comparisons based on the yeast genus tested, additional values for 
each genus were calculated for each donor from the median values relative to each 
strain (in the case of species in which two or more strains were analyzed, such as P. 
pastoris and S. cerevisiae). For practical reasons, these values are not shown in the 
graphics. 
 
DC maturation caused by different S. cerevisiae strains 
All S. cerevisiae strains analyzed were able to induce, though in some cases to different 
degree, upregulation of DC surface molecules. Among the three S. cerevisiae strains 
BY4742, S86c and W303-1a, BY4742 and S86c alternated as inducers of higher 
expression levels of DC surface markers (or higher levels of CD83-positive cells). For 
example, levels of CD86, HLA I and percentage of CD83+ cells were generally higher 
after DC incubation with BY4742, whereas levels of CD40, CD54 and CCR7 were 
higher in the case of S86c. Levels of CD58, CD80 and HLA II were similar for BY4742 
and S86c, and higher than for W303-1a. Thus, in terms of DC maturation, the S. 
cerevisiae strain W303-1a exhibits some degree of drawback compared to strains S86c 
and BY4742. 
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DC maturation caused by different S. cerevisiae mutants 
In order to verify the role of the yeast cell wall composition in DC maturation, two cell-
wall mutants of S. cerevisiae BY4742 were also tested, the Δmnn11 mutant, which lacks 
an α-1,6-mannosyltransferase and cannot elongate mannan chains, and the Δost3 
mutant, in which glycoproteins show an underglycosylated pattern due to the absence of 
an oligosaccharyltransferase (Karaoglu et al., 1995; Jungmann and Munro, 1998). In 
general, the mutants were more efficient than the parental strain in terms of 
upregulation of DC maturation markers, except in the case of CCR7. Higher surface 
marker levels (or percentage of positive cells) were observed after incubation of DCs 
with Δmnn11, except for HLA II, which was detected in higher levels after stimulation 
with Δost3 (Fig. 6). This higher activation induced by cell-wall mutants compared to the 
wild-type strain indicates that the degree of maturation depends on antigen nature. Also, 
shorter mannan chains on yeast cell surface seem to affect maturation in a more explicit 
manner than the presence of underglycosylated proteins. 
 
DC maturation caused by different P. pastoris strains 
Increases in the expression of DC surface markers induced by the two P. pastoris strains 
examined (GS115 and KM71) showed similar patterns, indicating that both strains share 
similar characteristics in terms of promoting DC maturation. The median of 
fluorescence intensity for most of the markers analyzed were slightly higher in the case 
of GS115 (CD40, CD54, CD58, CD80, CD86, HLA I, HLA II and CCR7), whereas the 
percentage of CD83+ cells was a little higher when KM71 was added to DCs. However, 
these differences are not distinct enough to place one strain in a more favoured position 
than the other with respect to DC maturation. 
 
DC maturation caused by different yeast genera 
When only the yeast genera are compared, it can be assumed that there is no 
preponderance of one genus among the set of genera analyzed. For instance, the highest 
levels of CD86, HLA I and HLA II were induced by K. lactis. Y. lipolytica caused the 
strongest upregulation of CD54 and CD80, Sz. pombe of CD40 and CD58, and S. 
cerevisiae of CCR7, whereas the percentage of CD83+ cells was more elevated after 
incubation with P. pastoris. 
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Comparing the viral and bacterial stimuli with the yeast genera, LPS led to stronger 
upregulation of all markers examined. In relation to the classical DC maturation marker, 
CD83, the viral stimulus led to a higher number of positive cells than fungal stimuli. 
When the adhesion molecules CD54 and CD58 are analyzed, HCMV was similar to 
many yeast genera in promoting upregulation of CD54, whereas all fungal stimuli were 
more potent in inducing upregulation of CD58 than the viral stimulus. This latter 
finding was also true for the costimulatory molecules CD40 and CD86. For the HLA 
classes I and II, as well as for CD80 and CCR7, higher variations were observed among 
different stimuli, and no explicit pattern could be defined. 
In sum, all yeast genera were able to effectively induce DC maturation, as 
observed by the upregulation of the adhesion molecules CD54 and CD58, the 
costimulatory molecules CD40, CD80 and CD86, the chemokine receptor CCR7, the 
classical maturation marker CD83, and the HLA molecules. Based on the analyses of 
these surface markers, differences among yeast strains could be observed, and they were 
greater among the S. cerevisiae strains tested than among the P. pastoris strains. Yeasts 
bearing mutations that affect their glycan structures also differ in their abilities to 
mature DCs, and the maturation was positively modulated when the two mutants were 
compared to the wild-type counterpart. Fungal stimuli were indeed less potent than the 
bacterial stimulus LPS in eliciting upregulation of expression of these surface markers, 
but, in many situations, stronger than the viral stimulus. 
 These results suggest that some differences in the immunological responses 
might be observed after in vivo application of distinct yeast genera as antigen carriers. 
 
 
1.2. Cytokine detection in DC culture supernatants 
Besides the elevated expression of maturation markers, DCs were assessed for secretion 
of a number of cytokines that are known to be associated with their particular activation 
status. Again, the nature of antigens (fungal, bacterial and viral) on cytokine secretion 
by DCs was examined. For this purpose, immature DCs were incubated with distinct 
yeast genera, LPS, HCMV lysate, or left untreated. After 48 h incubation, culture 
supernatants were collected and assessed for the presence of the cytokines GM-CSF, 
IFNα, IFNβ, IFNγ, TNFα, IL-1α2, IL-1β, IL-6, IL-8, IL-10, IL-12 p70, IL-15, IL-23 and 
IL-27. The main functions of these cytokines are summarized and outlined below: 
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• GM-CSF is involved in the production and functional activation of 
hematopoietic cells, particularly granulocytes and monocyte/macrophages (Metcalf, 
2008; Hercus et al., 2009). GM-CSF is also crucial for the proinflammatory activity of 
TH17 cells (McGeachy, 2011). 
• IFN-α and IFN-β belong to a family of cytokines (type I IFNs) with pleiotropic 
activities on nearly all somatic cells. Secretion of IFN-α/β is mainly induced upon viral 
infection, but can also occur in response to other biological stresses. One remarkable 
function of IFN-α/β is its interference with virus replication and spread (Huber and 
Farrar, 2011). IFN-α promotes a number of biological effects, such as induction of 
apoptosis and inhibition of cell growth, as well as induction of differentiation and 
activity of host immune cells (Rizza et al., 2010). IFN-β and IFN-γ inhibit upregulation 
of CCR7 expression in mature DCs, reducing their migratory capacity. However, unlike 
IFN-γ, IFN-β significantly inhibits production of IL-12 (Szabo et al., 2000; Yen et al., 
2010). Human T cells, in contrast to mice T cells, induce TH1 development in response 
to type I IFNs (Moser and Murphy, 2000). IFN-γ is a type II IFN, whose functions play 
an essential role in immunity towards intracellular microorganisms. IFN-γ is critical for 
TH1 cells responses, inhibiting differentiation of TH2 cells. It also stimulates APCs to 
upregulate expression of MHC class I and class II as well as costimulatory molecules. 
IFN-γ activates NK cells and stimulates macrophages to kill internalized microbes 
(reviewed by Abbas et al., 2007; Miller et al., 2009). 
• IL-1 is a proinflammatory cytokine comprising IL-1α and IL-1β, which are 
products from different genes and exert distinct immunological activities, but are 
mutually inductive (Horai et al., 1998; Nakae et al., 2001a). Both IL-1α and IL-1β 
induce inflammation and activate lymphocytes. IL-1β strongly activates humoral 
immune responses, whereas IL-1α is involved in the development of antigen-specific 
memory T cells (Nakae et al., 2001a; Nakae et al., 2001b). 
• IL-6 stimulates production of neutrophils, the growth of antibody-producer B 
cells and induces the proliferation and differentiation of TH17 cells (Abbas et al., 2007). 
• IL-8, a constituent of the chemokine family, exerts various functions on 
leukocytes, especially neutrophils, playing an important role in the establishment of 
acute inflammation. Among other functions, it is involved in leukocyte chemotaxis and 
induction of neutrophils to release lysosomal enzymes (Harada et al., 1994; 
Vlahopoulos et al., 1999). 
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• IL-10 possesses anti-inflammatory properties and targets different leukocytes. 
This cytokine functions to repress excessive inflammatory responses and to limit 
subsequent tissue damage. In phagocytes, IL-10 reduces antigen presentation and 
expression of inflammatory mediators, but enhances antigen uptake. Moreover, IL-10 is 
critical in the biology of B and T cells and contributes to induced tolerance (Sabat et al., 
2010; Ouyang et al., 2011). 
• IL-12 plays a crucial role in priming TH1 cell responses and stimulating IFN-γ 
production and cytotoxic activity by T lymphocytes and NK cells. Furthermore, it 
functions as a third signal in activation of CD8+ T cells and is involved in the 
reactivation and survival of memory CD4+ T cells (DelVecchio et al., 2007). IL-12 and 
type I IFN-α/β are important in responses against viruses due to their antimicrobial and 
immunoregulatory activities (Dalod et al., 2002). 
• IL-15 has been associated with the stimulation and survival of CD8+ memory T 
cells and NK cells (Zhang et al., 1998; Abbas et al., 2007). 
• IL-23 might expand the pool of IL-17-producing cells from activated and 
memory T-cell populations, but cannot trigger differentiation into TH17 cells from naive 
T-cell precursors (Bettelli et al., 2006). Leibundgut-Landmann and colleagues (2007) 
showed that Dectin-1 signaling in DCs through Syk kinase strongly triggers TH cell 
differentiation into TH17 cells, and also observed that Dectin-1 agonists induce TH17 
and TH1 responses in vivo. 
• IL-27 inhibits development of TH17 and TH2 cells, inducing CD4+ T cell 
differentiation into TH1 cells that produce IFN-γ (Baten et al., 2006; Yoshimoto et al., 
2007). 
• Secretion of the pluripotent cytokine TNF-α activates a cytokine cascade needed 
for proper cellular responses in the affected tissue. In monocytes, TNF-α leads to 
enhanced cytotoxic capacity and increased secretion of other inflammatory mediators, 
such as IL-1 and IL-8 (Vlahopoulos et al., 1999). 
 
As illustrated in Fig. 7, DCs incubated with yeasts up-regulated the production 
of several cytokines, in some cases even more pronounced than after LPS treatment. 
Results from four different blood donors showed great variability for a specific 
cytokine. This observation has also been described by others (Buentke et al., 2001; 
Barron et al., 2006; Remondo et al., 2009). 
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Fig. 7: Cytokine profile secreted by DCs after incubation with different stimuli. Human 
immature DCs were incubated with various yeasts (MOI 1), LPS, a lysate from HCMV-
infected fibroblasts, or left untreated. After 48 h, supernatants were collected and 
cytokine concentrations were determined using a multiplex cytokine/chemokine kit 
(PROGEN Biotechnik, Heidelberg, Germany). Graphics show cytokine concentration in 
pg/ml. Bars indicate median values from four donors. Sc = S. cerevisiae. Graphics 
identified with an asterisk (*) show values above the detection limit (47,836 pg/ml for 
GM-CSF; 20,000 pg/ml for IL-6; 12,647,444.85 pg/ml for IL-8). 
 
 
Stimuli were compared using the median values only. For comparison among single 
yeast genera, median values were calculated as described above for the surface markers. 
The high level of GM-CSF detected in supernatants of untreated DCs might have 
resulted from the presence of this cytokine in the culture medium to induce monocyte 
differentiation into immature DCs (Sallusto and Lanzavecchia, 1994). 
 
Cytokine secretion by DCs in response to different S. cerevisiae strains 
The S. cerevisiae strains S86c, BY4742 and W303-1a differently stimulated the 
secretion of cytokines by DCs, as observed for the maturation markers. Interestingly, 
the strain BY4742 led to secretion of higher levels of IFN-α, IFN-β, IFN-γ, IL-12 p70 
(TH1-driving cytokines), as well as of IL-1α2, IL-8, IL-15 and IL-27. Strain W303-1a 
elicited production of higher amounts of IL-1β, IL-6, IL-23 (TH17-driving cytokines), 
IL-10 and TNF-α. S86c, in turn, caused the highest secretion levels of GM-CSF among 
the three S. cerevisiae strains. These results show a different pattern than the findings 
related to DC maturation, in which W303-1a showed some disadvantage compared to 
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the other two strains. However, a significantly higher number of donors needs to be 
tested in order to confirm these observations. 
 
Cytokine secretion by DCs in response to S. cerevisiae BY4742 and its mutants 
Among the tested S. cerevisiae mutants, the wild-type strain BY4742 provoked superior 
secretion levels of IFN-β, IL-1α2, and IL-8 by DCs. Its isogenic Δost3 mutant induced 
higher expression levels of IL-27 only, whereas the Δmnn11 knock-out was more 
effective in inducing DC expression of GM-CSF, IFN-α, IFN-γ, TNF-α, IL-1β, IL-6, 
IL-10, IL-12 p70, IL-15 and IL-23. This bias for the Δmnn11 mutant confirms the 
results observed for DC maturation. Again, these results demonstrate a positive 
influence of shorter mannose structures within yeast cell wall components on immune 
recognition and activation in comparison to normal yeasts or yeasts carrying 
glycosylation defects. 
 
Cytokine secretion by DCs in response to the P. pastoris strains 
As observed for the DC surface maturation markers, no outstanding difference in 
cytokine production was seen after incubation of DCs with either P. pastoris GS115 or 
KM71, except for IL-8, whose levels were more than hundred fold higher in 
supernatants from DCs incubated with GS115. Levels of GM-CSF, IFN-β, IL-1α2, IL-
1β and IL-6 were very similar in supernatants from DCs incubated with either strain 
GS115 or KM71. Higher production of IL-10 and TNF-α was detected after incubation 
of DCs with KM71, whereas slightly higher levels of IFN-α, IFN-γ, IL-8, IL-12 p70, 
IL-15, IL-23 and IL-27 were measured after incubation with GS115. The much higher 
levels of IL-8 observed after incubation of DCs with strain GS115 could be 
advantageous, since IL-8 acts as chemoattractant and inflammatory mediator, and it has 
been demonstrated that its synthesis precedes upregulation of the activation marker 
CD40 (Hellman and Eriksson, 2007). 
 
Cytokine secretion by DCs in response to different yeast genera 
Comparing the single yeast genera only, a slight bias could be observed towards P. 
pastoris, which induced the highest expression levels of IL-1α2, IL-1β, IL-8, IL-10, IL-
15, IL-27 and TNF-α by DCs, while Y. lipolytica led to secretion of the highest levels of 
GM-CSF, IFN-γ and IL-23, S. cerevisiae of IFN-β, IL-6 and IL-12, and K. lactis of 
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IFN-α. However, it has to be underscored that levels of IFN-β, IL-1α2, IL-23 and IL-27 
in culture supernatants were very similar for all yeast genera analyzed. Yeast genera 
upregulated the production of almost all cytokines analyzed. Secretion of IL-15 and 
IFN-β by DCs was, in some cases such as after incubation with Y. lipolytica, not 
upregulated in comparison to the median value of the untreated control. However, no 
data in the literature describing secretion of both cytokines in response to yeast could be 
found. 
 
Comparing all yeast genera with the viral and the bacterial stimuli, it could be observed 
that LPS was responsible for the highest levels of IFN-β, IL-1α2, IL-6, IL-10, IL-12, IL-
15, IL-23 and IL-27. The lysate of HCMV-infected fibroblasts provoked more GM-CSF 
secretion than any other stimulus. Besides GM-CSF, the only cytokine whose level was 
higher in response to HCMV than to LPS was IL-8. Secretion of IL-8 was markedly 
high for almost all yeasts tested, especially P. pastoris, which was by far the most 
effective stimulus, with DCs exhibiting IL-8 levels above 106 pg/ml (Fig. 7). Levels of 
IFN-α, IFN-γ, IL-1β and TNF-α, as well as the already mentioned IL-8, were higher in 
response to at least one yeast stimulus than for the viral or bacteria stimulus. IFN-γ 
levels in response to LPS and especially to HCMV were several times lower than to any 
yeast genus tested. Interestingly, lowest secretion of IFN-α was observed when DCs 
were incubated with the viral stimulus, and IFN-β levels did not significantly increase 
after DC incubation with HCMV in comparison to the untreated samples. 
 From these results it could be inferred that a wide spectrum of cytokines can be 
produced by DCs after incubation with different yeast stimuli, and that yeasts differ in 
their ability to stimulate cytokine production by DCs. Moreover, for a given set of 
cytokines, fungal stimuli can promote stronger DC activation than bacterial or viral 
antigens. 
 
 
2. Fungal cell wall staining  
The observation that distinct yeast genera lead to maturation of human DCs and 
production of a variety of cytokines, and that the composition of the fungal cell wall 
plays an important role in these events (as demonstrated previously), provided the 
rationale for investigating the variations in yeast cell wall constitution more closely. For 
this purpose, three of the major yeast cell wall components, mannan, β-glucan and 
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chitin, were examined in each one of the yeast species and strains used for DC 
maturation and activation. 
 Concanavalin A (Con A), a lectin of the jack bean (Canavalia ensiformis), has 
binding affinity for terminal α-D-glucopyranosyl, α-D-mannopyranosyl, β-D-
fructofuranosyl, or α-D-arabinofuranosyl residues. Con A does not interact with yeast 
glucan or chitin, therefore FITC-labeled Con A can be used to specifically stain α-
mannan in yeast cell walls (Goldstein and So, 1965; So and Goldstein, 1968; Tkacz et 
al., 1971). 
The mouse monoclonal anti-β-1,3-glucan antibody recognizes linear β-1,3-
oligosaccharides present in β-glucans. When an anti-mouse IgG-FITC antibody is 
subsequently used after incubation of yeasts with the primary antibody, linear cell wall 
β-1,3-glucans can be detected by fluorescence microscopy or flow cytometry. 
Wheat germ agglutinin (WGA) is a lectin from Triticum vulgaris which 
specifically interacts with β-1,4-N-acetylglucosamine oligomers, such as those found in 
fungal chitin. WGA-FITC was used in this study to stain chitin on yeast cell walls, as 
described by others (Buck and Andrews, 1999; Mora-Montes et al., 2011). 
 The cell walls of different yeast genera were analyzed both by flow cytometry 
and fluorescence microscopy with respect to the presence and distribution of mannan, β-
1,3-glucan and chitin. Among some yeast species, different strains (as for S. cerevisiae 
and P. pastoris) were analyzed, and among one S. cerevisiae strain (BY4742), two cell 
wall mutants were evaluated. As depicted in Fig. 8, mannan, β-glucan and chitin 
staining patterns varied among yeast genera, species, strains and cell-wall mutants, to 
greater or lesser extents. Unstained yeasts showed no fluorescence (data not shown). All 
yeasts could be stained for mannan and β-glucan. Both S. cerevisiae mutants, Δmnn11, 
which bears a mutation that affects mannan biosysnthesis, and Δost3, which contains 
underglycosylated glycoproteins, could also be specifically stained by Con A on their 
cell surfaces. These results were not unexpected, since the mutations do not exclude 
mannans from the cell walls. With respect to chitin, fluorescence microscopy of yeast 
cells stained with WGA-FITC revealed a higher discrepancy among the yeasts 
analyzed. Some yeast species, such as P. pastoris and Y. lipolytica, exhibited green 
fluorescence outlining the cells, whereas others showed fluorescence only in discrete 
patches (e.g. K. lactis) or almost no fluorescence (Sz. pombe). In the case of β-glucan 
staining, the budding yeasts showed the existence of restricted regions on the cell wall 
where this structure is exposed. In fission yeast, linear β-1,3-glucan is restricted to the 
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septum (Humbel et al., 2001). In contrast, mannan structures are more homogeneously 
distributed over the cell walls (Fig. 8). 
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Fig. 8: Fluorescence microscopy after mannan, β-1,3-glucan and chitin staining of 
diverse yeast genera. Yeasts exponentially grown in SC medium were stained for 
mannan with Con A-FITC, β-glucan with mouse anti-β-1,3-glucan and anti-mouse IgG-
FITC, and chitin with WGA-FITC, and analyzed with a fluorescence microscope (GFP 
channel). Each column shows fluorescence (left) and the matching bright field (right) 
micrographs. 50× zoom. 
 
 
Additional flow cytometric analyses confirmed that the majority of all yeast genera, 
species, strains or mutants stained positive for mannan (i.e. O- and N-linked mannose 
residues) and β-1,3-glucan but, in some cases, not for chitin (Fig. 9). Different staining 
patterns were observed, also between strains. Among the three S. cerevisiae strains 
analyzed (S86c, BY4742 and W303-1a) mannan and β-glucan staining resulted in a 
similar number of positive cells, while chitin distribution varied dramatically (about 
37%, 72% and 98% positive cells of BY4742, S86c and W303-1a, respectively). The 
BY4742 mutants Δmnn11 and Δost3 showed a similar percentage of positive cells after 
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Con A binding (~84% and ~86%, respectively), which was not only lower than in the 
parental strain BY4742 (~93%), but also than in any other strain tested. The two P. 
pastoris strains examined showed no relevant difference in relation to β-glucan and 
chitin, whereas the percentage of KM71 cells positive for mannan was about 10% lower 
in comparison to GS115. Sz. pombe showed the lowest percentage of cells positive for 
β-glucan (28,6%) and chitin (~5%). The first observation is in agreement with the fact 
that growth by elongation, unlike budding, does not unmask β-glucan. The presence of 
chitin in Sz. pombe is controversial. Little amounts of this polymer in Sz. pombe have 
been found by some authors, whereas other investigators failed to detect this structure 
(Horisberger et al., 1978; Sietsma and Wessels, 1990). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9: Flow cytometric analysis of mannan, β-1,3-glucan and chitin from various yeast 
genera. Yeasts exponentially grown in SC medium were stained with Con A-FITC for 
mannan, WGA-FITC for chitin, or with anti-β-glucan and FITC-conjugated secondary 
antibody for β-1,3-glucan, and analyzed by flow cytometry. Bars indicate the 
percentage of positive cells. Values relative to unstained yeasts (negative controls) were 
subtracted. 
 
 
Thus, each yeast strain has its peculiarities in terms of cell wall composition. Evidently, 
other yeast cell wall components, like β-1,6-glucan and β-1,6-branched β-1,3-glucan, 
also play an important role in yeast recognition by the immune system. However, 
mannan β-1,3-glucan                     chitin
S. cerevisiae S86c
S. cerevisiae W303-1a
S. cerevisiae BY4742
S. cerevisiae BY4742 Δmnn11
S. cerevisiae BY4742 Δost3
Sz. pombe
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Y. lipolytica
C. glabrata
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detection of such structures was not possible in this study due to the lack of commercial 
antibodies or specific lectins. 
 In this way, the particular set of PAMPs of a specific yeast strain should be 
taken into account in terms of immune recognition and interaction with host cells. 
 
 
3. Uptake of different yeast genera by mammalian phagocytic cells 
A necessary feature of a possible antigen carrier is its interaction with cell surface 
receptors of antigen-presenting cells in order to trigger its subsequent internalization. In 
this study, the ability of murine macrophages and human DCs to phagocytose four 
representative yeast genera (S. cerevisiae, Sz. pombe, P. pastoris and K. lactis) that are 
among the most widely used expression systems in biotechnology were characterized. 
 
3.1. Uptake of whole yeast cells by IC-21 murine macrophages 
The pattern of S. cerevisiae, K. lactis, P. pastoris, and Sz. pombe uptake by IC-21 
murine macrophages was microscopically monitored using 24-well plates and a light 
microscope. First, yeasts were incubated with macrophages at MOI 5 for varying 
periods of time, following the same protocol described in the Methods section. Fig 10 A 
shows that S. cerevisiae, K. lactis, and P. pastoris were phagocytosed by IC-21 in a 
similar fashion, in which these yeasts were quickly internalized by macrophages, 
whereas recognition and engulfment of Sz. pombe occurred more slowly (for example, 
after 4 h 65% ± 4%, 65% ± 3%, 65% ± 6%, and 31% ± 5% of the macrophages had 
ingested at least one single yeast cell of S. cerevisiae, K. lactis, P. pastoris, and Sz. 
pombe). However, after 12 h of incubation, a plateau level was reached, and all yeast 
genera showed almost the same pattern of internalization (81% ± 4% for S. cerevisiae, 
82% ± 3% for K. lactis, 82% ± 3% for P. pastoris, and 79% ± 3% for Sz. pombe). Some 
macrophages ingested a high number of yeast cells, especially in the case of P. pastoris. 
The presence of several yeast cells inside a single macrophage was not due to yeast 
growth within the phagosome, as the total yeast cell number remained constant in the 
course of the experiment (data not shown). Upon microscopic visualization, only yeast 
cells which were localized inside the boundaries of the macrophage cell membrane were 
counted, ensuring that yeasts that had not been internalized were excluded (Fig. 10 B). 
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Fig. 10: (A) Uptake kinetics of yeasts by mouse macrophages. The yeasts S. cerevisiae, 
K. lactis, P. pastoris and Sz. pombe were incubated at a 5:1 ratio with mouse 
macrophages for different periods. After each time point indicated, medium was 
aspirated and macrophages were extensively washed to remove unbound yeasts. Then, 
cells were fixed and examined under light microscopy for the percentage of phagocytes 
binding at least one single yeast cell. (B) Confocal laser scanning microscopy after 4 h 
co-cultivation of IC-21 macrophages and yeasts at MOI 5. Micrographs show that S. 
cerevisiae, K. lactis, and P. pastoris are rapidly internalized, whereas many Sz. pombe 
cells are found in the neighbourhood of the macrophages. 
 
 
Next, the effect of the MOI on the uptake of different yeast genera by IC-21 
macrophages was examined. Initially, ingestion of yeast cells increased proportionally 
with the MOI (Fig. 11 A), and reached a maximum at MOI 7 for K. lactis (65% ± 1% of 
macrophages ingesting) or 9 for S. cerevisiae (69% ± 5%), P. pastoris (73% ± 3%) and 
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Sz. pombe (30% ± 4%). When the phagocytic index was determined, i.e., the number of 
internalized yeast cells in 100 macrophages, it could be seen that the average number of 
yeast cells per phagocyte enhanced continuously as MOIs increased. This observation 
was valid for all yeast species tested and, again, internalization of Sz. pombe showed to 
be less effective in comparison to the other species. In all MOIs tested, uptake of S. 
cerevisiae, K. lactis and P. pastoris by IC-21 macrophages was equivalent, and the 
difference to Sz. pombe became higher each time when MOI was increased. At MOI 11 
and after 4 h of co-incubation, there was approximately one single fission yeast cell per 
macrophage, and 3.5 yeasts/macrophage in the case of the other yeasts (Fig. 11 B). 
 
A 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
Fig. 11: (A) Effect of yeast/macrophage ratio on phagocytosis. IC-21 murine 
macrophages were incubated with the yeasts S. cerevisiae, Sz. pombe, K. lactis and P. 
pastoris at varying MOIs for 4 h. After this period, cells were thoroughly washed to 
remove unbound or attached yeasts, fixed, and analyzed under a light microscope for 
assessment of percent ingestion. (B) Alternatively, the total number of yeast cells in 100 
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macrophages was assessed for each MOI. Results are presented as mean values ± 
standard deviation from triplicates. 
 
 
3.1.1. Role of Dectin-1 on yeast uptake by IC-21 murine macrophages 
Since some macrophages do not bear the mannose receptor (MR) on the cell surface, 
such as resident peritoneal mouse macrophages (Taylor et al., 2002) and the J774 
murine macrophage cell line (Martinez-Pomares et al., 2003), the presence of this 
receptor in IC-21 cells was investigated. 
 Murine macrophages were incubated with rat anti-mouse MR or mouse anti-
mouse Dectin-1 and subsequently with anti-rat IgG-FITC and anti-mouse IgG-FITC, 
respectively, before being analyzed by flow cytometry. As shown in Fig. 12 A, IC-21 
macrophages do not express MR on their surface. In contrast, Dectin-1 is highly 
expressed in this cell line (Fig. 12 B).  
 
        A                                                        B 
 
 
 
 
 
 
Fig. 12. IC-21 murine macrophages were assessed for surface expression of MR (A) 
and Dectin-1 (B). Cells were first stained with monoclonal anti-MR, anti-Dectin-1, or 
an isotype control antibody, and then with a FITC-conjugated anti-IgG secondary 
antibody. Dashed lines represent cells stained with the isotype control antibody. Green 
solid lines represent cells stained for the mannose receptor and red solid lines represent 
cells stained for the Dectin-1 receptor. A total of 25,000 cells was analyzed. 
 
 
Next, the effect of Dectin-1 on yeast uptake by IC-21 was examined. Cells were 
incubated with 25 μg/ml anti-Dectin-1 for 1 h at 37°C, prior to the addition of S. 
cerevisiae, K. lactis, P. pastoris and Sz. pombe, at MOI 5. This yeast:macrophage ratio 
was chosen because it provided sufficient yeast-phagocyte interactions, and MOI values 
higher than 5 are very difficult to analyze microscopically. The appropriate antibody 
concentration was previously determined (not shown). After 4 h of incubation, cells 
were vigorously washed, fixed, and analyzed by light microscopy. As seen in Fig. 13, 
blocking of Dectin-1 caused a decrease in uptake of all yeast species tested. The 
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percentage of macrophages ingesting at least a single yeast cell decreased from 65% ± 
5% to 49% ± 4% for S. cerevisiae, 63% ± 5% to 46% ± 5% for K. lactis, 60% ± 2% to 
42% ± 2% for P. pastoris, and from 31% ± 2% to 19% ± 3% for Sz. pombe. This 
diminished internalization was statistically significant in all cases. No significant 
difference was observed between untreated cells and cells incubated with an isotype 
control antibody. 
 
 
 
 
 
 
 
 
 
 
Fig. 13: Dectin-1 in murine IC-21 macrophages recognizes the yeasts S. cerevisiae, K. 
lactis, P. pa  storis and Sz. pombe. IC-21 cells were pre-treated with anti-Dectin-1 for 1 
h, then incubated with yeasts (MOI 5) for another 4 h. After extensive washing, cells 
were fixed and analyzed by light microscopy. Results show mean values ± standard 
deviation from triplicates. Asterisks indicate significant differences compared to 
untreated macrophages (* p < 0.05, ** p < 0.01). 
 
 
In sum, recognition of the four tested yeast genera by IC-21 murine macrophages 
involves Dectin-1, but not MR. Many other PRRs are associated with yeast recognition 
by phagocytes, nevertheless analyzing the participation of each of them is a task outside 
the scope of this work. 
 
 
3.2. Uptake of whole yeast cells by human dendritic cells 
Previous studies have demonstrated that several yeast genera are effectively recognized 
and phagocytosed by immature human DCs, among them S. cerevisiae (Stubbs et al., 
2001; Barron et al., 2006), Histoplasma capsulatum (Gildea et al., 2001), Malassezia 
furfur (Buentke et al., 2000) and Candida albicans (Newman and Holly, 2001; Cambi 
et al., 2003). 
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In order to analyze and compare the internalization patterns of the four 
biotechnologically relevant yeasts S. cerevisiae, Sz. pombe, K. lactis and P. pastoris, 
immature monocyte-derived DCs were incubated with unopsonized live yeast cells at 
MOI 5 for varying time periods. As shown in Fig. 14 A, approximately 80 % of DCs 
had ingested one or more yeast cell after 2 h in the case of S. cerevisiae (80 ± 2 %) K. 
lactis (86 ± 1 %), and P. pastoris (83 ± 3 %), and the number of phagocytozing DCs 
reached a plateau level after 6 h (90 ± 1 %; 93 ± 1 %; 88 ± 2 %, respectively). In 
contrast, ingestion of Sz. pombe by DCs occurred less effective and in a more time-
dependent manner. After 2 h, the number of cells ingesting at least a single yeast cell 
was 28 ± 4 %, and increased gradually at least until 24 h after the co-incubation (56 ± 4 
%). The same was true when DCs were examined for their ability to engulf live yeasts 
at various MOIs ranging from 1 to 11 after 4 h at 37 °C. As expected, the number of 
cells engulfing at least one yeast was enhanced by increasing the MOI, reaching a 
plateau level at MOI 7 for S. cerevisiae (92 ± 1 %), K. lactis (93 ± 3 %) and P. pastoris 
(86 ± 2 %), and was maximum for Sz. pombe at MOI 9 (54 ± 1 %; Fig. 14 B). Analysis 
of phagocytic indices revealed a similar pattern as obtained with murine macrophages, 
with S. cerevisiae, K. lactis and P. pastoris being much more efficiently internalized 
than Sz. pombe (Fig. 14 C). However, human DCs appear to have a greater capacity of 
phagocytosis than murine IC-21 macrophages. When MOI 1 was examined, practically 
all yeasts had been taken up after 4 h of incubation with DCs. However, and as 
observed for IC-21, increasing MOI values implied greater differences of internalization 
between Sz. pombe and the other species. 
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Fig. 14: Uptake of different yeast genera by human dendritic cells. Immature DCs were 
incubated with S. cerevisiae, K. lactis, P. pastoris and Sz. pombe cells at MOI 5 (A) for 
varying periods of time or (B) for 4 h with varying MOIs. The data are presented as the 
percentage of phagocytic cells (i.e. percentage of DCs containing at least one ingested 
yeast cell). (C) The phagocytic indices (number of internalized yeast cells per 100 DCs) 
were determined for distinct MOIs after 4 h incubation. Uptake was verified by light 
microscopy. The data represent the mean ± standard deviation of triplicates. One 
representative experiment is shown [Bazan et al., 2011]. 
 
 
3.2.1. Involvement of Dectin-1 and mannose receptor in yeast uptake 
Next, the effect of two major receptors recognizing fungal structures (Dectin-1 and MR) 
on phagocytosis of the different yeast genera by human DCs was determined and 
compared. As shown in Fig. 15, internalization of all yeast genera was significantly 
inhibited when DCs were pre-incubated with anti-human Dectin-1 or anti-human MR 
monoclonal antibodies. No significant differences were observed relative to untreated 
cells or cells incubated with an isotype control antibody. In detail, inhibition of Dectin-1 
led to a greater reduction in yeast uptake than blockage of MR for S. cerevisiae, Sz. 
pombe, and P. pastoris. Interestingly, the opposite effect was observed for K. lactis, 
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although the cell wall composition of this yeast species does not significantly differ 
from that of S. cerevisiae or P. pastoris. Noteworthy, and in contrast to the other yeast 
genera tested, blockage of Dectin-1 dramatically impaired phagocytosis of fission yeast 
cells. After incubation of DCs with anti-MR, the percentage of DCs internalizing at 
least a single yeast cell was reduced from 84% ± 4% to 64% ± 2% for S. cerevisiae, 
76% ± 2% to 43% ± 6% for K. lactis, 75% ± 2% to 52% ± 5% for P. pastoris, and from 
32% ± 1% to 25% ± 3% for Sz. pombe. With respect to inhibition of Dectin-1, yeast 
uptake dropped to 50% ± 9% for S. cerevisiae, 57% ± 2% for K. lactis, 42% ± 6% for P. 
pastoris and 4% ± 2% for Sz. pombe. 
 
 
 
 
 
 
 
 
 
Fig. 15. Dectin-1 and mannose receptor (MR) are involved in phagocytosis of S. 
cerevisiae, K. lactis, Sz. pombe and P. pastoris by human dendritic cells. DCs were 
preincubated with anti-MR- or anti-Dectin-1-antibodies for 1 h, yeast cells were added 
at MOI 5 and the number of phagocytic DCs was determined after 4 h at 37 °C. 
Ingestion was verified by light microscopy. Results are expressed as average of 
triplicates with error bars indicating standard deviation. Asterisks indicate significant 
differences compared to untreated macrophages (* p < 0.05, ** p < 0.01, *** p < 0.001) 
[Bazan et al., 2011]. 
 
 
Taken together, these results show that both MR and Dectin-1 are involved in 
recognition of the four yeast genera analyzed, and that Sz. pombe cells, in contrast to S. 
cerevisiae, P. pastoris and K. lactis, are taken up less effectively by human DCs. 
 
 
4. Recombinant expression of model antigens in different yeast genera 
After demonstrating the abilities of several yeast genera to mature human DCs and 
induce cytokine secretion, and having shown that some selected yeast genera are 
endocytosed by mammalian phagocytic cells, the activation of antigen-specific T cells 
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after protein delivery by yeast to APCs was determined. For this purpose, the model 
antigens Ova and pp65 were used for recombinant expression in the yeasts S. cerevisiae 
S86c, Sz. pombe PW260, K. lactis GG799 and P. pastoris GS115. 
 
4.1. Heterologous expression of Ova-derivatives in yeast 
 
4.1.1. Construction of yeast expression vectors for heterologous expression of Ova 
variants 
The ova and ovacyt coding sequences were PCR-amplified from vectors pYES/Ova and 
pYES/Ovacyt using the following oligonucleotide primer pairs: 5’HindIII_EcoRI_Ova 
and 3’BglII_NotI_Ova, or 5’EcoRI_XhoI Ova and 3’SalI_BglII_Ova. Ovacyt lacks the 
internal secretion signal sequence within the ova open reading frame (Jochen Stritzker, 
University of Würzburg, Germany). For cell surface display strategies, the ovacyt-coding 
sequence without stop codon was inserted upstream of the anchor gene sed1 from S. 
cerevisiae and downstream of a genus-specific secretion signal sequence. The ovacyt 
gene without stop codon was amplified with the oligonucleotides 5’HindIII_EcoRI_Ova 
and 3’Ova_AvrII_ohneStop. The anchor DNA fragment encoding the C-terminal 319 
amino acids of Sed1p was PCR-amplified from S. cerevisiae genomic DNA using 
oligonucleotide primers 5’AvrII_Sed1 and 3’NotI_Sed1 (Müller, 2008). The amplified 
segments were inserted into the pSTBlue-1 vector for routine sequencing, as decribed 
previously. The Ova derivatives used in this work are depicted in Fig. 16. 
The glucanase-extractable cell wall protein Sed1p contains a 
glycosylphosphatidylinositol (GPI) attachment signal. Two signal sequences are present 
in the primary translation product of GPI-anchored proteins: an N-terminal sequence 
targeting the product to the ER membrane, and a C-terminal sequence directing the 
attachment of a GPI anchor. Both sequences are removed during processing, and the C-
terminal GPI sequence is replaced with GPI by a GPI transamidase in the ER. The GPI 
anchor is then partially cleaved within its glycan moiety, losing its inositol-containing 
lipid moiety. The glycosyl remnant of the GPI structure, together with the attached 
protein, becomes covalently linked to cell-wall β-1,6-glucans (Orlean and Menon, 2007; 
Varki et al., 2009). 
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Fig. 16. Schematic representation and subcellular localization of the different Ova 
derivatives used in this study. Ova is secreted due to the presence of an internal 
secretion signal (SS), which is removed for intracellular expression (Ovacyt). 
Alternatively, Ovacyt was fused to the C-terminal part of the cell wall protein Sed1p 
leading to a anchoring of the fusion within the cell wall; in this derivative, the particular 
genus-specific SS was used. The position of the epitope SIINFEKL is indicated. 
 
 
Cloning into yeast expression vectors was performed as follows: 
S. cerevisiae 
The ova and ovacyt coding sequences were digested from the cloning vector pSTBlue-1 
with XhoI and BglII for inserting into XhoI/BglII-digested S. cerevisiae pFB2 
expression vector. The resultant plasmids were named pPGK/ova and pPGK/ovacyt, 
respectively. For cell-surface display of Ovacyt, the fusion ovacyt/sed1 was excised from 
vector pPIC9/ovacyt/sed1 (described below) by digestion with NotI, end-filling with 
Klenow polymerase, and then restricting with EcoRI. This fragment was cloned into 
pFB2 digested with BglII, blunted with Klenow and finally digested with EcoRI. This 
pPGK-derived expression vector contains a KRE1 signal peptide sequence upstream of 
the cloning region. The resultant plasmid was named pFB/ovacyt/sed1. 
 
Sz. pombe 
The multiple cloning site of the thiamine-repressible expression vector pREP1 was 
modified and the plasmid is referred to as pREP-BD (Diehl, 2008). This Sz. pombe 
expression vector was XhoI and BglII digested for ligation with both full-length 
ovalbumin and ovacyt which were isolated from XhoI/BglII-digested pSTBlue-1 vector. 
The resulting plasmids were named pREP-BD/ova and pREP-BD/ovacyt, respectively. 
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K. lactis 
For cloning into the K. lactis expression vector, full-length ova was digested with 
HindIII and NotI and ligated to pKLAC1 previously digested with the same restriction 
endonucleases. The gene encoding ovacyt was restricted with HindIII/BglII and inserted 
into the HindIII and BglII sites of pKLAC1. The fusion ovacyt/sed was digested from 
pPIC9/ovacyt/sed1 with EcoRI, filled with Klenow polymerase and subsequently 
digested with NotI for cloning into pKLAC1 restricted with SalI, blunt-ended and 
digested with NotI, giving rise to pKLAC1/ovacyt/sed. The constructed vectors 
pKLAC1/ova, pKLAC1/ovacyt and pKLAC1/ovacyt/sed were linearized with SacII prior 
to integrative transformation of chemically competent K. lactis GG799. The expression 
cassette can therefore integrate into the K. lactis genome at the LAC4 locus by means of 
homologous recombination. 
 
P. pastoris 
The genes encoding ova and ovacyt were excised from pSTBlue-1 by digestion with 
EcoRI and NotI, and ligated to the EcoRI/NotI sites in pPIC3.5 vector, giving rise to 
pPIC3.5/ova and pPIC3.5/ovacyt. To link ovacyt to sed1, the sequence encoding ovacyt 
without stop codon was isolated as an EcoRI-AvrII fragment from pSTBlue-1 and 
inserted upstream of the sed1 coding sequence in vector pPIC9/sed1 previously digested 
with EcoRI and AvrII, generating pPIC9/ovacyt/sed1. The vectors were linearized with 
SalI before transformation of P. pastoris cells in order to direct genomic integration at 
the his4 locus. 
 
 
4.1.2. Analysis of recombinant expression of Ovacyt by different yeast genera 
In order to verify cytosolic expression of recombinant Ovacyt, lysates from 3×108 yeast 
cells cultured for until 72 h in the respective media were precipitated with DOC/TCA 
and applied to SDS-polyacrylamide gels. Western blots were performed using rabbit 
anti-chicken egg albumin and goat anti-rabbit IgG-peroxidase. 
After transformation of S. cerevisiae S86c with pPGK/ovacyt, some transformant 
colonies were inoculated in ura d/o medium and then analyzed for cytosolic expression 
of the recombinant protein. Foreign protein expression in S. cerevisiae was driven from 
the constitutive promoter PGK. As seen in Fig. 17 A (lane 1), a single protein band in 
the expected size of ~28 kDa could be detected by the anti-Ova antibody in cell lysates 
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of S. cerevisiae transformed with pPGK/ovacyt. This band was absent in the cell extract 
of S. cerevisiae carrying the empty vector YEp352 (Fig. 17 A, lane 2). 
Sz. pombe strain PW260 was transformed with the expression vector pREP-
BD/ovacyt, as well as with the plasmid pREP-BD containing no insert. To induce 
expression from the nmt1 promoter, transformants were grown in EMM medium 
lacking leucine. Fig 17 B shows a 28 kDa protein band specific to the cell extract of 
yeast cells transformed with pREP-BD/ovacyt (lane 2). It was observed that some lower 
molecular weight proteins present in the cell lysates of Sz. pombe containing pREP-
BD/ovacyt reacted positively with the antibody, probably being produced or created 
during recombinant protein expression, and presumably resulting from degradation of 
Ovacyt, since these bands are not present in lysates of PW260 cells carrying the empty 
vector (Fig. 17 B, lane 3). 
K. lactis GG799 transformant colonies selected on YCB agar plates were 
cultivated in YPGal medium for LAC4-driven expression of Ovacyt. As a control, K. 
lactis was also transformed with empty pKLAC1. As shown in Fig. 17 C, a 28-kDa 
protein band in total yeast extracts reacted positively with the anti-Ova antibody (lane 
2). This band was absent in cell lysates from K. lactis harbouring the empty vector 
pKLAC1 (Fig. 17 C, lane 1). Some proteins above the Ovacyt band reacted 
unspecifically with the anti-Ova antibody, as they also appeared in the negative control 
(K. lactis carrying the empty vector pKLAC1). 
Colonies of P. pastoris GS115 transformed with the expression vector 
pPIC3.5/ovacyt and selected onto his d/o agar medium were grown in BMG medium and 
shifted to inducing BMM medium for proper protein expression. Methanol was added 
every 24 h (final concentration = 0.5% v/v) to maintain induction. As shown in Fig. 17 
D, cell lysates of induced P. pastoris cells showed a specific 28-kDa protein band 
corresponding to Ovacyt (lane 2), which was absent in total extracts from methanol-
induced control cells (lane 3). Additional bands present in the lysates from cells 
harboring pPIC3.5/ovacyt and pPIC9 reacted unspecifically with the anti-Ova antibody. 
Another lower molecular weight protein band could be seen in the lysate from Ovacyt-
expressing cells (~15 kDa, lane 2), which might indicate degradation of the recombinant 
protein. 
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A                                      B                                  C                                D 
 
 
 
 
 
 
 
 
 
 
Fig. 17: Expression of Ovacyt by different yeast genera. Immunoblots of cell extracts 
from 3×108 yeast cells. Analyses were performed using monoclonal anti-Ova antibody. 
Commercially available Ova was used as positive control. The Ovacyt 28-kDa band is 
indicated by an arrow. (A) S. cerevisiae S86c. Lane 1, pPGK/ovacyt; lane 2, empty 
vector Yep352; lane 3, positive control. (B) Sz. pombe PW260. Lane 1, positive control; 
lane 2, pREP-BD/ovacyt; lane 3, empty vector pREP-BD. (C) K. lactis GG799. Lane 1, 
empty vector pKLAC1; lane 2, pKLAC1/ovacyt; lane 3, positive control. (D) P. pastoris 
GS115. Lane 1, positive control; lane 2, pPIC3.5/ovacyt; lane 3, empty vector pPIC9. 
The positions of the bands of the molecular weight marker (“Pre-stained protein 
ladder”) as well as their sizes in kDa are indicated. 
 
 
The amount of recombinant Ovacyt produced by each yeast strain was quantified by 
western blotting. For this purpose, protein bands from yeast lysates (3×108 cells) were 
compared to a standard curve of known concentration of Ova. Fig. 18 shows that the 
particular protein levels in cell lysates varied significantly among the yeast genera, i.e., 
the Ovacyt amount in 3×108 cells varied between 52.7 ng in S. cerevisiae, 37.1 ng in P. 
pastoris, 11.6 ng in K. lactis and 11.4 ng in Sz. pombe after 72 h of cultivation (mean 
values from experiments performed in triplicate). No secretion of Ovacyt was detected 
(data not shown). 
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Fig. 18: Amount of recombinant Ovacyt after recombinant expression by the different 
yeast genera. The values correspond to the total cell extract of 3×108 yeast cells after 72 
h cultivation. Expression levels were quantified against a standard curve of 
commercially available Ova. Bars represent mean values with standard deviations from 
triplicate determinations. 
 
 
4.1.3. Analysis of Ova secretion by different yeast genera 
For detection of secreted Ova into the culture supernatants, a medium volume 
corresponding to 3×108 yeast cells was precipitated with DOC/TCA and the resulting 
products were applied to SDS-polyacrylamide gels. Western blots were performed using 
a specific anti-Ova antibody, as described before for Ovacyt. Cultivation conditions were 
the same as above for all yeast strains. 
As seen in Fig. 19 A, Ova could be secreted in the culture medium by S. 
cerevisiae S86c transformed with pPGK/Ova (lane 2); no bands were detectable in 
culture supernatants of negative control cells (lane 1). Fig 19 B shows a ~45 kDa 
protein band in the culture supernatant of Sz. pombe transformed with pREP-BD/ova 
(lane 1), which is absent in the culture medium of Sz. pombe carrying the empty vector 
pREP-BD (lane 2). From Fig. 19 C (lane 2), it was observed that a protein band of the 
predicted size, ~45 kDa, was detected in the supernatant from K. lactis transformed with 
pKLAC1/ova. This band was not observed in culture supernatants of K. lactis carrying 
the empty vector pKLAC1 (lane 1). Fig. 19 D shows that Ova could also be detected in 
the culture supernatant of P. pastoris transformed with pPIC3.5/ova (lane 1). Culture 
medium of induced cells carrying the empty vector pPIC9 showed no reaction with the 
anti-Ova antibody (lane 2). 
 
A                                B                                C                                D 
 
 
 
 
 
 
 
 
 
Fig. 9: Secretion of full-length Ova by different yeast genera. Culture supernatants from 
3×108 cells. The ~45 kDa Ova band is indicated by an arrow. The positions of the bands 
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of the molecular weight marker (“Pre-stained protein ladder”) and their sizes in kDa are 
given. (A) S86c Lane 1, empty vector Yep352; lane 2, pPGK/ova; lane 3, positive 
control. (B) Lane 1, PW260/pREP-BD/ova; lane 2, PW260/pREP-BD; lane 3, positive 
control. (C) K. lactis GG799 Lane 1, /pKLAC1/ova; lane 2, K. lactis/pKLAC1; lane 3, 
positive control. (D) P. pastoris GS115. Lane 1, pPIC3.5/ova; lane 2, empty vector 
pPIC9, lane 3, positive control. 
 
 
As shown in Fig. 19, yeast-expressed Ova has a slightly higher molecular weight 
than the commercially available Ova (used as positive control), although both are 
derived from chicken (Gallus gallus, GenBank accession number NP_990483). Chicken 
Ova contains two putative N-glycosylation sites, and both mono- and di-glycosylated 
forms were reported to be secreted by yeast (Ito and Matsudomi, 2005). Since only one 
protein band was seen in the four yeast genera analyzed, it might represent the di-
glycosylated form, as Ova from egg white is mono-glycosylated only (Nisbet et al., 
1981; Ito et al., 2007). The two bands visualized in the positive control may be the 
result of other post-translational modifications which have been reported for this protein 
(acetylation and phosphorylation; Nisbet et al., 1981). 
 The amount of recombinant Ova secreted by each yeast strain was also 
quantified. Culture media from 3×108 yeast cells were analyzed by western blot, as 
described before. As observed for Ovacyt, the level of secreted Ova showed great 
variation among the yeast genera (Fig. 20). The amount of Ova present in the culture 
supernatant from 3×108 cells after 72 h cultivation was 857 ng for Sz. pombe, 497 ng for 
S. cerevisiae, 438 ng for P. pastoris, and 39 ng for K. lactis (mean values from three 
different experiments). 
 
 
 
 
 
 
 
 
Fig. 20: Amount of recombinant Ova secreted into the culture supernatant of 3×108 
yeast cells after 72 h cultivation. Recombinant Ova secretion by the different yeast 
genera was quantified by western blotting based on a standard curve of commercially 
available Ova. Shown are the means and standard deviation from triplicate 
determinations. 
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4.1.3.1. Ova secretion in a phagolysosome-like milieu 
Next, it was investigated whether yeasts would be able to deliver secreted Ova to 
macrophages. Lorenz and Fink (2001) demonstrated that the glyoxylate cycle, a 
metabolic pathway that allows cells to use molecules containing two carbon atoms as 
carbon source, was induced in live yeast isolated from macrophage phagolysosomes. 
Although the exact composition of the phagolysosome is not completely elucidated, this 
finding indicates the existence of simple carbon sources in this milieu. In order to 
examine whether yeasts carrying plasmid vectors containing full-length Ova would be 
able to secrete this recombinant protein inside the macrophage phagolysosomes, yeasts 
were cultivated for 72 h in the respective culture medium under inducing conditions, 
washed, then transferred to an acetate solution, and incubated for another 8 h. After that, 
supernatants corresponding to 3×108 cells were collected, precipitated with DOC/TCA, 
and analyzed by western blotting. As shown in Fig. 21 A, Ova could be detected in the 
supernatant of all yeast species after 8 h incubation, although some degree of 
degradation was observed. Again, the amount of recombinant Ova protein in the 
supernatants varied considerably among the different yeasts (Fig. 21 B). 
 
      A                                                  B 
 
 
 
 
 
 
 
 
 
 
 
Fig. 21. Secretion of Ova in acetate-containing medium. (A) Western blot analysis 
reveals Ova secretion by all yeast genera tested after 8 h incubation in a medium 
containing a two-carbon compound as C-source. Yeasts were grown for 72 h in the 
respective medium, then washed and shifted to acetate medium. A volume 
corresponding to 3×108 cells was centrifuged and precipitated prior to analysis. Lane 1, 
K. lactis pKLAC1/ova; lane 2, P. pastoris pPIC3.5/ova; lane 3, S. cerevisiae pPGK/ova; 
lane 4, Sz. pombe pREP-BD/ova; lane 5, positive control (commercial Ova). (B) 
Quantification of Ova secreted by the diverse yeast genera after 8 h in acetate-
containing medium. Ova was quantified by western blotting, in which the band 
intensities were compared to those from commercial Ova of known concentration. 
Shown are mean values and standard deviation from three different determinations 
[Bazan et al., 2011]. 
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In S. cerevisiae and, to a lesser extent, also in P. pastoris, the amount of secreted Ova in 
acetate solution corresponded roughly to the intracellular level, whereas Sz. pombe and 
K. lactis secreted significantly more Ova protein. Of note, the expression profile of 
secreted Ova after 8 h in acetate-containing medium was very similar among the yeast 
genera to that after growth in the conventional culture media after 72 h, indicating that 
expression under artificial ‘phagosomal’ conditions resembles the expression after 
optimal cultivation. 
 
 
4.1.4. Recombinant expression of Ovacyt on yeast cell walls as Sed1p-fusions 
Yeasts transformed with vectors harboring the ovacyt/sed1 fusion were cultivated in the 
respective medium for 3 days, re-inoculated (5% v/v) and allowed to grow for 
approximately 2 h. Detection of cell-surface displayed Ovacyt was carried out by indirect 
immunofluorescence using rabbit anti-chicken egg albumin and goat anti-rabbit IgG-
PE. Fluorescent labelling was measured by fluorescence microscopy and flow 
cytometry. Figure 22 (A and B) shows the fluorescence, bright field and merge 
micrographs of immunolabeled Ovacyt/Sed1p-expressing S. cerevisiae and P. pastoris 
cells, as well as the correspondent control yeasts (yeasts expressing an irrelevant Sed1p-
fusion protein). The red fluorescence of the immunostained Ovacyt/Sed1p fusion protein 
was observed on the cell surface of S. cerevisiae carrying pPGK/ovacyt/sed1 and P. 
pastoris harboring pPIC9/ovacyt/sed1. No fluorescence was observed outlining yeast 
cells harboring irrelevant Sed1p-fusion protein (Figure 10 A and B, lower panels). This 
result indicates that the fusion protein Ovacyt/Sed1p is anchored and successfully 
displayed on the cell surface of S. cerevisiae and P. pastoris. Again secretion of OVAcyt 
was not detected (data not shown). No fluorescence could be detected in K. lactis cells 
transformed with pKLAC1/ovacyt/sed1 (not shown).  
 Variation in fluorescence intensity among the cell population of yeasts 
expressing the Ovacyt/Sed1p fusion protein was observed for both genera, indicating 
differences in the amount of anchored protein. To investigate this assumption, 
expression levels of Ovacyt/Sed1p on the cell wall of S. cerevisiae and P. pastoris were 
compared using flow cytometry (Fig 22 C and D) and showed a strong variation among 
both genera, with approximately 38% in S. cerevisiae and 66% in P. pastoris. 
Comparison of mean fluorescence values of Pichia to Saccharomyces cells indicated a 
~1.3-fold higher amount of OVAcyt at the cell surface of Pichia, which is in accordance 
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with a quantification performed by western analyses after glucanase extraction of cell 
walls (Fig. 23). 
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Fig. 22: Visualization of displayed proteins on the yeast cell surface. Cells were 
immunostained with rabbit anti-Ova IgG and PE-labeled goat anti-rabbit IgG. (A and 
B) Confocal laser scanning microscopy. Fluorescence micrographs (left panels), light 
micrographs (central panels) and merge (right panels) of S. cerevisiae (A) and P. 
pastoris (B). Upper panels, cells expressing Ovacyt on the cell wall; lower panels, cells 
harboring negative control plasmids. Magnification: 63×20. (C and D) Histograms 
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showing flow cytometric analysis of S. cerevisiae (C) and P. pastoris (D). Dashed lines 
represent yeasts expressing an irrespective Sed1p fusion protein. Red solid lines show 
transformants displaying Ovacyt/Sed1p. Vertical axis represents total cell number and 
horizontal axis indicates PE fluorescence intensity. The percentage of positive cells is 
shown. A total of 50,000 cells was analyzed. 
 
 
In order to confirm that Ovacyt was anchored on the cell surfaces of S. cerevisiae and P. 
pastoris, 3×108 yeast cells expressing the fusion protein Ovacyt/Sed1p, as well as yeasts 
expressing an unrelated Sed1p-fusion protein, were lysed with glass beads, and cell 
walls were extensively washed prior to treatment with β-1,3-glucanase (laminarinase). 
Then, supernatants were concentrated by precipitation with DOC/TCA and the presence 
of Ovacyt/Sed1p was analyzed by western blotting using the monoclonal anti-Ova 
antibody. As seen in Fig. 23 A, a very faint band of approximately 64 kDa could be 
detected in cell wall extracts of S. cerevisiae carrying pPGK/ovacyt/sed1 (lane 2), but not 
in the negative control (S. cerevisiae expressing another Sed1p-fusion protein, lane 3). 
This protein band corresponds to the Ovacyt/Sed1p protein, which has a theoretical 
molecular weight of ~64 kDa. Additional low molecular weight bands could be seen in 
the blot, some of them reacted unspecifically with the anti-Ova antibody, since they are 
also present in the negative control extracts. The other bands that appear only in the cell 
wall extracts of the Ovacyt/Sed1p-producing yeast are probably degradation products of 
Ovacyt/Sed1p. In Fig. 23 B, a slight band was seen in the cell wall extract of P. pastoris 
carrying pPIC9/ovacyt/sed1 (lane 2), corresponding to the 64-kDa Ovacyt/Sed1p. This 
band was not detected in the negative control (P. pastoris expressing an irrelevant 
Sed1p-fusion protein, lane 3). 
 
                A                                                          B 
 
 
 
 
 
 
 
Fig. 23: Laminarinase extraction of Ovacyt/Sed1p from yeast cell walls. The 
Ovacyt/Sed1p bands are indicated with arrows. As positive control, commercially 
available Ova was used. (A) Lane 1, positive control; lane 2, laminarinase extracts of 
cell walls of S. cerevisiae/Ovacyt/Sed1p; lane 3, laminarinase extracts of cell walls of S. 
cerevisiae expressing an irrelevant Sed1p-fusion protein. (B) Lane 1, positive control; 
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lane 2, laminarinase extracts of P. pastoris expressing Ovacyt/Sed1p; lane 3, 
laminarinase cell wall extracts of P. pastoris expressing an irrelevant Sed1p-fusion 
protein. 
 
 
4.2. The HCMV pp65 tegument protein as model antigen 
 
4.2.1. Construction of yeast expression vectors for recombinant expression of pp65 
The sequence encoding pp65 was amplified by PCR with the oligonucleotide primers 
5’pp65 and 3’pp65 using the vector pPGK/pp65 as template. The resulting PCR product 
was cloned into pSTBlue-1 for sequencing analysis (pSTBlue-1/pp65) and subsequently 
used to clone the gene pp65 into expression vectors for S. cerevisiae, Sz. pombe, K. 
lactis and P. pastoris for intracellular, secreted, and cell-wall anchored expression. 
However, the latter approach turned out to be infeasible, since fusion of pp65 to a 
secretion signal sequence did not lead to protein secretion, as described later in this 
section. Fig. 24 shows the pp65 variants used for recombinant expression in yeast. 
 
     A 
 
     B 
 
Fig. 24. Schematic representation of pp65 variants used throughout this work. (A) Full-
length pp65 for intracellular expression. (B) The pp65 gene also fused to a secretion 
signal (SS) sequence in order to direct the protein for secretion. 
 
 
The gene encoding full-length pp65 was cloned into the yeast expression vectors as 
follows: 
S. cerevisiae 
The construct pPGK/pp65 for foreign expression in S. cerevisiae was already available 
(Schumacher, 2001). In order to drive secretion of pp65 in S. cerevisiae, the pp65 open 
reading frame was inserted downstream of the sequence encoding the KRE1 signal 
peptide. For this purpose, the gene pp65 was digested from the pSTBlue-1/pp65 vector 
with SalI, end-filled with Klenow polymerase, and subsequently digested with EcoRI. 
The expression vector pFB2 (Breinig and Schmitt, 2002) was restricted with BglII, 
blunt-ended with Klenow polymerase, and further digested with EcoRI. After ligation, 
the resulting vector, named pPGK/kre1/pp65, was used to transform S. cerevisiae S86c. 
pp65 
pp65 SS 
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Sz. pombe 
For cloning into the Sz. pombe expression vector pREP1, pp65 was digested from 
pSTBlue-1/pp65 with XhoI and BamHI for inserting into the SalI/BamHI-digested 
pREP1, generating pREP1/pp65. 
The signal peptide of the K28 preprotoxin was used to direct pp65 into the 
secretion pathway of Sz. pombe. This secretion signal has been shown to efficiently 
drive the secretion of recombinant proteins in this yeast species (Heintel et al., 2001; 
Eiden-Plach et al., 2004). Therefore, the K28 signal peptide/pp65 fusion was amplified 
by PCR using the oligonucleotide primers 5’K28, 3’Prepropp65, 3’pp65 and 
5’Prepropp65, and the plasmids pPGK-M28-I and pPIC9/pp65 as templates. The final 
PCR product, named prepropp65, was cloned into pSTBlue-1 for sequence analysis. 
Subsequently, the prepropp65 coding sequence was restricted from pSTBlue-
1/prepropp65 with XhoI and BamHI and ligated to the SalI/BamHI-linearized pREP1 
vector, giving rise to pREP1/prepropp65. 
 
K. lactis 
The K. lactis expression vector pKLAC1 requires linearization prior to transformation 
to allow integration into the yeast genome. Linearization can be performed with either 
SacII or BstXI restriction enzymes. Since both restriction sites are present in the pp65 
sequence, a site-directed mutagenesis was performed in order to eliminate one 
recognition sequence, without altering the amino acid composition of the resulting 
protein. Given that the SacII regognition sequence appears twice in the pp65 gene, the 
BstXI restriction site was chosen for the single nucleotide exchange. Using the primers 
5’pp65mutBstXI, 3’pp65XbaISalI, 5’pp65_EcoRIXhoISacI and 3’pp65mutBstXI, and 
the plasmid pSTBlue-1/pp65 as template, the pp65 gene was amplified by SOE-PCR as 
described in section 1.1 of Methods. After amplification, the final DNA fragment 
(pp65mut) was cloned into pSTBlue-1 for sequence analysis, which revealed the desired 
mutation (substitution of a cytosine for an adenine at position 540, so that codon ACC 
became ACA, but still coding for threonin). 
Intracellular protein expression in K. lactis implies digesting the pKLAC1 
expression vector with HindIII to remove the α-mating factor signal sequence. 
Therefore, for cloning into the K. lactis expression vector, pp65mut was digested from 
pSTBlue-1/pp65mut with EcoRI, blunt-ended with Klenow polymerase and then 
digested with SalI. The vector pKLAC1 was digested with HindIII, end-filled with 
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Klenow and digested with SalI. For integrative transformation of chemically competent 
K. lactis, the construct pKLAC1/pp65mut was linearized with BstXI. 
Full-length pp65 was also cloned downstream of the α-mating factor signal 
peptide for protein secretion. For this purpose, pp65 was digested from pSTBlue-1 with 
XbaI, blunt-ended with Klenow polymerase, and then restricted with XhoI. The vector 
pKLAC1 was digested with NotI, blunt-ended with Klenow polymerase, and digested 
with SalI. The ligation product, pKLAC1/secpp65mut, was used to transform competent 
K. lactis cells. 
 
P. pastoris 
Cloning of pp65 into P. pastoris expression vectors pPIC3.5 for intracellular expression 
and pPIC9 for protein secretion was performed by digesting the gene encoding pp65 
from pSTBlue-1/pp65 with EcoRI and XbaI and ligating to the EcoRI/AvrII sites in 
pPIC3.5 and pPIC9 vectors. The resulting plasmids were named pPIC3.5/pp65 and 
pPIC9/pp65. Both expression vectors were linearized with SalI before transformation of 
competent P. pastoris cells. 
 
 
4.2.2. Intracellular pp65 expression by different yeast genera 
For detection of pp65 in the cytoplasm of the tested yeast genera, lysates from 3×108 
yeast cells cultured for 72 h in the respective medium were precipitated with 
DOC/TCA, as described before. Western blots of cell extracts were performed using 
mouse monoclonal anti-pp65 antibody and goat anti-mouse IgG-peroxidase. 
Colonies of S. cerevisiae S86c transformed with pPGK/pp65 and selected based 
on uracil prototrophy were cultured in ura d/o medium for recombinant protein 
expression. Lysates from yeast cells carrying both pPGK/pp65 and the empty vector 
YEp352 were analyzed. As seen in Fig. 25 A, pp65 was detected as a ~65-kDa band in 
the total extract of S. cerevisiae carrying the expression vector pPGK/pp65 (lane 3). No 
bands were seen in the sample corresponding to S. cerevisiae harboring YEp352 vector 
(lane 2). 
Sz. pombe PW260 cells harbouring the pREP1/pp65 vector were grown in EMM 
leu d/o medium to induce pp65 expression from the nmt1 promoter. Cells of Sz. 
pombe/pREP1/pp65 and Sz. pombe/pREP-BD were subjected to expression analysis. As 
seen in Fig. 25 B, the corresponding western blot result showed a single 65-kDa protein 
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band in the lysate of Sz. pombe/pREP1/pp65 (lane 1). The band corresponds to pp65, as 
it reacted specifically with the anti-pp65 monoclonal antibody. This protein was absent 
in Sz. pombe lysates carrying the empty vector pREP-BD and cultivated under the same 
conditions (lane 2). 
After pKLAC1/pp65mut had been integrated into the K. lactis genome, cells 
were grown in YPGal medium for 72 h at 30°C, under agitation at 220 rpm. Total 
extracts from 3×108 cells were precipitated with DOC/TCA and analyzed by western 
blotting using monoclonal anti-pp65. No specific signal could be detected in K. lactis 
lysates, while the 65-kDa band of the positive control sample reacted specifically with 
the anti-pp65 antibody (data not shown). Many clones were analyzed for pp65 
expression, however without success. The genomic DNA of some K. lactis clones was 
isolated and subjected to PCR analysis using the oligonucleotide primers 5’pp65 and 
3’pp65. The presence of the pp65 gene integrated in the K. lactis genome was 
confirmed (data not shown), ruling out the possibility that the heterologous protein 
could not be detected because the recombinant DNA had not been integrated into the 
genome. This fact may indicate that the expression level of pp65 in K. lactis was below 
the detection limit, or that this protein was rapidly degraded by proteases, or even that 
pp65 is not expressed at all by this yeast strain. 
P. pastoris colonies grown on selective agar medium lacking histidine and 
cultivated in BMG medium were shifted to BMM medium in order to induce AOX1-
driven protein expression. As shown in Fig. 25 C, an immunoreactive band of pp65 
(~65 kDa) was observed in the cell lysate of P. pastoris carrying the expression vector 
pPIC3.5/pp65 (lane 1). This band was not observed in total extracts from yeast cells 
carrying the empty vector pPIC9 (lane 2). 
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Fig. 25. Intracellular expression of pp65 by distinct yeast genera. Shown are western 
blots of yeast lysates from 3×108 yeast cells probed with monoclonal anti-pp65. As 
positive control, commercial pp65 was used. The yeast-derived 65 kDa protein bands 
identified as pp65 are indicated by arrows. The positions of the bands of the molecular 
weight marker (“Prestained protein ladder”) are indicated. (A) S. cerevisiae. Lane 1, 
positive control; lane 2, lysate from cells harbouring the empty vector YEp352; lane 3, 
cell extracts from cells transformed with pPGK/pp65. (B) Sz. pombe. Lysates from cells 
carrying pREP1/pp65 (lane 1) or empty vector pREP-BD (lane 2); lane 3, positive 
control. (C) P. pastoris. Extracts from cells transformed with pPIC3.5/pp65 (lane 1) or 
empty vector pPIC9 (lane 2); lane 3, positive control. 
 
 
4.2.3. Pp65 secretion by different yeast genera 
The presence of pp65 in culture medium collected after 24, 48 or 72 h was investigated 
as follows: a volume of culture medium equivalent to 3×108 yeast cells was collected 
and concentrated with DOC/TCA prior to SDS-PAGE and western analysis using 
monoclonal anti-pp65, as mentioned in the previous section. 
 S. cerevisiae transformants carrying pPGK/kre1/pp65 were cultivated as 
described. Supernatants from a culture of S. cerevisiae carrying the empty vector 
YEp352 served as negative control; the commercially available pp65 served as positive 
control. No detectable pp65 could be seen in lanes corresponding to yeast transformants 
harboring pPGK/kre1/pp65, or in negative control cells. As expected, the positive 
control revealed a protein signal at 65 kDa, representing pp65 (data not shown). To 
determine whether pp65 was present in the cytoplasm of yeasts transformed with 
pPGK/kre1/pp65, transformants were lysed with glass beads and total cell extracts were 
analyzed by SDS-PAGE and probed with monoclonal anti-pp65. Recombinant pp65 
could be detected in the cytosolic extracts analyzed, indicating that secretion of this 
protein was for some reason impaired. 
The presence of pp65 in culture supernatants of Sz. pombe transformed with 
pREP1/prepropp65 was verified. Supernatants from a culture of Sz. pombe harbouring 
pREP-BD were used as negative control and commercial pp65 as positive control. 
Western blot revealed no pp65-specific signal (12 lanes, each representing one clone), 
whereas the positive control band promptly reacted with the antibody (data not shown). 
Sz. pombe cells transformed with PREP1/prepropp65 were then lysed with glass beads 
and analyzed for the presence of pp65 in the cytoplasm. This protein could be detected 
in the cell lysates (not shown), indicating that its absence in culture medium was not 
due to lack of expression. 
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 K. lactis transformed with pKLAC1/secpp65 was inoculated in YPGal medium 
and supernatants were assessed for the presence of pp65. After western analysis, no 
recombinant protein could be detected in the supernatant. Cell pellets (3×108 cells) were 
subjected to lysis to check if pp65 was retained in the cytoplasm but, again, no signal 
was verified after wester blotting using anti-pp65 (data not shown), as already reported 
for K. lactis carrying pKLAC1/pp65. 
 P. pastoris carrying pPIC9/pp65 induced with methanol were analyzed for pp65 
secretion. As for the other yeast strains tested, no pp65 could be detected in the culture 
supernatant, whereas the 65-kDa band appeared in the positive control lane (not shown). 
Some clones were lysed with glass beads and assessed for the presence of pp65 in the 
cytoplasm. Western analysis revealed a pp65-specific signal in all transformants 
examined, confirming that this protein was expressed in P. pastoris transformed with 
the pPIC9/pp65 vector, but not secreted (data not shown). 
 In this way it must be concluded that cell-wall anchoring of full-length pp65 
would most probably be unsuccessful, since none of the tested yeasts was able to secrete 
pp65. 
 
 
4.3. Cloning and expression of Gag-fusions in S. cerevisiae 
Delivery of antigens by virus-like particles has been considered a versatile approach. 
Since VLP are inherently highly immunogenic, strategies employing chimeric particles 
are considered very promising in immunological applications. 
Fusion of L-A Gag with a truncated version of pp65 (Δpp65) has been 
demonstrated by Powilleit and colleagues (2007). In that study, Δpp65 was fused to the 
3’ end of gag in the [0]-frame position, and the resulting Gag/Δpp65 fusion self-
assembled in vivo into VLP. In addition, purified chimeric Gag/Δpp65 VLP have been 
shown to stimulate pp65-specific memory T cells in a whole blood assay (Powilleit et 
al., 2007). 
In this work, the sequences encoding Ovacyt or full-length pp65 were cloned 
downstream of gag in the [0]-frame to prevent gag/ovacyt or gag/pp65 frameshift 
occurrence in yeast (Fig. 26). The resulting recombinant proteins were partially purified 
and assessed for correct assembly into VLP. Since Ova represents an easy applicable 
system for a number of in vitro and in vivo settings, it would be interesting to examine 
the delivery of Ovacyt by VLP in comparison to Ovacyt alone. Furthermore, yeast 
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assembled Gag/pp65 VLP were analyzed in terms of activation of pp65-specific 
memory T lymphocytes in a whole blood assay and compared to pp65 alone. 
 
A 
 
B 
 
Fig. 26: Schematic representation of gag fusions performed in this work. The sequences 
coding for ovacyt (A) and pp65 (B) were cloned in frame and downstream of the L-A 
gag sequence for recombinant expression in the virus-free yeast strain S. cerevisiae 
S86c. 
 
 
4.3.1. Cloning and expression of Gag/Ovacyt in S. cerevisiae 
To insert the ovacyt gene downstream of gag without causing frameshift formation in 
vivo, SacI restriction was used for cloning. However, given that SacI cleaves the ovacyt 
sequence at position 56, and that there was no available conventional restriction enzyme 
which would leave compatible cohesive ends, site-directed mutagenesis was performed 
in order to destroy this site in the ovacyt gene without altering the amino acid 
composition of the resulting protein. Using pPIC3.5/ovacyt as template and the 
oligonucleotide primers 5’Ovacytmut 3’BglII_NotI_Ova, 3’Ovacytmut, and 5’ 
XbaISacI_Ovacyt, the ovacytmut sequence was amplified by SOE-PCR, as described 
before. The resulting PCR product was cloned into pSTBlue-1 and subjected to 
sequence analysis to confirm the correct sequence. A silent single base mutation could 
be obtained, in which a cytosine at position 57 was replaced by a thymine. Therefore, 
the codon CTC was changed into CTT, but the correspondent amino acid, leucine, was 
still the same. 
The ovacytmut coding sequence was recovered from pSTBlue-1 by SacI and 
BglII restriction and subsequently inserted into the SacI/BamHI-digested S. cerevisiae 
pPG[0]G expression vector, yielding pPG[0]G/ovacytmut. 
After transformation of S. cerevisiae S86c with pPG[0]G/ovacytmut, some 
transformants were inoculated in ura d/o medium and cultured for 72 h for PGK-driven 
recombinant protein expression. For detection of Gag/Ovacyt in yeast cell lysates, crude 
extracts from 3×108 cells were precipitated with DOC/TCA and applied to SDS-
polyacrylamide gels. Western blots were performed using rabbit anti-Ova antibody and 
gag                                                             ovacyt 
  gag                                                          pp65 
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goat anti-rabbit IgG-peroxidase. Yeasts transformed with the pG vector (i.e., expressing 
Gag only) were used as negative control; commercial Ova served as positive control. 
As observed in Fig. 27, western analysis of total cell extracts from yeasts 
transformed with pG[0]G/ovacytmut revealed a ~103 kDa protein fusion (lane 1), which 
was absent in lysates from pG-carrying yeasts (lane 2). In lane 1, additional low-
molecular weight immunoreactive bands were detectable which probably represent 
degradation products of full-length Gag/Ovacyt. 
 
 
 
 
 
 
 
 
 
Fig. 27. Expression of Gag/Ovacyt in S. cerevisiae S86c. Total extracts from 3×108 
cells were separated by SDS-PAGE and probed with anti-Ova. Lane 1, lysates from S. 
cerevisiae carrying pG[0]G/ovacytmut; lane 2, lysates from S. cerevisiae carrying pG; 
lane 3, positive control (Ova). The fusion protein Gag/Ovacyt is indicated by an arrow. 
The positions of the bands of the molecular weight marker (“Prestained protein ladder”) 
are indicated. 
 
 
Next, the Gag/Ovacyt fusion protein expressed in S. cerevisiae was evaluated for its 
ability to assemble into VLP. For this purpose, cell lysates were applied onto a 45% 
sucrose cushion and after ultracentrifugation the resulting pellet was dissolved and 
applied onto a sucrose gradient (20-70%). A total of 18 fractions were recovered from 
the gradient after overnight ultracentrifugation. Aliquots from each fraction were 
separated by SDS-PAGE and analyzed by western blotting using an anti-Ova antibody 
(Fig. 28). Protein bands of approximately 103 kDa could be detected in all aliquots 
analyzed, showing a similar distribution pattern as previously described for Gag/GFP 
particles (Powilleit, 2004). Additional low molecular weight bands were observed in 
some fractions and in the gradient pellet, which most probably represent degradation 
products. 
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Fig. 28. Western blot analysis for the detection of Gag/Ovacyt in sucrose gradient 
fractions 1-18 and in the gradient pellet. Lanes 1-18, fractions 1-18; lane 19, gradient 
pellet. Pooled fractions are indicated with a red line. Sucrose concentrations are shown. 
 
 
Some of the Gag/Ovacyt samples that reacted positively with anti-Ova were pooled 
(fractions 3-7), dialyzed against PBSE overnight, concentrated to 200 µl with 
Vivaspin™ and analyzed by transmission electron microscopy (TEM). TEM analysis 
identified correctly assembled VLP in samples purified from S. cerevisiae 
pG[0]G/ovacytmut. Gag/Ovacyt particles appeared symmetric and homogeneous in size, 
with a diameter of approximately 40 nm (Fig. 29). These particles were not seen in cell 
extracts from S. cerevisiae carrying the empty vector YEp352 subjected to the same 
procedure (data not shown). 
 
 
 
 
 
 
 
 
 
 
Fig. 29. Transmission electron microscopy of Gag/Ovacyt chimeric particles. Electron 
micrograph of sucrose gradient-purified Gag/Ovacyt derived from S. cerevisiae. Some 
particles are indicated by arrows. Sample was negatively stained with 2% uranyl 
acetate. Magnification of 98,000×. Bar = 200 nm. 
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As seen in Fig. 29, recombinant Gag/Ovacyt VLP exhibit a conformation which closely 
resembles those from Gag/GFP particles recombinantly expressed in the same yeast 
strain (Powilleit, 2004; data not shown). In general, particles appear relatively dark, 
with a clear margin. 
 
 
4.3.2. Cloning and expression of Gag/pp65 in S. cerevisiae 
The gene encoding pp65 was PCR-amplified using the primers 5’ SacIpp65 and 
3’BamHIpp65 and plasmid pREP1/pp65 as template. After cloning into pSTBlue-1 and 
further sequencing, the mutation-free pp65 coding sequence was recovered from 
pSTBlue-1 by treatment with BamHI and SacI and subsequently inserted into 
BamHI/SacI-digested pPG[0]G, yielding the yeast expression vector pPG[0]G/pp65. 
Selected S. cerevisiae S86c transformants carrying pPG[0]G/pp65 were 
inoculated in ura d/o medium and cultured for 72 h recombinant protein expression. For 
detection of Gag/pp65 in yeast cell lysates, crude extracts from 3×108 cells were 
precipitated with DOC/TCA, separated by SDS-PAGE and probed with monoclonal 
anti-HCMV pp65. 
 Fig. 30 shows that the Gag/pp65 fusion protein was detected as a 
immunoreactive 141-kDa band in the cell lysates of S. cerevisiae carrying pG[0]G/pp65 
(lane 2). This band was not detected in cell extracts from clones lacking pp65 (S. 
cerevisiae transformed with pG, lane 3). Commercially available pp65 was used as 
positive control (lane 1). 
 
 
 
 
 
 
 
 
Fig. 30. Expression of Gag/pp65 in S. cerevisiae S86c. Total cell extracts were 
separated by SDS-PAGE and probed with monoclonal mouse anti-HCMVpp65. Lane 1, 
positive control (commercial pp65); lane 2, lysate from cells carrying pG[0]G/pp65; 
lane 3, lysate from cells harbouring pG. Positions of Gag/pp65 and pp65 are indicated. 
The positions of the bands of the molecular weight marker (“Prestained protein ladder”) 
are given. 
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VLP preparations were performed as described for Gag/Ovacyt and aliquots of the 
gradient fractions were applied to SDS-polyacrylamide gels and analyzed by western 
blotting using monoclonal anti-pp65 (Fig. 31). 
 
 
 
 
 
 
 
 
 
Fig. 31. Western analysis of Gag/pp65 in gradient fractions 1-18 and gradient pellet. 
Lanes 1-18, fractions 1-18; lane 19, gradient pellet; lane 20, positive control 
(commercial pp65). Pooled fractions are indicated with a red line. 
 
 
Recombinant Gag/pp65 shows a different sedimentation profile as Gag/Ovacyt VLP. As 
seen in Fig. 31, the fusion protein (~141 kDa) could only be detected in fractions 
containing higher sucrose concentrations, and in the gradient pellet. This fact possibly 
reflects the higher molecular weight of Gag/pp65 in comparison to Gag/Ovacyt. 
 In order to investigate whether Gag/pp65 assembled into VLP, fractions 1-6, 
which were positive for the presence of Gag/pp65, were pooled, dialyzed overnight 
against PBSE, concentrated to 200 µl and analyzed by transmission electron microscopy 
(Fig. 32). 
 
 
 
 
 
 
 
 
 
Fig. 32. TEM analysis of Gag/pp65 chimeric VLP. Electron micrograph of sucrose 
gradient-purified Gag/pp65 derived from S. cerevisiae. Particles are indicated by an 
arrow. Sample was negatively stained with 2% uranyl acetate. Magnification of 
150,000. Bar = 100 nm. 
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As shown in Fig. 32, TEM analysis revealed the presence of VLP, which appear 
heterogeneous in size (35-55 nm in diameter) and symmetry. The dark core surrounded 
by a clear margin correlates well with the previous findings for Gag/Ovacyt VLP. White 
globules that also appear in the sample may indicate the presence of other proteins, or 
even unassembled Gag/pp65 fusions. This latter possibility would explain the 
occurrence of only a limited number of assembled VLP, suggesting that Gag/pp65 
assembly efficiency is somehow limited. 
 
 
5. Activation of antigen-specific T cells after delivery of recombinant yeasts 
Having characterized the heterologous expression of model proteins in yeasts, the 
selected recombinant yeast genera were tested in vitro (Ova) or ex vivo (pp65) for 
priming of antigen-specific T lymphocytes. 
 
 
5.1. Influence of antigen localization on activation of Ova-specific CD8+ T cells 
The yeast genera expressing the Ova derivatives were tested in an in vitro antigen 
presentation assay using murine BMM as antigen-presenting cells and the activation of 
Ova (SIINFEKL)-specific CD8+ T lymphocytes as read-out system. In this well-defined 
system, the recombinant yeast cells act as protein delivery vectors that feed antigens 
into the cytosolic MHC class I-restricted antigen presentation pathway. These 
experiments were performed in collaboration with Dr. Gernot Geginat at the Faculty for 
Clinical Medicine Mannheim of the University Heidelberg (Mannheim, Germany). 
BMM were incubated with four different yeast:macrophage ratios (MOI 14, 7, 3, 
1.5) or left untreated. Uptake kinetics of the diverse yeast genera by murine 
macrophages were previously analyzed (section 4.1). 
As shown in Fig. 33, infection of mouse BMM with Ovacyt-expressing yeast led 
to the activation of T cells recognizing the Ova epitope SIINFEKL and the consequent 
production of IFN-γ. Optimal activation of Ova-specific CD8+ T cells was obtained at 
MOI 7 in the case of S. cerevisiae and P. pastoris. In contrast, K. lactis provoked only a 
slight activation, whereas Sz. pombe hardly activated any T cells, not even at the highest 
MOI 14. Interestingly, regarding the subcellular localization of the Ova antigen, the 
pattern of activation differed considerably between S. cerevisiae and P. pastoris. 
Although S. cerevisiae contained only a roughly 1.4 times higher amount of 
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intracellular Ovacyt than P. pastoris, the former activated a several times higher number 
of T lymphocytes. In contrast, and in agreement with the lower amount of cytosolic 
Ovacyt as well as (in the case of fission yeast) the diminished uptake by BMM, K. lactis 
and Sz. pombe activated only a small population of CD8+ T cells. Notably, only a minor 
activation by S. cerevisiae and P. pastoris secreting Ova was observed, although the 
amount of secreted Ova was comparable to or even higher than the intracellular Ovacyt. 
Here, K. lactis and Sz. pombe failed to induce any detectable amount of IFN-γ. In the 
case of cell-surface displayed Ovacyt, activation of antigen-specific lymphocytes was 
significantly higher using P. pastoris as carrier system in comparison to S. cerevisiae. 
Noteworthy, at all MOIs applied, P. pastoris expressing Ovacyt on the cell surface 
induced an even higher CD8+ T cell response in comparison to cytosolic Ovacyt, despite 
the considerably lower level of protein. In contrast, in S. cerevisiae, activation by 
intracellular Ovacyt exceeded the cell wall-bound form at all MOIs. As expected, yeasts 
harbouring empty vectors caused no activation of Ova-specific lymphocytes as well as 
untreated macrophages. 
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Fig. 33: Activation of Ova-specific CD8+ T lymphocytes after yeast-mediated delivery 
of Ova-derivatives by bone marrow-derived macrophages in vitro. Adherent BMM from 
C57BL/6 mice were loaded with yeast genera expressing the different Ova derivatives. 
After 16 h, CD8+ T cells specific for the MHC class I-restricted SIINFEKL epitope 
were added and incubated for another 18 h. Antigen presentation was measured by T 
cell activation which was assessed by measuring the amount of IFN-γ in culture 
supernatants by ELISA. Results are expressed as mean and SD values of three 
independent experiments [Bazan et al., 2011]. 
 
 
This assay could no longer be repeated within this work in order to test antigen delivery 
when Ovacyt VLP were recombinantly expressed in S. cerevisiae. 
In conclusion, delivery of a protein antigen by different yeast genera was able to 
activate antigen-specific CD8+ T lymphocytes. Moreover, lymphocyte activation was 
influenced by antigen localization in yeast. 
 
 
5.2. Activation of pp65-specific memory T lymphocytes from HCMV-positive 
donors in an autologous system 
To simulate a condition more closely resembling an in vivo situation, the yeast-based 
delivery system was also tested using human DCs, the most effective inducers of T cell-
mediated immunity. By means of an ex vivo T cell stimulation assay, human DCs 
loaded with distinct yeast genera expressing pp65 were assessed for efficient activation 
of antigen-specific CD4+ and CD8+ T lymphocytes. The incubation time of DCs with 
yeasts (48 h) is sufficient to induce DC maturation and activation, as previously shown 
in section 1 of Results. 
Immature DCs derived from monocytes isolated from HCMV-positive donors 
were incubated for 48 h with yeasts expressing pp65 or yeasts carrying empty vectors 
(MOI 5); as positive and negative controls a lysate from HCMV-infected fibroblasts or 
untreated cells were used, respectively. Then, autologous lymphoctes were added at a 
ratio of 1:1 (lymphocyte:DC), as well as anti-CD49d and anti-CD28. Cells were co-
cultured for 6 h, during the last 4 h in the presence of Brefeldin A to inhibit protein 
secretion. Cells were stained for the surface molecules CD4 or CD8 and CD69 and 
intracellular IFN-γ. Activation of pp65-specific CD4+ and CD8+ memory T 
lymphocytes was analyzed by flow cytometry. 
 Fig. 34 shows the frequencies of CD8+ T cells expressing CD69 and IFN-γ in 
response to pp65. Responses to yeasts delivering pp65 were higher than those obtained 
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against yeasts harbouring empty vectors, and even higher than after using a HCMV 
lysate. Some degree of unspecific responses to the yeast vectors were also observed, and 
were higher for S. cerevisiae (0.07%), followed by P. pastoris (0.06%), and Sz. pombe 
(0.02%). The percentage of activated pp65-specific memory CD8+ T cells was 0.20% 
when S. cerevisiae was used as pp65 delivery system, 0.18% when Sz. pombe was used 
as vector and 0.14% when P. pastoris delivered pp65. Remarkably, these responses 
were significantly stronger compared to the response against a HCMV lysate (0.09%). 
The value corresponding to unspecific activation caused by untreated DCs was 0.01%. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 34: Activation of antigen-specific memory CD8+ T lymphocytes in an autologous 
system, as measured by CD69 and IFN-γ expression. DCs incubated with yeasts 
producing recombinant pp65 or harbouring empty vectors for 48 h were incubated with 
autologous T lymphocytes for antigen presentation. The HCMV lysate was used as 
positive control (CMV). Sc = S. cerevisiae; PW = Sz. pombe; GS = P. pastoris. Results 
of a single experiment are shown. 
 
 
With respect to activated pp65-specific CD4+ T cells, the observed difference between 
yeasts carrying pp65 and empty vectors was not significant (data not shown). Although 
the percentage of activated CD8+ T cells in response to yeast-delivered pp65 were 
above the threshold of significant T cell responses (0.05%, Breinig et al., 2006), levels 
of double positive cells were still relatively low. Many other donors were tested, but 
since the lymphocytic activation observed was not significantly better, activation of T 
cells was subsequently analyzed in whole blood assays. 
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5.3. Activation of pp65-specific T lymphocytes in whole blood assay 
It is well established that yeasts act as adjuvant and serve as efficient protein delivery 
system, stimulating potent immune responses (Stubbs et al., 2001; Ardiani et al., 2010). 
Activation of pp65-specific memory T lymphocytes using a cell lysate of Sz. pombe 
expressing recombinant pp65 in an ex vivo whole blood assay has been reported 
(Breinig et al., 2003). The same method was used here to investigate the ability of 
different yeast genera to stimulate antigen-specific memory T cells. 
S. cerevisiae S86c, Sz. pombe PW260, and P. pastoris GS115 were used in this 
ex vivo stimulation assay, and their efficiencies as delivery vectors were compared. For 
this purpose, yeasts were cultivated under the respective inducing conditions for 
expression of recombinant pp65 (also Gag/pp65 in the case of S. cerevisiae). As 
negative controls, yeasts carrying empty vectors (or a Gag-encoding vector) were used. 
For all yeast species analyzed, three different variants were tested: an ethanol-
precipitated yeast cell lysate; heat-treated yeasts (65°C, 1 h); and whole yeasts without 
receiving any treatment. Under each condition, the equivalent of 7.5×105 yeast cells was 
incubated with 450 μl blood. This optimal condition (1.7×106 yeast cells/ml) had been 
previously established by Breinig et al. (2003). 
Expression of recombinant proteins was achieved for 72 h. For protein 
precipitation purposes, yeasts were resuspended in PBS and lysed with glass beads and 
crude extracts were precipitated with ethanol, as described in the Methods section. The 
resulting pellets were then resuspended in PBS. Whole yeasts were incubated at 65°C 
for 1 h, or left untreated, before being used in the whole blood assay. The frequencies of 
activated pp65-specific T lymphocytes were determined by means of three-colour flow 
cytometric analysis. As negative control, assays using whole blood from HCMV 
seronegative donors were also performed. 
As depicted in Fig. 35, flow cytometric analyses of T cells from a HCMV 
positive donor revealed positive IFN-γ and CD69 responses against the HCMV lysate, 
in contrast to the HCMV negative donor. This latter exhibited strong T cell activation in 
response to the superantigen SEB, eliminating the possibility that the absence of 
response to HCMV antigens could result from potential experimental flaws. In both 
donors, incubation of the blood with only anti-CD28 and anti-CD49d did not cause any 
relevant effect on IFN-γ and CD69 production by T cells. 
Lysates from all yeast genera failed to induce pp65-specific responses in 
HCMV-positive donors (data not shown), contradicting previous findings (Breinig et 
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al., 2003). IFN-γ/CD69 expression in the samples incubated with yeasts harboring 
empty vectors or unmodified Gag protein alone was considerably low. In contrast, live 
or heat-treated S. cerevisiae, Sz. pombe and P. pastoris engineered to express pp65 (or 
Gag/pp65) showed the ability to activate memory CD4+ and CD8+ T lymphocytes (Fig. 
35). 
 Comparing untreated yeasts expressing pp65 derivatives, Sz. pombe expressing 
pp65 provoked the highest CD4+ T cell stimulation (2.27%), followed by S. cerevisiae 
expressing the fusion protein Gag/pp65 (2.01%) and pp65 alone (0.78%). Whole P. 
pastoris cells were less potent in stimulating antigen-specific CD4+ T lymphocytes 
(0.57%). Among the heat-treated yeasts carrying pp65, S. cerevisiae expressing 
Gag/pp65 caused the highest activation of CD4+ T lymphocytes (2.05%), followed by 
P. pastoris (1.8%), Sz. pombe/pp65 (1.59%) and S. cerevisiae/pp65 (1.26%). Thus, in 
terms of CD4+ T cell activation, heat treatment was beneficial in the case of S. 
cerevisiae and P. pastoris, but not in Sz. pombe. Unspecific T cell activation, as 
measured upon incubation with yeasts harbouring control plasmids, was not higher than 
0.32% (Fig. 35 A). 
 In relation to CD8+ T cell responses (Fig. 35 B), S. cerevisiae delivering 
Gag/pp65 induced greater frequencies of pp65-specific lymphocytes (0.7%), followed 
by Sz. pombe/pp65 (0.45%) and S. cerevisiae/pp65 (0.31%). Production of cytokines 
induced by P. pastoris carrying pp65 was very similar to the values obtained with this 
same yeast harbouring the empty vector (0.18% and 0.17%, respectively). However, 
when P. pastoris was heat-treated, this difference increased dramatically (0.39% vs. 
0.06%). This synergistic effect was not observed for the other yeasts in the case of 
CD8+ T cell activation, in which the frequency of positive cells was markedly reduced 
(Fig. 35 B). 
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(A) CD4+ T Lymphocytes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(B) CD8+ T Lymphocytes 
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Fig. 35. Recombinant pp65 within whole yeasts is able to activate specific memory T 
cells in HCMV seropositive, but not seronegative, donors. Frequencies of antigen-
specific CD4+ (A) and CD8+ (B) T cell activation after stimulation by yeasts expressing 
pp65 are shown. Antigens were added to whole blood of HCMV seropositive and 
HCMV negative donors. Whole blood was stimulated for 6 h. Activated T lymphocytes 
were identified by expression of CD69 and IFN-γ using flow cytometry. Neg = negative 
control (sample incubated with costimulatory antibodies only); SEB = Staphylococcus 
enterotoxin B (positive control); CMV = sample incubated with a lysate of HCMV-
infected fibroblasts; Sc = S. cerevisiae; PW = Sz. pombe; GS = P. pastoris. Data from a 
single representative experiment are shown. 
 
 
Higher frequencies of antigen-specific memory CD4+ T cells in comparison to CD8+ T 
cells were obtained in all assays performed throughout this work. Nevertheless, in a 
whole blood assay using total extracts of Sz. pombe producing pp65 higher frequencies 
of pp65-specific CD8+ T cells related to CD4+ T cells have been described (Breinig et 
al., 2003). Unspecific responses to the yeast vehicles observed in all donors tested have 
also been described, and are directly linked to yeast cell wall components, as pointed 
out by Heintel et al. (2003). 
 Using S. cerevisiae as antigen carrier, the Gag/pp65 fusion has proven to be 
more effective in stimulating pp65-specific lymphocytes than pp65 alone. Since both 
proteins were synthesized in equivalent amounts (Fig. 36), these results support 
previous findings from Powilleit et al. (2007). 
 For comparison, expression levels of recombinant pp65 by the different yeast 
strains were quantified. After 72 h of expression, extracts from 3×108 cells were 
analyzed by western blotting. As shown in Fig. 36, P. pastoris expresses the highest 
levels of pp65 (mean value = 222.3 ng in 3×108 cells), followed by Sz. pombe (19.3 ng). 
Recombinant protein production was lower in S. cerevisiae, in which pp65 and 
Gag/pp65 were expressed at similar levels (10.8 ng and 10.6 ng in 3×108 cells, 
respectively). 
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Fig. 36. Expression levels of recombinant pp65 produced in different yeast genera. 
Quantification was performed based on a standard curve of purified recombinant pp65 
of known concentration. Shown are mean values and standard deviations from triplicate 
determinations. 
 
 
From these data it can be concluded that activation of antigen-specific memory T 
lymphocytes does not correlate with the amount of recombinant protein expressed by 
each yeast, indicating that the yeast vehicle itself can influence cell-mediated responses. 
These findings are in agreement with the results observed for delivery of cytosolic Ova. 
 
 
6. Effect of heat treatment on β-glucan exposure on yeast cell walls 
The findings from the whole blood assays, in which heat treatment of yeasts led to a 
different T cell activation profile, encouraged a deeper investigation of the basis of the 
observed effects. Gantner and colleagues (2005) have demonstrated that heat-killed C. 
albicans expose more β-glucan at the cell surface. Normally, β-glucan is hidden by the 
outer mannose layer of yeast cell walls, and becomes only apparent in surface 
deformities such as bud and birth scars. Therefore, Dectin-1 binding to living yeast cells 
is restricted to these localized patches. Upon heating, β-glucan is uniformly exposed on 
the cell wall, in a manner that it is recognized by Dectin-1. Since C. albicans hyphae do 
not expose β-glucan by virtue of their filamentous growth, host Dectin-1 is not 
activated, which plays an important role in C. albicans pathogenicity. Therefore, 
Dectin-1 activation is a necessary step in the development of immune responses such as 
cytokine and chemokine production, as well as killing mechanisms against a variety of 
microorganisms (Gantner et al., 2005). 
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Exponentially grown yeasts were incubated for 1 h at 65°C, or left untreated at 
room temperature. Afterwards, cells were incubated with a monoclonal anti-β-1,3-
glucan antibody and subsequently with a FITC-conjugated secondary antibody. Yeasts 
were analyzed by fluorescence microscopy and flow cytometry. Cells incubated with an 
isotype control antibody and FITC-coupled secondary antibody served as negative 
control (Fig. 37). 
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                                     Sz. pombe                                                P. pastoris 
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Fig. 37. Effect of heat-treatment on the exposure of β-glucan on the yeast cell surface. 
The yeasts S. cerevisiae, K. lactis, P. pastoris and Sz. pombe were incubated at 65°C for 
1 h, or left untreated, before being incubated with anti-β-glucan or an irrelevant 
antibody (isotype control). Then, cells were incubated with a FITC-coupled secondary 
antibody and analyzed by fluorescence microscopy (A) and flow cytometry (B and C). 
(A) Fluorescence micrographs (left panels) and light micrographs (right panels) of 
yeasts stained for β-glucan. (B) Histograms showing the fluorescence pattern of β-
glucan staining among the yeast genera. Dashed lines represent cells incubated with an 
isotype control antibody; blue lines represent cells incubated at room temperature and 
stained for β-glucan; green solid lines indicate heat-treated cells stained for β-glucan. 
(C) Mean fluorescence intensity from untreated (blue bars) or heat-treated (green bars) 
yeast cells incubated with anti-β-glucan antibody, or untreated cells incubated with the 
isotype control antibody (grey bars). The fold increase in fluorescence observed after 
heat treatment in comparison to no treatment is shown. Ab =  antibody. 
 
 
As shown in Fig. 37, heat-treatment significantly increased β-glucan exposure on the 
cell surface of S. cerevisiae, K. lactis and P. pastoris. In contrast, Sz. pombe cells 
showed a slight reduction in mean fluorescence after incubation at 65°C. 
In Fig. 37 A, fluorescence microscopy analyses show that β-glucan staining was 
observed in localized patches on the cell walls of untreated S. cerevisiae, K. lactis and 
isotype control Ab 
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P. pastoris, such as birth and bud scars. Heat-treatment triggered an increase in 
fluorescence of cell walls of the three budding yeasts analyzed, whose entire cell walls 
became homogeneously stained. These results support earlier findings of Gantner et al. 
(2005), who demonstrated such a staining pattern for C. albicans and S. cerevisiae. 
Nonetheless, these observations are not valid for fission yeast. In the case of untreated 
Sz. pombe cells, a signal could be seen in the septum, where linear β-1,3-glucan is 
present in this species (Humbel et al., 2001). However, when this yeast was subjected to 
heating, fluorescence was not augmented and was detected only in punctuate regions. 
The microscopic examinations corroborate with the flow cytometric analyses (Fig. 37 
B). The lines depicting the heat-treated yeasts (green solid lines) show a shift to the 
right in comparison to the lines representing untreated yeasts (blue lines) in the 
histograms of S. cerevisiae, K. lactis and P. pastoris, but not Sz. pombe. As expected, no 
fluorescence was observed in cells stained with the isotype control antibody. Heat-
treated cells were also stained with the same irrelevant antibody, and also showed no 
detectable fluorescence (data not shown). Fig. 37 C shows that the greatest increase in 
mean fluorescence of heat-treated cells in comparison to untreated cells was observed 
for S. cerevisiae (112.62 vs. 26.06), followed by K. lactis (476.59 vs. 175.96) and P. 
pastoris (660.86 vs. 283.33). The opposite effect was observed for Sz. pombe (36.67 vs. 
43.28). 
In sum, heat-treatment strongly enhances β-glucan exposure on the cell wall of 
budding yeasts, but not of fission yeast.  
 
 
6.1. Production of reactive oxygen species in whole blood after incubation with 
yeasts 
The effect of heat-treatment on β-glucan exposure and its consequences were further  
analyzed. Gantner et al. (2005) showed that β-glucan sensing is a prerequisite for 
production of reactive oxygen species (ROS) by phagocytic cells in response to fungal 
stimuli. In this regard, yeasts were subjected to heating (65°C, 1 h) or left untreated and 
the production of ROS in whole blood was determined by means of a luminol 
chemiluminescence assay. 
Generation of ROS by phagocytes is a significant aspect in the response against 
fungi. ROS production by macrophages in response to the yeast form of C. albicans and 
S. cerevisiae zymosan (a preparation containing β-glucans, mannans, mannoproteins 
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and chitin) has been demonstrated (Gantner et al., 2005; Wellington et al., 2009). 
However, generation of ROS in whole blood after incubation with yeasts has not been 
described. The choice for this system was based on the fact that incubation of yeasts 
with IC-21 macrophages did not result in any detectable luminescence (data not shown). 
Furthermore, whole blood chemiluminescence exhibits some advantage in comparison 
to chemiluminescensce assays performed on isolated PBMCs, as preactivation of 
leukocytes as a consequence of the purification process is avoided. Additionally, whole 
blood chemiluminescensce assays permit evaluation of cellular responses in a 
physiologic environment that more closely resembles the in vivo situation in comparison 
to isolated cells (Kopprasch et al., 1996). 
 In this experiment, untreated and heat-treated S. cerevisiae, Sz. pombe, K. lactis, 
and P. pastoris were compared with respect to their ability to stimulate ROS production 
by blood leukocytes. Yeasts were exponentially grown in SC medium. Subsequently, 
2.5×105 yeast cells were added in each well to 10-fold diluted heparinised fresh venous 
blood previously mixed with luminol. In the blank samples, luminol was substituted for 
DMSO, and in the resting samples, yeasts were replaced by the equivalent volume of 
buffer. A series of blood dilutions was tested in this assay (undiluted, 10-, 50-, 100-, and 
500-fold), and the 10-fold dilution has proven to be the most appropriate experimental 
set-up (data not shown). The final volume was 100 μl/well. Chemiluminescence was 
continuously monitored for 150 minutes at 37°C, with 1 s integration time. 
As seen in Fig. 38 (A-C), chemiluminescensce was detectable approximately 6 
minutes after incubation with S. cerevisiae, K. lactis, and P. pastoris, reaching a 
maximum after ~30 minutes and declining thereafter. Chemiluminescence was higher 
when these three yeast species had been previously incubated at 65°C. Interestingly, in 
the case of fission yeast, untreated yeasts caused a higher ROS production by blood 
phagocytic cells then heat-treated cells (Fig. 38 D). Also, chemiluminescence signals 
occurred after approximately 20 minutes of incubation, and reached a maximum after 
45 minutes for the untreated yeasts, whereas incubation with heat-treated yeasts showed 
a different pattern, reaching a plateau after 64 minutes. Slower kinetics of Sz. pombe 
uptake by phagocytic cells was demonstrated in other experiments with human and 
murine phagocytic cells in this work, and might be the cause of the delay in ROS 
production observed. In contrast to the other yeasts examined, ROS production by blood 
phagocytic cells after incubation with heat-treated Sz. pombe was considerably lower 
than with untreated yeasts. 
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When either luminol or yeast was absent (blank or resting samples), no 
significant chemiluminescence was detected (Fig. 38). With respect to the blank 
samples, both untreated and heat-treated yeasts incubated with blood and DMSO 
resulted in the same chemiluminescence pattern (data not shown). 
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D 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 38. ROS production detected by chemiluminescence kinetics of whole blood 
depends on the extent of β-glucan exposure on yeast cell surface. Whole blood was 
incubated with heat-treated, untreated, or no yeast, in the presence of luminol. Blood 
samples incubated with yeasts and DMSO served as blank. Blood samples incubated 
with luminol without yeasts were referred to as resting. Chemiluminescence was 
recorded at 37°C over a 150-minute interval. RLU = relative luminescence units. 
Results represent mean values of triplicate determinations. 
 
 
All yeast genera analyzed are able to stimulate phagocytic cells in the blood to produce 
reactive oxygen species, a host’s defence mechanism of the innate immunity. The 
results observed in these chemiluminescence studies are in agreement with the findings 
reported for flow cytometry and fluorescence microscopy, i.e., budding yeasts expose 
more β-glucan on their cell surface after being subjected to heating, whereas fission 
yeast seems somehow to react in a different way. 
Altogether, these findings might help planning future experiments involving 
yeasts as delivery systems. The choice of a certain yeast species for specific purposes 
should take into account the manner this microorganism behaves after being subjected 
to a particular treatment. 
 
 
7. Stimulation of CD8+ transgenic cells from OT-I mice after vaccination 
It could be demonstrated that yeast is an effective vehicle for delivery of cytosolic 
recombinant antigens (Results, section 5). To investigate whether yeast delivery of 
Ovacyt would stimulate antigen-specific CD8+ T cells in an in vivo system, the S. 
cerevisiae W303-1a strain was used as protein carrier in a preliminar experiment with 
OT-I transgenic mice. This S. cerevisiae strain has been employed in various studies 
using whole yeasts in vaccination protocols (Riemann et al., 2007; Lu et al., 2004; 
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Wansley et al., 2008). Furthermore, this strain was also able to induce DC maturation 
and activation, as previously demonstrated (Results, section 1). 
 Experiments with OT-I mice were performed in collaboration with Elisabeth 
Kenngott at the Medical Clinic for Rheumatology and Clinical Immunology (Charité, 
Berlin). OT-I mice express high levels of a transgenic T-cell receptor in CD8+ T 
lymphocytes which recognizes OVA257-264 (SIINFEKL peptide) in MHC class I H-2Kb 
molecules (Hogquist et al., 1994). 
OT-I mice were given recombinant S. cerevisiae expressing Ovacyt, S. cerevisiae 
carrying an empty vector, or PBS, three times, s.c., with 1-week interval between each 
immunization. One week after the last immunization, spleens and inguinal lymph nodes 
were harvested, and single cell suspensions (2×106 cells/ml) were restimulated with 10 
μg/ml PMA/ionomycin for 4 h, or SIINFEKL peptide for 6 h (spleen cells only). PMA 
and ionomycin are frequently used in immunological approaches to stimulate cytokine 
production in a non-specific manner (Picker et al., 1995). Production of IFN-γ by 
activated lymphocytes was assessed by flow cytometry (Fig. 39). 
 
 
 
 
 
 
 
 
 
Fig. 39. Schematic representation of vaccination regimes and subsequent analysis of 
specific CD8+ T cell immune response in spleen and lymph nodes. Yeasts expressing 
recombinant Ovacyt or carrying an empty vector (5×107 cells in 100 μl PBS), or 100 μl 
PBS were injected three times s.c. in OT-I mice, with one-week intervals between 
doses. One week after the last immunization, spleens and inguinal lymph nodes were 
removed, and single-cell suspensions were restimulated with SINFEKL or 
PMA/ionomycin before being stained for CD8, Vβ5 and IFN-γ. 
 
 
Fig. 40 A shows the production of IFN-γ by Ova-specific CD8+ T cells after spleen cells 
had been incubated with 10 μg/ml SIINFEKL peptide. Mice receiving S. 
cerevisiae/Ovacyt showed an increased frequency of IFN-γ+-cells in comparison to the 
other groups (mean value = 3.34%). CD8+Vβ5+ lymphocytes isolated from spleen of 
mice receiving S. cerevisiae harbouring the empty vector also showed a certain degree 
5×107 yeasts/Ovacyt s.c. 
or 
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of background activation (mean value of IFN-γ+ cells = 2.4%). Specific cells from mice 
receiving PBS showed a minimal IFN-γ production (mean value = 1.48%). When spleen 
cells were stimulated with PMA/ionomycyn, the frequency of IFN-γ-producing CD8+ 
cells increased substantially, but this increase was observed for all groups (Fig. 40 B). 
Mean values of the frequencies of CD8+ IFN-γ+ cells were slightly higher in the group 
receiving S. cerevisiae/Ovacyt than S. cerevisiae/empty vector (11.29% vs. 10.32%, 
respectively), whereas specific cells from mice receiving PBS only showed a frequency 
of 7.19% cells expressing IFN-γ. 
Due to the low number of cells recovered after extraction of inguinal lymph 
nodes, cell suspensions were only stimulated with PMA/ionomycin. However, no 
significant increase in the frequency of specific cells producing IFN-γ could be seen 
(data not shown). 
 
A                                                                        B 
 
 
 
 
 
 
 
 
 
Fig. 40. OT-I transgenic mice were immunized with S.cerevisiae/Ovacyt, S. 
cerevisiae/empty vector, or PBS. Then, spleens were harvested 7 days postvaccination 
and the percentage of transgenic CD8+ T cells producing IFN-γ after ex vivo 
restimulation with 10 μg/ml of SIINFEKL peptide (A) or PMA/ionomycin (B) was 
determined by flow cytometry. 
 
 
Although the differences between the Ovacyt-receiving group and the control groups 
were not statistically significant, there was a tendency for enhanced IFN-γ production 
by spleen lymphocytes from Ovacyt-vaccinated mice, especially when the cells were 
restimulated with the Ova peptide. This indicates that better results might be obtained 
by optimizing the immunization protocol. 
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V. DISCUSSION 
 
 
Vaccination approaches aiming at inducing robust cell-mediated immune responses 
have been the focus of intense research. Strategies employing yeast as antigen carrier 
have been established in the past decade. A number of in vitro studies, as well as 
preclinical and clinical trials attest the intrinsic adjuvant properties of yeasts (Franzusoff 
et al., 2005; Ardiani et al., 2010). However so far, the overwhelming majority of these 
studies are restricted to the conventional yeast S. cerevisiae. 
 Hitherto, there is no study comparing the effectiveness of different yeast genera 
as vaccine vehicles. Although such comparison is sometimes difficult due to the 
difference in expression levels of the recombinant protein among the yeasts examined, 
testing the applicability of yeasts species alternative to S. cerevisiae in the development 
of novel antigen delivery systems could be of relevance. 
 The use of yeasts as antigen delivery system provides the following benefits: (i) 
yeasts can be engineered to express one or more recombinant proteins, and correctly 
perform post-translational modifications; (ii) cost-effectivenes of the system, also in 
large-scale productions; (iii) yeast cell wall components per se activate dendritic cells 
and amplify signals required for T cell activation; (iv) antigen presentation occurs via 
both MHC class I and MHC class II pathways, eliciting antigen-specific T cell 
responses; (v) absence of yeast-induced neutralizing immune responses, enabling 
repeated administration; and (vi) heat-killed and live yeasts trigger similar protective 
immunity, reducing the risks associated with the injection of live yeasts in 
immunocompromised individuals (Ardiani et al., 2010). 
 A set of “non-conventional”, biotechnologically relevant yeast genera has been 
utilized in the past decades as alternative expression host to S. cerevisiae. Yeast species 
such as K. lactis, P. pastoris, and Sz. pombe have proven to be efficient cell factories 
and have offered some advantages over baker’s yeast, for instance with respect to 
protein glycosylation. Hyperglycosylation and addition of allergenic α-1,3-linked 
mannose residues to N-glycans have been repeatedly reported in S. cerevisiae (Porro et 
al., 2005; Varki et al., 2009). This drawback, together with other limitations, such as 
plasmid instability, can be overcome in the majority of cases with the use of the 
previously mentioned alternative yeasts. 
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 Yeast has been shown to be taken up by phagocytic cells through recognition of 
PAMPs, such as mannan and β-glucan, by pattern recognition receptors, such as Dectin-
1 and the mannose receptor (Netea et al, 2006; Brown, 2011; Romani, 2011). After 
receptor-mediated phagocytosis, yeasts are killed and processed for antigen presentation 
(Gildea et al., 2001; Newman and Holly, 2001; Syme et al., 2002; Heintel et al., 2003). 
Besides, yeasts cause dendritic cells to undergo maturation (Buentke et al., 2001; 
Stubbs et al., 2001). For all these reasons, yeasts are appropriate vectors for delivering 
vaccine antigens. 
 The aim of this work was to compare four yeast strains – S. cerevisiae, Sz. 
pombe, K. lactis, and P. pastoris – as antigen delivery vector for activating T 
lymphocytes, as well as the influence of the subcellular localization of the recombinant 
protein on this activation. For this purpose, the interaction of different yeast strains with 
phagocytes was analyzed, as well as yeast-induced DC maturation. Subsequently, the 
genes coding for the model antigen Ovalbumin or the clinically relevant HCMV protein 
pp65 were cloned in expression plasmids specific for each yeast species and 
recombinantly expressed. In the case of full-length pp65, only intracellular expression 
was achieved (except for K. lactis), whereas Ova could be secreted, intracellularly 
expressed (Ovacyt), or cell-wall anchored (Ovacyt/Sed1p). This latter variant was only 
observed in S. cerevisiae and P. pastoris. Pp65-harboring yeasts, as well as S. cerevisiae 
assembling chimeric pp65 VLP, were analyzed in an ex vivo whole blood assay for their 
ability to stimulate pp65-specific CD4+ and CD8+ T lymphocytes from HCMV-
seropositive donors. Yeasts carrying the plasmid-encoded Ova variants were analyzed 
in vitro by means of antigen-presentation assays using Ova-specific T lymphocytes. 
Finally, a preliminary in vivo experiment was performed in order to confirm the 
feasibility of the system. 
 
 
1. Yeasts induce DC maturation and cytokine secretion 
In order to efficiently stimulate T cells, DCs have to be in a mature state. Mature DCs in 
lymphoid tissues are the most powerful stimulators of naïve T cells. Maturation implies 
both functional and phenotypic changes. After antigen uptake and exposure to 
inflammatory stimuli, immature DCs in peripheral tissues are induced to migrate into 
the regional lymph nodes where, as mature cells, they express surface molecules that 
further activate T cells (Janeway et al., 2001; Lechmann et al., 2002). 
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DC maturation and activation can be elicited by diverse stimuli, such as 
microbial components, cytokines and costimulatory molecules. Maturation is 
accompanied by increased expression of adhesion, costimulatory and MHC molecules, 
altered expression of chemokine receptors (such as CCR7), production of some specific 
cytokines, such as IL-lβ and IL-12, and decreased capability of antigen uptake. In the 
lymph nodes, mature DCs present antigens to naïve T cells and activate these 
lymphocytes, thus connecting innate and adaptive immunity (Verhasselt et al., 1997; 
Akira et al., 2001; Abbas et al., 2007). 
DCs are able to ingest a wide variety of antigens and efficiently process them in 
context of MHC class I and II molecules for presentation to T cells. Additionally, DCs 
express a set of costimulatory molecules that stimulate naïve T cells, and dictate the 
differentiation of naive lymphocytes into distinct classes of effectors, controlling the 
quality of the T cell response. These antigen-specific, adaptive responses play a critical 
role in combating infections and tumors (Mellman et al., 2001; Heath and Carbone, 
2001). DCs can also efficiently process and present internalized, exogenous antigens via 
MHC class I, in a process known as “cross-presentation”. Due to this remarkable 
ability, many efforts have been made in the vaccination field to target and activate DCs, 
thus providing the potential to generate both CD4+ and CD8+ immune responses. 
In this work, it could be shown that incubation of monocyte-derived human DCs 
with different yeast genera resulted in increased expression of the DC surface markers 
CD83, CD80, CD86, CD54, CD58, CD40, MHC classes I and II, and led to secretion  
of GM-CSF, IFN-α, IFN-β, IFN-γ, IL-1α2, IL-1β, IL-6, IL-8, IL-10, IL-12p70, IL-15, 
IL-23, IL-27, and TNF-α. These observations indicate that all yeasts examined are able 
to induce DC maturation and activation. Importantly, these data demonstrate that the 
yeast vehicle per se is able to augment all three signals required for T cell activation, 
since increased expression of MHC molecules (involved in signal 1), costimulatory 
molecules (which provide signal 2) and cytokines (which deliver signal 3) were 
observed. 
With respect to DC maturation, upregulation of the expression of CD83, MHC 
class I, MHC class II, CD80, CD86, CD40, CD54, and CD58 was observed after 
incubation of DCs with all yeast genera and the HCMV lysate, as well LPS, which was 
used as positive control since its effects on DC maturation have been repeatedly 
demonstrated (Bernstein et al., 2008; Huang et al., 2009). However, expression of 
CCR7 after contact with yeasts or HCMV lysate, as well as with the classical stimulator 
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LPS, did not significantly increase, in contrast to all other surface markers analyzed. A 
possible explanation for this finding might be the presence of IFN-β and IFN-γ (which 
were released into the culture medium by DCs), as they have been shown to inhibit the 
expression of this homing receptor (Yen et al., 2010). 
LPS, a component of Gram-negative bacterial outer membranes, is detected by 
TLR4 (Pålsson-McDermott and O'Neill, 2004). Maturation and cytokine production by 
DCs in response to LPS has been described. For instance, high-level secretion of IL-6, 
IL-8, IL-12 and TNF-α, and upregulation of MHC classes I and II, CD40, CD80, CD86, 
CD54 and CD58 have been shown (Sallusto et al., 1995; Verhasselt et al., 1997). In the 
present work, LPS induced higher expression levels of all surface markers and eight out 
of fourteen cytokines analyzed compared to yeast genera and the viral stimulus. 
Nevertheless, it has to be considered that yeasts and LPS, as well as viruses, stimulate 
and mature DCs through different mechanisms, i.e. different pathways are activated by 
distinct stimuli, leading to modulation of a particular set of genes (Huang et al., 2001). 
With respect to immune response against viruses, DCs generally become 
activated after antigen uptake and synthesize a number of cytokines, such as IFN-α, IL-
12 and IL-15 (Lambotin et al., 2010). However, viral infections can either stimulate or 
repress the maturation and functional activation of DCs (Moutaftsi et al., 2002). 
Responses to HCMV seem to depend on the DC subset. For example, in one study, 
HCMV did not lead to maturation of monocyte-derived DCs, as the expression of MHC 
class I, CD40 and CD80 diminished after HCMV infection (Moutaftsi et al., 2002). In 
contrast, another DC type (blood CD11c+ DC) showed an elevated expression of MHC 
molecules and CD83, as well as IL-6, IL-10 and type I IFN secretion following HCMV 
exposure (Kvale et al., 2006). In the present study, upregulation of maturation markers 
and cytokine secretion could be detected following incubation of monocyte-derived 
DCs with the viral stimulus. However, since the stimulus used here consisted of a lysate 
of HCMV-infected fibroblasts, viral protein aggregates, instead of intact viral particles, 
might have contributed to the maturation and activation profile observed. 
Yeast-dependent upregulation of surface molecules indicative of DC maturation 
has been described for both non-pathogenic and opportunistic yeast species, such as S. 
cerevisiae, C. albicans and M. furfur. Cytokine secretion by DCs in response to fungi 
has been shown to be a more complex task, varying from one fungal stimulus to another 
(d’Ostiani et al., 2000; Buentke et al., 2001; Remondo et al., 2009). In the present 
study, upregulation of DC surface markers and cytokine secretion were, as expected, 
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variable among yeast genera. This observation might result from the particular 
composition of the cell wall of each yeast. This variability in DC responses might 
explain why some yeast species have been shown to induce TH1-biased responses, such 
as S. cerevisiae, whereas others, such as M. furfur, have been reported to favour the 
production of TH2-type cytokines (Buentke et al., 2001; Remondo et al, 2009). Also, 
murine DCs incubated with C. albicans yeasts have been shown to secrete IL-12 and 
prime TH1 cells, whereas C. albicans hyphae inhibited TH1 priming and led to a TH2 
response through induction of IL-4 production (d’Ostiani et al., 2000). One important 
finding of the present work was that all yeast genera analyzed led to release of IFN-γ 
and IL-12 by DCs, cytokines that drive TH1 differentiation. Such outcome is desirable 
when considering the use of yeasts as vehicles to induce CTL responses. Nonetheless, it 
is not possible to affirm whether this scenario would also occur in vivo, since the 
microenvironment or cytokine milieu in the initial DC location in peripheral tissues may 
affect the antigen presentation in secondary lymphoid organs and T cell differentiation 
into the distinct TH phenotypes (Liu et al., 1998). 
The production of many pro-inflammatory cytokines has been linked to the 
NFκB signaling pathway. Recognition of β-glucans by Dectin-1 results in signaling 
through Syk kinase and Raf-1 pathways, inducing activation of NFκB and subsequently 
production of cytokines including IL-10, IL-1β, IL-6, IL-23, and GM-CSF (Rogers et 
al., 2005; Brown, 2011). TLRs detect several mannose-containing structures and also 
other components of the yeast cell wall yet to be determined. Nonetheless, the role of 
each TLR in immunity against fungi still remains to be determined, due to the large 
amount of contradictory literature for almost every TLR and fungus (Brown, 2011). 
Stimulation of TLRs also triggers the activation of signaling pathways and leads, for 
example, to the production of TNF-α, IL-8 and IL-12 (as a result from NFκB activation 
via MyD88-Mal) and type I IFNs (Netea et al., 2008; Romani, 2011). Dectin-1 has been 
shown to augment specific TLR-mediated signaling. As a consequence, production of 
TNF-α is enhanced due to a synergistic effect between Dectin-1 and TLR2 (Gantner et 
al., 2003). In contrast, these collaborative responses mediated by Dectin-1 and TLR2 
lead to down-regulation of IL-12 expression in comparison to the levels obtained only 
by TLR ligation (Dennehy et al., 2009). 
The signaling pathway activated by MR has not been completely elucidated 
since no classical signaling motifs are present in the cytoplasmic tail of this receptor 
(Willment and Brown, 2007). However, MR has also been demonstrated to elicit NFκB 
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activation and consequent cytokine production, including IL-12, IL-1β, IL-6, IL-10, 
GM-CSF, and TNF (Pietrella et al., 2005; Brown, 2011). 
 The recognition pathway of chitin has not been intensively studied, as well as its 
function in fungal infection (Netea et al., 2008). No study showing the specific role of 
chitin in DC maturation caused by entire yeasts or hyphae could be found. Nevertheless, 
it has been suggested that the signalling pathways involved after chitin recognition 
includes NF-κB (via TLR2 and Dectin-1) for TNF production as well as Syk and MR 
for IL-10 production (via Dectin-1-dependent and TLR2-dependent and -independent 
pathways; Da Silva et al., 2009). 
The set of cytokines expressed by human DCs is based on the condition of 
activation and the cell subset (de Saint-Vis et al., 1998). Distinct DC subsets influence 
the initiation of adaptive antifungal responses. TH17 and TH2 cell responses towards 
fungi are initiated by inflammatory DCs, while tolerogenic DCs stimulate TH1 and 
regulatory T cell responses. Prevailing TH1 cell responses are associated with protective 
antifungal immunity and efficient vaccines against fungal infections. TH1 cell activation 
can result from DC responses to a combination of signals provided by fungi via CLRs 
and TLRs (Romani, 2011). 
Some studies analyzing the immune response against isolated yeast components 
have been conducted. Huang et al. (2009) showed that both particulate and soluble S. 
cerevisiae-derived β-glucans led to the production of high levels of TNF-α by DCs, 
while IL-12p70 levels were undetectable. Sheng et al. (2006) could demonstrate that 
mannan from S. cerevisiae induced maturation of murine DCs and cytokine production 
(including IL-6, IL-1β, GM-CSF and TNF-α). Production of IL-12, TNF-α and IFN-γ 
by murine spleen cells in response to chitin has been demonstrated (Shibata et al., 
1997). Another investigation reported IL-10 and TNF-α secretion by murine 
macrophages after treatment with chitin particles (Da Silva et al., 2009). Moreover, this 
latter study showed that the effects observed depend on chitin size, since distinct 
combinations of receptors (such as TLR2, Dectin-1, and MR) and, consequently, 
different signaling pathways, were activated by different-sized chitin particles. 
However, it is complicated to draw conclusions about the role of each cell wall 
component in DC stimulation since, for a given cytokine, additive, antagonistic, and 
irrelevant effects can be observed when the combination of all yeast PAMPs is 
compared to the contribution of each individual PAMP (Huang et al., 2009). Moreover, 
it is tempting to speculate that the extent of DC activation caused by each stimulus is 
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strongly linked to the DC receptors involved in recognition of the referred antigen. In 
this way, since the composition of the yeast cell wall greatly varies among the yeast 
genera, the participation of a given receptor may also differ from one case to another. 
The findings reported in this work indicate that all the yeast genera analyzed 
induce DC activation responses that in vivo would most probably lead to migration to 
secondary lymphoid organs and interaction with T lymphocytes for antigen 
presentation. Moreover, in an in vivo situation, a large spectrum of fungal PAMPs 
would be displayed in variable concentrations, leading to stimulation of several host 
PRRs. In this way, combinations of diverse ligands would result in complex patterns of 
inflammatory responses. The type of receptors stimulated in response to fungi and the 
extent of this stimulation strongly influence the nature of the immune responses (Levitz, 
2010). In sum, the results of this work support the usage of yeasts as promising delivery 
system and suggest that different yeasts might lead to distinct responses. Furthermore, 
although each PRR alone stimulates the production of a particular pattern of cytokines 
(among other responses), the mechanisms by which all this is integrated remain to be 
determined (Brown, 2011). 
 
 
2. Staining of yeast cell wall components 
Stimulation of T lymphocytes in response to fungi is credited to fungal cell wall 
components (Heintel et al., 2003). Moreover, several studies have demonstrated the 
immunomodulatory effects of mannan and β-glucan (Suzuki et al., 1989; Toda et al., 
1997). Particulate yeast β-glucan has been successfully used to stimulate robust CTL 
responses for combating tumors in animal models (Li et al., 2010; Qi et al., 2011). Li et 
al. (2010) demonstrated that yeast-derived, particulate whole glucan particles led to 
production of IL-12 and IFN-γ in the tumor environment and elicited antitumor TH1 
responses. Clinical trials combining β-glucan with antitumor therapy have also been 
conducted (ClinicalTrials.gov ID: NCT005455459). Alternatively, purified glucan 
particles from S. cerevisiae were used as vaccine delivery system, eliciting T cell 
responses, production of IFN-γ and IL-17 and secretion of antigen-specific antibodies 
(Huang et al., 2010). 
Strategies exploiting yeast mannosylation of antigens for augmented 
immunogenicity have been aimed (Lam et al., 2005; Luong et al., 2007). Antigen 
mannosylation by yeast promoted increased antigen-specific CD4+ and CD8+ T cell-
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mediated immune responses (Lam et al., 2005). Alternatively, mannan coating of a 
liposome preparation containing a DNA vaccine led to the activation of TH1 cells (Toda 
et al., 1997). 
Little has been investigated about the adjuvant effects of chitin. This component 
of the yeast cell wall has not been a focus of intense research, maybe due to the fact that 
it is a minor constituent of the fungal cell wall and has been, in some cases, not clearly 
identified in the cell wall of some yeast species (Arellano et al., 2000). However, chitin 
has been demonstrated to enhance antigen-specific T cell proliferation and to possess 
adjuvant properties in TH1, TH2 and TH17 immune responses, as well as in IgE 
production (Da Silva et al., 2010). 
Recently, S. cerevisiae has been employed as a complex antigen vaccine to 
induce cross-protection against systemic aspergillosis and coccidioidomycosis (Capilla 
et al., 2009; Stevens et al., 2011; Liu et al., 2011). Subcutaneous administration of heat-
killed yeast protected mice against lethal systemic coccidioidomycosis challenge 
(Capilla et al., 2009). This protection was conferred by adaptive immune responses, 
which were mainly mediated by CD8+ T cells and also involved production of IFN-γ, 
IL-6 and IL-17 (Liu et al., 2011). 
 Secretion and glycosylation of proteins, as well as the cell wall composition, 
differ among yeast genera. The Golgi apparatus of S. cerevisiae diverges significantly 
from those of Sz. pombe and P. pastoris, which resemble more closely the ones of 
higher eukaryotes. For instance, many S. cerevisiae glycans bear terminal α-1,3-
mannose, whereas some mannose structures contain terminal α-galactose in Sz. pombe, 
α-1,2-linked mannose in P. pastoris and N-acetylglucosamine in K. lactis (Glick, 1996; 
Varki et al., 2009). Treatment of various fungal particles with Con A-FITC followed by 
flow cytometry or microscopic analyses does not allow distinction of these diverse 
structures. 
Luong et al. (2007) showed that immunogenicity of an antigen recombinantly 
expressed by P. pastoris was enhanced by O-linked mannosylation and decreased by N-
linked mannosylation, but the mechanisms by which this occurs are still unclear. An 
interesting aspect is that N-linked glycans in Pichia have a high-mannose configuration, 
whereas O-linked glycans are short (generally 2-3 mannose residues; Trimble et al., 
2004; Luong et al., 2007). This fact might explain the observation that the S. cerevisiae 
BY4742 cell-wall mutants caused, in general, higher upregulation of DC surface 
markers and cytokine secretion in comparison to their wild-type counterpart. Since 
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Mnn11p is thought to function in outer chain elongation by adding α-1,6-mannose, the 
Δmnn11 mutant produces proteins with shortened, truncated mannan backbones (Dean, 
1999). Yeasts lacking functional OST3 gene have been described to underglycosylate 
soluble and membrane bound glycoproteins (Karaoglu et al., 1995). In this way, not 
only the type, but also the length of glycans seems to influence the host’s immune 
responses. 
Different β-glucan compositions also lead to distinct biological effects, as seen 
for zymosan, which contains 12-14% β-glucan, and purified whole glucan particles, 
composed of > 85% β-glucan (Li et al., 2010). Yeasts exposing more β-glucan should 
lead to increased Dectin-1-driven signaling. Mannan and α-1,3-glucan prevent or 
decrease β-glucan recognition via Dectin-1 (Rappleye et al., 2007; Netea et al., 2008). 
Therefore, it would be expected that yeasts bearing mutations in genes that result in 
reduction of mannan would promote different responses than yeasts containing, for 
instance, a dense mannan layer and α-1,3-glucan, such as Sz. pombe. With respect to 
chitin, it has been shown that this polymer associates with bud necks at the end of yeast 
cell division and become component of bud scars (Rodrigues et al., 2008). This fact 
might explain why chitin was poorly detected in fission yeast. The much higher 
percentage of cells positive for chitin in S. cerevisiae cell wall mutants compared to the 
parental strain might result from a compensatory mechanism to maintain cell wall 
stability, as hypothesized by Uccelletti et al. (2006). They observed increased chitin 
amounts in K. lactis mutants with reduced mannoprotein contents compared to wild-
type. 
It has to be pointed out that the yeast cell wall is a highly dynamic structure and, 
therefore, antigenically inconstant. Factors such as strain, age of cultured cells and type 
of growth medium have been described to exert influence on yeast antigenicity, i.e. on 
the display of epitopes on the cell suface (reviewed by Nelson et al., 1991). Thus, 
fluorescence detection of mannan and glucan as performed in this work may diverge 
from one experiment to another, also when attempts to keep the same experimental 
conditions are made. The different patterns of cell wall staining observed here are in 
accordance with literature data, which show that massive differences can be observed 
when the cell walls of different fungal species and also strains within a species are 
compared (Levitz et al., 2010). 
 To date, distinct molecules have been identified as receptors for mannose or β-
glucans on APCs, but information about how each receptor discriminates its ligands is 
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still missing (Qi et al., 2011). Additionally, and as stated before, glycan structures vary 
from one yeast strain to another and the simultaneous presence of several yeast PAMPs 
as in whole yeasts may lead to different responses than those observed against each 
particular PAMP separately (Huang et al., 2009). In this work, staining of yeast cell 
wall components was performed in an attempt to determine if there was a causal 
relation between the yeast cell wall and DC maturation or activation. The results 
suggest that no direct correlation could be established between the mannan, β-1,3-
glucan and chitin contents on the surface of yeast cells and the degree of stimulation of 
human DCs. This fact was not surprising by virtue of the dynamic nature of yeast cell 
walls and the consequent fluctuation in glycan contents. 
 
 
3. Interaction patterns between yeasts and mammalian phagocytic cells 
Immune recognition of fungal particles takes part mostly at the cell wall level. While 
the yeast cell wall consists of an interconnected structure of polysaccharides, 
glycoproteins and some glycolipids, mainly carbohydrate structures are involved in the 
interaction between yeast and mammalian host cells. 
The findings reported in this study show that the interactions between human 
DCs and the biotechnologically relevant yeasts S. cerevisiae, Sz. pombe, K. lactis and P. 
pastoris are mediated by both mannan and glucan. Specific blocking of MR and Dectin-
1 in DCs was able to impair, to a greater or a lesser extent, host cell binding of all yeast 
species tested. In general, yeast cell wall consists of an outer layer of mannosylated 
proteins and an inner layer of β-glucans and chitin. However, β-glucans may be 
permanently exposed at the surface in specific regions like bud and birth scars, which is 
sufficient for Dectin-1 sensing (Gantner et al., 2005). Specific blockage of Dectin-1 led 
to a greater reduction in yeast binding compared to MR blockage in three out of four 
species tested (S. cerevisiae, Sz. pombe, and P. pastoris). Interestingly, and in 
agreement with its low phylogenetic relationship to other yeast genera and its notable 
difference in cell wall architecture (Russell and Nurse, 1986), uptake of Sz. pombe by 
DCs was almost completely abrogated after anti-Dectin-1 treatment. The fission yeast 
β-D-glucan repertoire is basically composed of β-1,6-branched β-1,3- and β-1,6-
glucans, while linear β-1,3-glucan is absent in the cell wall and exclusively found in the 
primary septum (Humbel et al., 2001). However, since Dectin-1 recognizes both β-1,3- 
and β-1,6-glucans (Brown and Gordon, 2001), the lack of linear β-1,3-glucan structures 
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in Sz. pombe does obviously not confer any advantage for this microorganism in terms 
of being less recognizable by Dectin-1. With respect to MR, blocking of this receptor 
does not mean that yeast mannan is no longer recognized, since alternative mannose 
receptors are present on the surface of DCs, such as DC-SIGN (Cambi et al., 2003). 
As observed for human DCs, the kinetic pattern of Sz. pombe internalization was 
different from the other three yeast species analyzed. S. cerevisiae, K. lactis and P. 
pastoris are round-shaped yeasts, in contrast to the rod-like shape of fission yeast. It has 
been demonstrated that phagocytosis depends on both particle size and shape, and 
particles requiring only gradual actin ring expansion are more efficiently phagocytosed 
(Champion and Mitragotri, 2006). Since Sz. pombe was taken up more slowly, possibly 
the morphology of fission yeast does not favour internalization in such a rapid manner 
as for the other three yeast species analyzed. 
Since IC-21 mouse macrophages do not express the mannose receptor, only the 
effect of Dectin-1 on yeast uptake was analyzed in this work. Lack of MR in some 
murine macrophage cell lines, such as J774 and RAW264.7, as well as resident 
peritoneal mouse macrophages has been described (Taylor et al., 2002; Martinez-
Pomares et al., 2003; Lin et al., 2010). Incubation of IC-21 macrophages with anti-
Dectin-1 diminished yeast uptake, indicating that recognition of yeasts by IC-21 cells 
involves Dectin-1. This interaction was specific, since addition of an isotype control 
antibody to the cells led to similar results than those for untreated cells. The differences 
among yeast genera observed after Dectin-1 blocking might reflect the amount of 
exposed β-glucan on cell walls of each genus. 
 Uptake of S. cerevisiae and Sz. pombe in whole blood has been analyzed 
(Breinig et al., 2003), with no significant differences among both yeasts. However, 
yeasts are avidly internalized in whole blood by a great sort of phagocytic cells, 
including neutrophils and monocytes, so that the different systems cannot be directly 
compared. 
 An important characteristic of the mannose receptor is that it recycles to the cell 
surface after having released its ligand. Thus, ligands can be delivered in much larger 
amounts than the number of receptors, which provides an unlimited antigen 
accumulation capacity (Stahl et al., 1980; Sallusto et al., 1995). Antigens internalized 
by MR might, after receptor dissociation, be trafficked to lysosomes rich in MHC class 
II molecules (Tan et al., 1997; Keler et al., 2004). Moreover, it has been demonstrated 
that mannosylated peptides are more efficiently presented to antigen-specific T cells 
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than non-mannosylated proteins (Engering et al., 1997; Tan et al., 1997). In this way, 
MR targeting has become an attractive approach to increase vaccine efficacy (Keler et 
al., 2004). 
Dectin-1-mediated uptake has also been demonstrated to enhance antigen 
presentation via MHC class II and increase antigen-specific T cell activation, as well as 
cross-presentation (Xie et al., 2010; Weck et al., 2008). Other C-type lectin receptors on 
DCs, such as DC-SIGN, have also been targeted in order to improve antigen 
presentation (Adams et al., 2008) and consequently augment vaccine efficiency. 
Therefore, and according to the findings of this work, yeasts naturally target 
CLRs on phagocytes, including macrophages and DCs, so that vaccination approaches 
using whole yeasts are of significant potential. 
 
 
4. Expression and delivery of different Ova variants by yeasts 
One line of investigation in this work was to study the efficiency of different yeast 
genera as protein delivery vector, and to analyze the influence of subcellular antigen 
(Ova) localization on its processing and presentation in context of MHC class I to 
specific CD8+ T lymphocytes. An interesting question was to evaluate the antigen 
presentation efficiency of SIINFEKL epitope when Ova was located in different yeast 
compartments. In order to get basic information which system would be more 
advantageous in terms of vaccination approaches, recombinant S. cerevisiae, P. 
pastoris, Sz. pombe, and K. lactis expressing either full-length Ova, which is destined 
for secretion, and a truncated version of this protein, Ovacyt, which lacks the internal 
secretion signal and remains intracellular, were used. Given that yeast cell-surface 
display is an attractive tool in vaccine approaches, as surface-anchored epitopes are 
stably maintained due to the rigid, thick cell wall architecture (Kim et al., 2010), a cell-
wall anchoring system, in which Ovacyt is exposed on the yeast cell surface of S. 
cerevisiae and P. pastoris as Sed1p fusions was also tested. The presence of Ovacyt in 
the cell wall of K. lactis and Sz. pombe could not be detected (data not shown). No data 
was found in the literature showing the functionality of Sed1p from S. cerevisiae in K. 
lactis, and this type of anchoring system is likely to be inefficient in Sz. pombe due to its 
particular cell wall composition. K. lactis was transformed with another Sed1p-
containing fusion protein, but the presence of the recombinant protein on cell surface 
was again undetectable (data not shown), indicating that the foreign protein was not the 
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cause of the anchoring failure. Cell-surface display of a recombinant protein (α-
galactosidase) as α-agglutinin fusion has been described for K. lactis (Schreuder et al., 
1996b), but to date no other GPI-anchoring system has been reported for this species. 
Expression levels of cytosolic, secreted, and cell wall-anchored Ova varied 
drastically among the yeast genera tested in the present study. However, it is difficult to 
directly compare productivity between different yeast genera, since each expression 
system has its particularities and variations in plasmid copy number and stability, as 
well as codon bias index, influence recombinant protein levels (Buckholz and Gleeson, 
1991). 
In relation to the surface-display of Ova in S. cerevisiae and P. pastoris, it was 
observed that, although cell-surface expression could be detected by 
immunofluorescence and flow cytometric analyses, it was heterogeneously distributed 
over the cell population. This observation has been repeatedly reported for S. cerevisiae 
(Schreuder et al., 1993; Schreuder et al., 1996a; Breinig and Schmitt, 2002; Feldhaus et 
al., 2003, Kim et al., 2010). In one study, it was hypothesized that this staining pattern 
could be attributed to variations in plasmid copy number and expression levels among 
individual cells, or even to differences in cell physiology (Kim et al., 2010). Another 
reason for the observed uneven distribution of cell surface expressed proteins could be 
the polarized growth and varying morphology in yeast, so that mother cells do not 
express the fusion on their cell walls (Feldhaus et al., 2003). 
Fusion of Ovacyt to Gag led to the formation of abundant VLP which were 
homogeneous in size and shape, as confirmed by electron microscopy. Unfortunately, S. 
cerevisiae expressing Gag/Ovacyt VLP could not be analyzed in the T-cell activation 
assay so far. However, this very promising approach can be useful in future 
applications. Crisci et al. (2009) reported that VLP from rabbit hemorrhagic disease 
virus delivering the Ova SIINFEKL epitope led to the induction of specific cytotoxic 
and memory T cells responses. Moreover, mice immunized with these chimeric VLP 
could resolve infection caused by a recombinant vaccinia virus expressing Ova (Crisci 
et al. 2009). These findings reaffirm the potential of VLP in vaccination approaches. 
Activation of Ova-specific CD8+ T lymphocytes, determined by the amount of 
released IFN-γ in supernatants, was also very variable among the yeast genera used. The 
data from this work suggest that the most efficient antigen loading strategy by S. 
cerevisiae and P. pastoris is cytosolic and cell surface bound antigen delivery, 
respectively. In contrast, secreted Ova caused only a weak activation of lymphocytes in 
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S. cerevisiae and hardly any in P. pastoris. This latter finding was unanticipated, 
because in vitro activation of antigen-specific T cells after delivery of proteins secreted 
by gram-positive bacteria has been demonstrated (Ikonomidis et al., 1994; Pan et al., 
1995; Soussi et al., 2000; Loeffler et al., 2006). Furthermore, protein secretion most 
likely still occurs in macrophage phagolysosomes (as shown by western blotting after 
cultivating yeasts for 8 h in acetate-containing medium), indicating that the lack of 
lymphocyte activation observed in this case was not related to the absence of Ova in 
macrophages. A significant amount of protein, however, might be subsequently 
degraded in phagolysosomes and thus become unavailable for subsequent cytoplasmatic 
antigen processing steps. In contrast, antigen bound to the cell wall or antigen residing 
in the cytoplasm of the yeast cell might be more efficiently protected from degradation 
and thus be more efficiently cross-presented. 
Cell-surface displayed Ova caused lymphocyte activation only when P. pastoris 
cells were used in the assay, and it proved to be better than cytosolic Ova at the highest 
MOI tested in this species. This observation confirms data from Howland and Wittrup 
(2008), who compared the cross-presentation of an antigen derived from the human 
cytomegalovirus phosphoprotein pp65 displayed on the cell-surface (as Aga2-fusion) or 
intracellularly expressed in S. cerevisiae. They concluded that antigen exposed on the 
yeast external surface, more accessible to proteases, is more efficiently cross-presented 
than antigen trapped inside the yeast cell wall, after observing that cross-presentation of 
the epitope expressed in the yeast cytoplasm by DCs was half of that from surface-
anchored antigen, although the expression level of the recombinant peptide was much 
higher in the cytosol than on the cell surface. Thus, this seems also true for Pichia 
pastoris. However, the very weak T cell activation after cell-surface expression in S. 
cerevisiae, in particular compared to the intracellular derivative, is somehow surprising 
and is not consistent with the hypothesis of Howland and Wittrup. In this respect, both 
the slightly higher antigen amount in the cell wall of Pichia and the higher number of 
Ova-expressing cells within the population in comparison to S. cerevisiae could play a 
role. Alternatively, this observation may be explained by differences in the type of cell 
wall protein used for cell wall targeting. Whereas the Ovacyt/Sed1p fusion used in our 
study is covalently linked to and embedded in the cell wall, Howland and Wittrup 
anchored their antigen via disulfide bonds to the yeast cell surface allowing the antigen 
to be released under reducing conditions. 
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The differences in T cell activation seen in this study can be attributed to many 
distinct factors. For example, it might be related to the levels of recombinant protein 
expressed by each yeast clone. However, it is not clear whether higher levels of antigen 
in a specific compartment necessarily lead to an increase in antigen-specific 
lymphocytic activation. For example, S. cerevisiae expressed 1.4 fold more Ovacyt than 
P. pastoris, but the level of IFN-γ in the culture supernatant after lymphocytic activation 
was about 12.5 fold greater at MOI 7 in the case of the budding yeast, which suggests 
that other factors, like the particular composition of the yeast cell wall, might also be 
involved. MHC I-presentation of a certain CTL epitope in infected cells is affected, 
among other factors, by the degradation rate of the antigen in the cytoplasm and the 
efficiency with which the peptide is processed from the antigen by cellular proteases 
(Sijts et al., 1996). Ovalbumin contains a single disulphide bridge between Cys73 and 
Cys 120 (Nisbet et al., 1981), whose lack results in a less stable and more fluctuating 
protein conformation in comparison to intact Ova (Ishimaru et al., 2011). Given that in 
the Ovacyt coding sequence the fragment encoding amino acids 20-145 is missing, 
degradation of Ovacyt might be somehow easier, contributing to better antigen 
processing and presentation, which is in agreement with the results observed so far. This 
diminished stability of Ovacyt could also explain the lower levels quantified for this 
protein in comparison to secreted Ova after the same expression period. Lower Ovacyt 
levels in comparison to secreted Ova have been reported as being the result of its greater 
proteolysis and consequently shorter half-life (Shen and Rock, 2004; Rowe et al., 
2006). 
A multitude of studies showing the use of whole yeast as vaccine vehicles 
expressing recombinant proteins intracellularly (Stubbs et al., 2001; Lu et al., 2004; 
Barron et al., 2006; Haller et al., 2007; Riemann et al., 2007; Wansley et al., 2008; 
Remondo et al., 2009; Tanaka et al., 2011) or on the cell surface (Schreuder et al., 
1996a; Wadle et al., 2006; Zhu et al., 2006; Kim et al., 2010) have been reported. 
Nevertheless, almost all of them employ the conventional yeast S. cerevisiae as carrier 
system. In this study, all species tested proved to be appropriate for delivering 
intracellularly expressed Ova, although the efficiency of antigen presentation varied. 
Delivery of cell surface-anchored Ova was more effective in P. pastoris than in S. 
cerevisiae, and none of these yeasts showed to be efficient at delivering secreted Ova. 
Bacterial delivery has also been used in immunologic approaches. The 
microorganisms used for such strategies, including Listeria, Salmonella and Yersinia, 
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are generally attenuated or contain a suicide gene that promotes bacterial destruction 
(Husseiny and Hensel, 2005; Wiedig et al., 2005; Loeffler et al., 2006). However, 
application of bacteria into a mammal usually implies unpredictable side effects that can 
only be seriously examined in large clinical trials (Pálffy et al., 2006). The use of non-
pathogenic yeasts is therefore safer, and the benefits of using eukaryotic microbes, 
which can express a recombinant polypeptide in a manner that closely resembles the 
native protein, should also be taken into consideration. 
Until now there is no study comparing the efficiencies of different yeast genera 
routinely used in biotechnology as protein delivery vectors on the activation of antigen-
specific lymphocytes. Data from this work show that, besides S. cerevisiae, three 
additional yeast genera with biotechnological importance are able to deliver a protein 
antigen to mammalian antigen-presenting cells and to subsequently activate specific T 
cells, providing usefull basic knowledge for the design of superior yeast-based 
vaccination vectors. However, since peptide sequence per se has been described to exert 
influence on the efficiency of antigen presentation (Sijts et al., 1996), the most 
convenient approach for a specific therapeutic purpose has to be evaluated individually. 
 
 
5. Expression of pp65 by different yeast strains and activation of pp65-specific 
memory T lymphocytes in HCMV-seropositive donors 
Some advantages in choosing HCMV as model virus are that host specificity can be 
simply verified, validating the experiment (Suni et al., 1998) and that pp65-specific T 
cells are highly prevalent among HCMV-seropositive induviduals (Kern et al., 2002). 
The decision to use the entire pp65 protein instead of single CD4+ and CD8+ epitopes 
was based on the fact that some HCMV-seropositive individuals do not respond to some 
dominant epitopes, and response to subdominant or unpredicted epitopes might also 
occur (Solache et al., 1999, Kondo et al., 2004). Furthermore, immunodominant 
epitopes from viral proteins frequently undergo mutations in vivo, reducing their 
efficacy as therapeutic target (Bertoletti et al., 1994; Solache et al., 1999). Therefore, 
use of an entire polypeptide may provide a wide spectrum of epitopes deriving from the 
referred protein, increasing the odds that epitopes relevant for the MHC repertoire from 
a certain individual will be presented (Bui et al., 2010). The HCMV pp65 tegument 
protein is a good vaccine candidate, since it resembles an immunodominant antigen for 
T cells, and 70-90% of all CTL which are able to recognize HCMV-infected cells are 
                  Discussion 
 
  179 
specific for pp65 (McLaughlin-Taylor et al., 1994; Beninga et al., 1995; Wills et al., 
1996; Kern et al., 2002). 
 Thus, full-length pp65 was used for recombinant expression in different yeast 
genera, which were subsequently tested for their ability to deliver pp65 in an ex vivo 
assay. Recombinant pp65 could be detected in cell lysates of Sz. pombe, P. pastoris and 
S. cerevisiae, but not in K. lactis. A number of K. lactis transformants grown in 
selective medium and positive for the presence of integrated pp65 was tested under 
varying inducing conditions, however with no success. Some protease-deficient strains 
of K. lactis were also analyzed (YCT 389, YCT390, YCT569, YCT598, New England 
Biolabs), but the presence of pp65 in cell lysates could not be detected, indicating that 
the protein was either expressed under the detection level, or rapidly degraded or not 
expressed at all (data not shown). 
The fact that pp65 could not be secreted into the culture medium by Sz. pombe, 
P. pastoris and S. cerevisiae might suggest that this protein is somehow not properly 
processed in the secretory pathway. Cytoplasmic retention of recombinant proteins that 
were engineered to be secreted has been reported (Emr et al., 1984; Chaudhuri and 
Stephan, 1995). As a consequence to this problem, cell wall-anchoring of whole pp65 
also turned out inviable. Recombinant full-length pp65 expression in yeast has only 
been demonstrated in Sz. pombe (Breinig et al., 2003). In contrast, successful expression 
of pp65 epitopes in the cytoplasm or even on the cell surface S. cerevisiae as Aga2-
fusion has recently been reported (Powilleit et al., 2007; Howland and Wittrup, 2008). 
Whole recombinant yeasts expressing the HCMV pp65 matrix protein in the 
cytosol were assessed for protein delivery efficiency in a whole blood assay. It has been 
shown that full-length pp65 expressed in fission yeast or a fragment containing the 
major pp65 epitopes alone or in combination with Gag expressed in S. cerevisiae could 
elicit specific cellular immune responses, with higher frequencies of CD8+ than CD4+ T 
cells (Breinig et al., 2003; Powilleit et al., 2007). 
 It has also been reported that yeasts are rapidly internalized by blood phagocytes 
and efficiently processed for presentation to CD4+ and CD8+ T lymphocytes (Breinig et 
al., 2003; Heintel et al., 2003). In relation to pp65, antigen-specific memory CD4+ T 
cells were stimulated by untreated and heat-treated pp65-expressing cells of S. 
cerevisiae, Sz. pombe, and P. pastoris. Significant IFN-γ expression by pp65-specific 
CD8+ T lymphocytes was detected after incubation with untreated and heat-treated Sz. 
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pombe and heat-treated P. pastoris, whereas in S. cerevisiae neither untreated nor heat-
treated cells caused any significant activation. 
 Heat treatment was particular advantageous for P. pastoris, in terms of both 
CD4+ and CD8+ T cell responses. In the case of S. cerevisiae, pp65-specific CD4+ 
responses were more pronounced after heat treatment, whereas CD8+ responses were 
lower for heat-treated yeasts, but the relation pp65/empty plasmid was higher in 
comparison to untreated cells of S. cerevisiae. For Sz. pombe, lower frequencies of 
activated lymphocytes were observed when cells expressing pp65were heat-treated, 
however the ratio pp65/empty vector was higher after heat treatment. This means that 
lower responses to the yeast vehicle were detected after heat treatment. Since T cell 
responses to yeasts is uniquely based on the recognition of epitopes derived from cell 
wall proteins (Heintel et al., 2003), mannosyl rather than glucosyl residues should play 
the most important role. Upon heat treatment, the β-glucan layer turns out to be densely 
and homogeneously exposed on yeast cell surface, possibly masking mannoproteins 
from being promptly processed and presented by APCs after yeast uptake. T cell 
activation caused by C. albicans supports this hypothesis. Heintel et al. (2003) showed 
that T cell responses to the unicellular form of C. albicans were poor, in contrast to the 
robust responses directed against the hyphal form. Since β-glucan is not functionally 
accessible on Candida filaments (Gantner et al., 2005), it is tempting to speculate that 
mannoproteins dictate the activation of memory T cells. For this reason, yeasts alone 
subjected to incubation at 65°C caused a lesser extent of lymphocyte activation than 
untreated yeasts. 
When S. cerevisiae-delivered Gag/pp65 was analyzed, significant activation of 
both CD4+ and CD8+ T lymphocytes was observed, and IFN-γ levels were much higher 
than those caused by pp65 expression in the same yeast strain, although the amount of 
delivered protein was practically the same. This observation is in agreement with other 
reports, in that particulate antigens are highly efficient in inducing robust immune 
responses (Powilleit et al., 2007; Crisci et al., 2009). This fact can be attributed to the 
repetitive occurrence of epitopes and the particulate structure of VLP, which favour 
uptake by phagocytic cells (Fifis et al., 2004; Grgacic and Anderson, 2006). It has been 
shown that internalization of yeast-derived VLP by DCs occurs via macropinocytosis 
and receptor-mediated endocytosis involving mannose-recognizing receptors, though 
not the mannose receptor (Tsunetsugu-Yokota et al., 2003). 
                  Discussion 
 
  181 
Although electron microscopy of pp65 N-terminally fused to Gag revealed the 
presence of only a few particles, which were heterogeneous in size and shape (maybe 
due to the large size of pp65), the fusion protein nevertheless was more efficient in 
stimulating pp65-specific memory T lymphocytes than pp65 alone. Heat treatment was 
slightly beneficial for CD4+ responses, and exactly as observed for S. cerevisiae 
carrying unfused pp65, CD8+ responses were a little lower for the heat-treated yeasts, 
but the relation Gagpp65/Gag was higher in the heat-treated yeasts. VLP have 
repeatedly proven their potential as vector for vaccination and demonstrated to be 
powerful CTL inducers compared to adjuvants and/or live recombinant vectors (Allsopp 
et al., 1996; Crisci et al., 2009). For this reason, strategies combining whole yeasts and 
VLP as antigen carrier should be an prospective attempt. 
Responses to the HCMV lysate were notedly higher than any condition using 
yeast. However, this lysate contains all HCMV proteins and, consequently, a large 
variety of CD4+ and CD8+ T cell epitopes available for antigen presentation. 
 Frequencies of specifically activated memory T lymphocytes were higher for 
CD4+ cells than for CD8+ cells in all samples analyzed, which is consistent with 
previous observations (Suni et al., 1998; Sester et al., 2001). In the case of HCMV, the 
frequency of CD8+ T cells fluctuates significantly, whereas the frequency of the CD4+ T 
cell population is more stable. In addition, CD4+ T cells are considered more important 
than CD8+ T cells in terms of disease prediction (Sester et al., 2001). 
 The lower frequencies of CD8+ T lymphocytes observed in this work may also 
result from the presence of Brefeldin A, which has been described to inhibit MHC class 
I-restricted presentation of some protein antigens (Yewdell et al., 1989; Brossart and 
Bevan, 1997). Although contradictory effects have been observed, the pathway through 
which antigens are presented in the context of MHC class I seems to play a critical role 
in Brefeldin A sensitivity. Antigens processed by the phagosome-to-cytosol pathway are 
loaded onto newly synthesized class I MHC molecules prior to their egress from the 
trans-Golgi complex. Brefeldin A hinders vesicular exit from the ER and Golgi, 
blocking the presentation of peptide-MHC I complexes (Yewdell et al., 1989; 
Kovacsovics-Bankowski and Rock, 1995; Brossart and Bevan, 1997). The vacuolar 
pathway seems to be Brefeldin A-insensitive (Harding and Song, 1994; Pfeifer et al., 
1993), since peptides associate with recycling class I molecules in phagocytic vacuoles 
or after “regurgitation” and recapture of processed antigens (Harding and Song, 1994; 
Norbury et al., 1995). Tabi et al. (2001) showed that DCs cocultured with HCMV-
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infected fibroblasts led to CD8+ T cell responses to pp65, but CD8+ T cell stimulation 
was inhibited if DCs were pretreated with Brefeldin A, indicating a phagosome-to-
cytosol pathway. However, since the characteristics of the antigen might influence the 
pathway involved (Norbury et al., 1995), it is not possible to state whether Brefeldin A 
affected to any extent the results observed in the present work. 
 Low-level responses towards the yeast vehicle alone were sometimes observed, 
with varying extents among the donors and the yeast genera, but in all cases frequencies 
of activated lymphocytes were below 0.4%. In a study performed by Heintel et al. 
(2003), frequencies of yeast-specific memory T cells were determined using whole 
blood from five individuals. Activation of T lymphocytes was verified for most yeast 
genera, with frequencies up to 0.5% for CD4+ T cells and up to 6.4% for CD8+ T cells, 
depending on both the donor and the yeast species (Heintel et al., 2003). Despite some 
detectable response to the yeast carrier, frequencies of activated CD4+ and CD8+ cells 
were always higher for pp65-containing yeasts in the HCMV-seropositive donors, 
indicating host specificity. 
 Surprisingly, and in contrast to reports of Breinig et al. (2003), ethanol-
precipitated total yeast extracts from cells expressing pp65, including Sz. pombe, were 
not able to sufficiently activate pp65-specific memory T lymphocytes. However, since 
pp65-specific memory T cell activation shows great variability among individuals (Kern 
et al., 2002; Breinig et al., 2003; Powilleit et al., 2007), and giving that the donors 
analyzed in that study were different from those examined in this work, a direct 
comparison is not possible. 
In this work, delivery of pp65 by yeasts was also analyzed by means of an 
autologous system, i.e., a method in which DCs from HCMV-seropositive individuals 
are isolated, incubated for 48 h with yeasts and then given autologous lymphocytes. 
However, despite many attempts, only poor CD4+ and CD8+ T cell activation could be 
observed, and this method proved to be less effective than the whole blood assay. Suni 
et al. (1998) compared frequencies of antigen-specific activated T cells in whole blood 
samples and isolated PBMC in autologous plasma. Since whole blood preparations 
resulted in higher responses, they hypothesized that, within the 6 h incubation time, 
whole blood cultures form an upper band of PBMC over a layer of red cells, probably 
promoting a more physiological millieu to respond to stimuli. This sedimentation 
pattern might also provide improved cell-cell interactions within the PBMC population, 
not influenced by the lower layer of red blood cells (Suni et al., 1998). 
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Significant activation of pp65-specific memory T lymphocytes after incubation 
with pp65-expressing yeasts, determined by means of both whole blood assay and 
autologous system, could not be detected for some HCMV-seropositive individuals. 
One possible explanation for this fact is that some HCMV-seropositive persons lack 
pp65-specific memory lymphocytes, as it has been reported by others (McLaughlin-
Taylor et al., 1994; Kern et al., 2002). According to Kern et al. (2002), this lack of 
pp65-specific T lymphocytes in peripheral blood alone does not mean absence of 
protection from HCMV disease. In that study, they analyzed 40 healthy HCMV-
exposed donors and 12.5% of them had no T cell response to peptides derived from 
pp65. These individuals were not sick, and HCMV reactivation presumably occured as 
often as in other healthy individuals (Kern et al., 2002). 
 In sum, all three yeast species (S. cerevisiae, Sz. pombe, and P. pastoris) 
carrying pp65 were able to deliver the antigen, and the activation of pp65-specific 
memory lymphocytes observed indicates that recombinant pp65 probably mimics the 
native antigen in terms of recognition by the host. 
 
 
6. Effect of heat treatment of yeast on β-glucan exposure and ROS production in 
whole blood 
“ROS” include several oxygen species, such as singlet oxygen, hydroxyl radical, 
superoxide and hydrogen peroxide. In most cell types, ROS influence signaling 
pathways in different manners (Fialkow et al., 2007). Production of ROS (respiratory 
burst) by phagocytes, a process mediated through the NADPH oxidase, is considered a 
major mechanism of defense against fungi. A number of PRRs can elicit the respiratory 
burst, such as Dectin-1, TLRs and Fcγ receptors (Brown, 2011). 
According to previous studies, heat-treated C. albicans and S. cerevisiae expose 
more β-glucan at the cell surface than untreated cells (Fradin et al., 1996; Gantner et al., 
2005). Gantner et al. (2005) observed that most β-glucan in the yeast cell wall is 
inaccessible to Dectin-1 and that β-glucan is exposed only in certain subdomains such 
as birth and bud scars. Upon heat treatment, matricial cell wall components are released 
(Fradin et al., 1996), bringing β-glucan uniformly to the outer layer and consequently 
increasing the chance of phagocyte sensing through β-glucan receptors. 
The effect of heat treatment on β-glucan exposure in S. cerevisiae, K. lactis, Sz. 
pombe, and P. pastoris was analyzed by flow cytometry. All three budding yeasts 
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examined showed more than a two-fold increase in mean fluorescence after incubation 
at 65°C, indicating that heat treatment indeed enhances the amount of cell-wall exposed 
β-glucan. In contrast, this could not be observed in fission yeast, which showed even a 
slight reduction in mean fluorescence intensity. This observation was surprising, 
because although linear β-1,3-glucan is not found on the cell wall, it can be found in the 
primary septum of Sz. pombe (Humbel et al., 2001), so that at least a discrete increase in 
fluorescence would have been expected. However, the architecture of the cell wall in 
fission yeast might, for some reason, not allow significant β-glucan exposure upon heat 
treatment. 
Untreated and heat-treated yeasts were then incubated with whole blood for 
determination of ROS production. Since recognition of β-glucan by Dectin-1 leads to 
the generation of ROS (Gantner et al., 2003), it was reasonable to suppose that yeasts 
subjected to heat would be more effective in eliciting ROS production due to augmented 
ligand availability. In fact, this was true for S. cerevisiae, K. lactis and P. pastoris. 
Noteworthy, the amount of ROS was lower when blood phagocytes were incubated with 
heat-treated Sz. pombe cells in comparison to untreated cells. Again, this result was 
unexpected, since the cell surface of this yeast contains β-1,6-branched β-1,3-glucan, 
which is also a target for Dectin-1 (Humbel et al., 2001; Adams et al., 2008; this work), 
so that at least a similar kinetic pattern of ROS production would have been expected 
for untreated and heat-treated fission yeast cells. These observations indicate that heat 
treatment may alter the distribution of cell wall components in Sz. pombe in a different 
fashion than in budding yeasts. 
 A series of pre-clinical and clinical studies has resorted to the use of heat-
inactivated yeasts as protein delivery vectors, thus reducing the possible risks involved 
in using live cells, particularly in immunocompromised individuals (Lu et al., 2004; 
Franzusoff et al., 2005; Ardiani et al., 2010). Experiments employing either untreated or 
heat-treated yeasts have proven to be effective in terms of protective immunity (Stubbs 
et al., 2001; Franzusoff et al., 2005). Results from the whole blood assays performed in 
this work showed that heat treatment was beneficial in some cases, such as when P. 
pastoris was used as vector, but not always, as when Sz. pombe cells delivered the 
antigen. This fact indicates that the choice for such treatment should take into 
consideration the cell wall features of the yeast species being used in the specific 
approach. Nonetheless, a higher number of assays would have to be performed in order 
to confirm this hypothesis. 
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7. Immunization of OT-I transgenic mice with whole recombinant yeasts 
Initiation of immune responses after vaccination depends on several factors, such as 
antigen dose, form of administration, antigen access to processing pathways, co-
stimulation and cytokine milieu at the moment of antigen capture and presentation 
(Rush et al., 2002). 
 OT-I mice constitute an important model system for in vivo approaches. 
Analyses with mice bearing TCR-transgenic T cells eliminate the problem of low 
frequency of antigen-specific T cells and allow the isolation and quantitation of T cells 
as well as the determination of in vitro and in vivo antigen-specific responses 
(Miyagawa et al., 2010). In an attempt to examine CD8+ T cell responses after 
administration of yeast expressing Ovacyt to mice, an immunization protocol was 
established based on literature data, especially on Riemann et al. (2007). However, and 
in contrast to other works, yeasts were not heat-treated or frozen, but lyophilized to 
facilitate shipment. Since the majority of the studies published so far describing 
immunization approaches using yeast employ S. cerevisiae W303, this strain was also 
used for this experiment. Protocoll optimization and utilization of other yeast genera, as 
well as of a higher number of mice could no longer be performed in this work. 
 Splenic CD8+ T lymphoctes from mice vaccinated with S. cerevisiae carrying 
Ovacyt restimulated with OVA257-264 peptide were able to produce IFN-γ. Yeasts alone 
also stimulated OVA-specific CD8+ T lymphocytes, although to a lesser extent, still the 
difference between both conditions was not significant. Spleen CD8+ T lymphoctes 
restimulated with PMA/ionomycin showed the highest levels of IFN-γ, but the 
difference among the groups was even more discrete. Since PMA and ionomycin are 
potent inducers of cytokine production (Picker et al., 1995), lymphocytes were strongly 
and non-specifically activated, so that eventual subtle differences among experimental 
groups could have been masked. Inguinal lymph node cells were stimulated only with 
PMA/ionomycin due to the low number of recovered cells, and activation of CD8+ T 
lymphocytes from mice immunized with yeasts carrying Ovacyt was even lower than in 
the PBS control group. This latter result was unexpected, since most of the 
subcutaneously administered yeasts are taken up by monocyte-derived inflammatory 
DCs (or, to a lesser extent, by skin-derived DCs) and then transported to draining lymph 
nodes (Ersland et al., 2010). However, Wang et al. (2003) demonstrated that non-self 
peptides, including SIINFEKL, led to the generation of higher responses in the spleen 
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than in draining lymph nodes after s.c. immunization of mice with antigens mixed with 
adjuvant or pulsed on DCs. 
 Particulate antigens are efficiently cross-presented in vivo and are likely to 
stimulate robust CTL responses. Particles larger than 1 µm are taken up by 
phagocytosis. The higher efficiency with which particulate antigens are cross-presented 
in comparison to soluble antigen arises from the fact that (i) the amount of antigen 
internalized by phagocytosis is much greater than when soluble proteins enter APCs by 
fluid-phase pinocytosis, and (ii) antigens internalized by phagocytosis are thought to 
access the cross-presentation pathway more efficiently (reviewed by Rock and Shen, 
2005). Since yeast carrying Ovacyt is also a form of particulate antigen, cross-
presentation would be expected to occur, also when the antigen amount was not very 
high. 
 Despite the existence of several studies showing yeast as antigen carrier in 
immunization experiments, there is no data about IFN-γ production by antigen-specific 
CD8+ T lymphocytes, which might reflect the complexity of this type of analysis. 
However, the results obtained after incubation of spleen cells with Ova(257-264) peptide 
indicate that yeasts were internalized and Ovacyt-derived SIINFEKL could be processed 
for cross-presentation to CD8+ T lymphocytes. The low lymphocyte activation observed 
after restimulation of splenocytes with Ova(257-264) peptide was most probably not due to 
the presence of Brefeldin A, since it has been shown that DC treatment with this 
substance had no influence on presentation of exogenously added SIINFEKL (Brossart 
and Bevan, 1997). Western blot analysis of the yeasts used in this immunization 
protocol revealed low expression of Ovacyt (approximately 17 ng in 5×107 cells, data not 
shown), which might have difficulted the detection of more significant responses. 
Nevertheless, proliferation of CD8+ T lymphocytes in response to Ova has been 
demonstrated with as little as 0.2 ng antigen when delivered in a cell-associated form 
(Li et al., 2001). Maybe determination of the frequency of IFN-γ-producing cells is not 
a very sensitive method to detect CD8+ T cell responses when the antigen amount is 
low, so that analysis of T cell proliferation would, for example, represent an alternative 
method for such immunization experiments. 
 Nevertheless, these experiments clearly show the potential of whole, live yeast 
as antigen carrier and suggest that protocol optimization would most probably result in 
more convincing results. Moreover, the use of other yeast genera as examined 
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throughout this work could lead to the establishment of novel whole yeast-based 
vaccines. 
 
 
8. Perspectives 
Approaches using yeasts as vaccine vehicle exhibit a vast number of advantages over 
other carrier systems, and this field of research has made significant progress in the past 
decade. However, many issues remain to be explored or more profoundly investigated. 
In this work, the potential of different yeast genera as antigen carrier could be 
successfully demonstrated, as well as their ability to activate antigen-specific T cells. 
However, additional experiments, in particular involving in vivo models, are required in 
order to enable the establishment of more effective yeast-based antigen delivery 
systems. 
 With respect to the cytokines secreted by stimulated DCs, the T cell-biasing 
profile could probably be more clearly identified by analyzing a higher number of 
donors. Furthermore, the presence of IL-4 in the culture medium to induce 
differentiation of monocytes into DCs made it difficult to determine the amount of IL-4 
secreted by DCs. Consequently, it was not possible to ascertain if DC activation by 
some of the stimuli tested would result in the priming of TH2 cells. Repeated cell 
washings and resuspension in fresh medium depleted of cytokines would likely allow a 
more reliable IL-4 determination. 
 Recombinant protein expression in yeast could be optimized by altering distinct 
parameters. For example, gene optimization taking into account the codon usage bias of 
each yeast species and use of expression vectors that enable multi-copy integration into 
the yeast genome would most probably lead to higher protein yields. Additionally, 
different anchors for cell-surface expression could be tested in an attempt to identify the 
most effective anchoring system for a particular yeast species. 
 The shortcomings in the delivery of secreted Ova might have been a result of 
the extremely high stability of this protein. To test this hypothesis, ovacyt could be 
cloned downstream of a proper signal sequence for recombinant secretion in yeast. If 
antigen presentation was detected after delivery of secreted Ovacyt, a rather unstable 
Ova derivative, it would be in agreement with the assumption that highly stable proteins 
are lesser available for processing and presentation by virtue of their diminished 
degradation. In an immediate future, this finding could be helpful in terms of choosing 
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the most adequate protein variant to be delivered. However, the limited availability of T 
cell lines specific for a particular epitope restrains the applicability of such in vitro 
antigen presentation assays. 
 In relation to in vivo approaches involving recombinant yeasts, immunization 
schedules for the different yeast genera delivering all Ova derivatives (including Ova 
VLP) should be established. In this context, a higher number of yeast cells per injection 
and a higher number of mice per group, as previously suggested, should be employed. 
Furthermore, assessment of T cell proliferation would probably be a more appropriate 
method to verify T cell responses. Resorting to this technique, in which CFSE-labeled 
transgenic OT-I T cells were injected in mice which were then primed 1 day later with 
Ova, Li et al. (2001) could detect proliferation of OT-I cells in response to cell-
associated Ova even when the antigen amount was as low as 0.2 ng/mouse. Moreover, a 
number of immunization strategies should be evaluated, such as the use of different 
yeast genera, distinct subcellular antigen localizations and antigen-loaded VLP. Also, 
the results from the whole blood assays performed in this work support the use of heat-
treated yeasts in immunization approaches. One drawback is that, in the case of antigens 
designed to combating viral infections in humans, suitable animal models are frequently 
scarce, hampering the onset of several vaccination studies. 
 An ideal therapeutic vaccine should also stimulate the generation of CD4+ T 
helper responses, since TH cells can further promote the generation and proliferation of 
potent CTL responses via release of immunomodulatory cytokines (Ardiani et al., 
2010). Since different yeast species can trigger the secretion of a different set of 
modulatory cytokines, analyses of both CD4+ and CD8+ T cell responses should be 
considered in yeast-based immunization approaches. 
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VI. SUMMARY 
 
 
Yeasts represent promising vaccine vehicles and have been demonstrated to elicit robust 
innate and adaptive immune responses. Nonetheless, the vast majority of studies 
employing yeast as delivery system has so far been restricted to S. cerevisiae. 
Nowadays however, an additional set of yeast genera of biotechnological relevance is 
available which could be tested as potential antigen carrier. Therefore, in the present 
study, different yeast genera were assessed for APC activation and antigen delivery 
aiming at the stimulation of antigen-specific T cells. 
 
Distinct yeast genera, species, strains and mutants were able to induce maturation of 
human DCs, as analyzed by the upregulation of various cell-surface markers, including 
costimulatory, adhesion and MHC molecules, as well as a major chemokine receptor. In 
general, the diverse fungal stimuli differently triggered DC maturation, and to different 
extents than bacterial and viral stimuli. Yeasts also promoted cytokine secretion by 
human DCs, and cytokine levels differed among genera in most situations. As observed 
for the cell-surface molecules, the nature of the stimulus (bacterial, fungal, viral) led to 
DC activation in different ways. Importantly, all yeasts tested promoted release of TH1-
type cytokines such as IL-12 and IFN-γ, demonstrating that different yeast genera bear 
the potential to function as efficient carrier for activation of naïve T cells in antigen 
delivery approaches. 
 
Four biotechnologically relevant yeast genera (S. cerevisiae, P. pastoris, Sz. pombe and 
K. lactis) were assessed for interaction with mammalian phagocytic cells, such as 
human DCs and murine macrophages. Yeast phagocytosis was MR- and Dectin-1-
dependent in human DCs, and Dectin-1-dependent in IC-21 mouse macrophages. 
Furthermore, kinetic patterns of yeast internalization differed among budding and 
fission yeasts. 
 
In order to address the suitability of yeast as carrier for protein antigens, delivery of 
heterologously expressed Ova was investigated in a comparative study. Expression of 
recombinant Ova derivatives exhibited, in general, a great variation among yeast 
genera. S. cerevisiae, P. pastoris, Sz. pombe and K. lactis expressing full-length Ova 
(targeted to secretion) or Ovacyt (intracellular), as well as S. cerevisiae and P. pastoris 
expressing Ovacyt/Sed1p (cell-wall anchored) were assessed for antigen delivery by 
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means of an in vitro presentation assay. It could be shown that all yeasts tested varied in 
their ability to deliver protein antigens and, furthermore, that subcellular protein 
localization influenced the activation of antigen-specific CD8+ T cells. Cytosolic and 
cell-surface displayed Ovacyt were delivered by all yeast genera, albeit to different 
degrees, whereas secreted Ova led to slight lymphocyte activation in S. cerevisiae and 
P. pastoris. 
 
Yeasts were also genetically modified in order to express the clinically relevant 
tegument antigen pp65 from HCMV. Again, foreign protein expression was highly 
variable among yeast genera, and failed in K. lactis. Pp65 VLP were also recombinantly 
expressed in S. cerevisiae. Specific activation of pp65-specific memory CD4+ and CD8+ 
T cells from HCMV-seropositive individuals could be observed when heat-treated and 
untreated whole yeasts served as antigen vehicle in an ex vivo whole blood assay. T cell 
stimulation was specific, since no activation was detected in blood from HCMV-
seronegative donors and much lower responses against the yeast vectors were observed 
compared to yeasts carrying pp65. The extent of pp65-specific T-cell activation varied 
among yeast genera, and pp65 VLP were more effective than unmodified pp65 in S. 
cerevisiae. Further, heat-treatment of yeasts differently affected stimulation of T 
lymphocytes but showed, in general, a beneficial effect. The CD4+ T cell population 
exhibited a higher percentage of CD69+ IFN-γ+ cells in comparison to the population of 
CD8+ T cells in all cases analyzed. Also, detection of T cell activation by means of 
whole blood assay proved to be more advantageous than the method of T cell 
stimulation in an autologous system. 
 
Heat treatment affected the response of blood phagocytes towards S. cerevisiae, P. 
pastoris, Sz. pombe and K. lactis, as measured by the production of ROS. In the case of 
the budding yeasts, ROS production in response to heat-treated yeasts was higher than 
for untreated yeasts, but the opposite effect was observed in fission yeast. 
 
Finally, Ova-specific CD8+ T lymphocytes from OT-I transgenic mice immunized with 
S. cerevisiae carrying Ovacyt showed higher production of IFN-γ upon restimulation 
with an SIINFEKL peptide epitope than lymphocytes from mice receiving S. cerevisiae 
harbouring an empty vector or PBS only. This experimental procedure requires, 
however, further optimization. 
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